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This chapter gives an introduction to chirality and asymmetric catalysis. 
Recent trends in asymmetric hydrogenation with monodentate 


























1.1   Chirality 
1.1.1   Introduction to chirality 
Molecules are spatial structures of a collection of atoms. One of the 
most abundant atoms in nature is carbon (C). Carbon atoms in a molecule 
can possess four substituents. In 1874 Le Bell and Van ‘t Hoff proposed, 
independently, that the four substituents around a carbon atom are 
positioned in the corners of a tetrahedral structure.1 A consequence of this 
spatial arrangement is that there are two different forms possible if a 
carbon has four different substituents. These two different structures are 
mirror images and not superimposable. These molecules are called 
asymmetric or chiral (Greek; Χειρ (cheir) = hand). The two mirror images 










Figure 1.1: A pair of enantiomers: mirror images of a chiral molecule. 
1.1.2   Isomers 
Isomers are molecules with the same molecular formula but with 
different 3-dimensional structures (Figure 1.2). Two main classes of 
isomers can be distinguished; constitutional isomers and stereoisomers.2 
Stereoisomers can be divided in configurational and conformational 
isomers, where members of the latter class can be interconverted by 
rotation around a single bond. The former group can be subdivided in 
optical and geometric isomers. Enantiomers are part of the optical 
isomers, together with the diastereomers. As discussed before, 
enantiomers are mirror images of each other which are not 










atom. Diastereomers are chiral molecules which possess more than one 
stereogenic carbon atom. Almost all of the physical and chemical 
properties of enantiomers are identical,* which makes it difficult to 
distinguish between one and the other. On the other hand, diastereomers 
posses different physical and chemical properties, which makes it easier to 
differentiate them from each other.   
OH
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HO H HO H
HO H

















Figure 1.2: Classification of isomers. 
1.1.3   Chirality in daily life 
Chirality is an important aspect of life, since for 
example most natural α-amino acids occur only as 
a single enantiomer. Another striking example of 
the effects of chirality is the so-called Softenon 
                                                     

















(alias Thalidomide) (1) disaster. This medicine was administered to 
pregnant women in the beginning of the 1950’s to alleviate nausea and 
insomnia. The result was that many of these women gave birth to children 
with horrible birth defects. The cause of all these problems was that the 
medicine was administered as a mixture of the two enantiomers. Whereas 
one of the enantiomers alleviated the nausea and insomnia, the other 
enantiomer prevented the normal grow and development of the fetus. 
Recently Softenon has been in the centre of attention again. It was found 
that in combination with the steroid dexamethason, Softenon has a 
decelerating effect on multiple myeloma (a type of bone marrow cancer).3 
This example shows the importance of enantiomerically pure compounds.4 
1.2   Enantiomerically pure compounds 
 
Enantiomerically pure compounds can be obtained in three different 
ways (Figure 1.3). The first route makes use of chiral compounds which 
are obtained from agriculture or via fermentation, the so called ‘chiral 
pool’. These compounds can be used as obtained or modified without loss 
of the chiral information. The second route makes use of racemates i.e., a 
1:1 mixture of enantiomers. Separation of these racemates by resolution 
can be done in two ways.5 Crystallization is still the most used method in 
industry to obtain enantiomerically pure compounds.6 A racemate is 
derivatized with another chiral compound (auxiliary), so that 
diastereomers are formed, which can be separated by crystallization. 
Removal of the auxiliary gives the enantiomerically pure compound.  
In a kinetic resolution, a racemate is modified by chemical or 
enzymatical conversion. In a kinetic resolution one of the enantiomers of 
the racemic mixture will be transformed into a product faster than the 
other. In an ideal case the reaction stops after 50% of conversion and only 
one of the enantiomers is completely converted and the other one did not 
react at all. In a dynamic kinetic resolution one of the enantiomers is 
transformed into the product, whereas the remaining enantiomer 
racemizes. This racemic mixture undergoes a resolution again until all the 
starting material has been consumed. This can lead in an optimal case to 










The third route makes use of prochiral substrates which can be 
transformed into enantiomerically pure compounds by an asymmetric 
synthetic modification. The asymmetric synthesis can be performed in 
different ways i.e., using a chiral auxiliary7 or applying catalysis.8 In the 
case of a chiral auxiliary a chiral group is attached to the substrate. 
Introduction of an additional chiral centre will make the resulting product 
a diastereomer. In an ideal case the introduction of the additive 
stereogenic centre will be completely controlled by the chirality of the 
auxiliary and thus the reaction will be diastereoselective. Drawback of this 
method is that stoichiometric amounts of a chiral auxiliary have to be 
used, which have to be introduced and removed with two additional 
synthetic steps. 










Figure 1.3: Routes to enantiomerically pure compounds. 
A more elegant method is the application of catalysis, which is the main 
subject of this thesis. This method employs small amounts of a biological, 
e.g. antibodies or enzymes, or chemical catalysts to transform a prochiral 
substrate into large quantities of enantiomerically pure compounds. 
Biocatalysts are frequently highly specific for one substrate. In general, it 
is not possible to obtain both enantiomers of a product since usually only 
one of the enantiomers of a biocatalyst is available although recently 
directed enzyme evolution techniques have provided a solution to this 










(transition) metals modified with enantiomerically pure organic ligands, 
which makes it possible to obtain both enantiomers of the product by 
changing the configuration of the ligand. Asymmetric catalysis and more 
specific homogeneous asymmetric hydrogenations will be the central 
theme of this thesis. The next paragraphs will give an overview of these 
areas.  
1.3   Asymmetric catalysis 
 
Although a broad range of organocatalysts have been developed in 
recent years,10 (transition) metal catalysts are still the most abundantly 
used. The importance and elegance of homogeneous asymmetric catalysis 
was also recognized by the Nobel Prize Committee, who awarded the 2001 
Noble Prize in chemistry to Knowles, Noyori and Sharpless for their 
pioneering work on asymmetric hydrogenation and oxidation reactions.11 
The field of (transition) metal-catalyzed asymmetric synthesis has 
developed tremendously and a wide variety of reactions have been 
developed employing a range of transition metals, e.g. Pd, Rh, Ru, Ir, Cu 
etc.12 Homogeneous asymmetric hydrogenation is one of the most studied 
asymmetric catalysis reactions. An overview will be given in the next 
paragraph. 
1.4   Homogeneous asymmetric hydrogenation 
1.4.1   Asymmetric hydrogenations 
The field of homogeneous asymmetric catalytic hydrogenation has 
developed tremendously in the last 35 years. At the cradle of the 
development stand Knowles and Horner.13 Their ground-breaking work 
was based on a combination of earlier developments of Wilkinson and 
Horner.14 Wilkinson reported a soluble Rh-based hydrogenation catalyst 
for the hydrogenation of unhindered olefins i.e., [(PPh3)3RhCl], whereas 
Horner reported the discovery of methods to prepare optically active 
phosphines. Initial experiments on α-phenylacrylic acid (2) with chiral 










Although the enantioselectivity was modest, a principle was proven and a 








Scheme 1.1: Initial asymmetric hydrogenations by Knowles. 
Further optimization of the phosphine revealed that CAMP (L2) was a 
good ligand in the hydrogenation of α-amino acid precursors (Scheme 1.2). 
































95% e.e.  













The initial hypothesis that a chiral phosphorus centre 
was necessary to obtain good enantioselectivities was 
proven to be incorrect. Kagan et al. developed a new 
ligand based on tartaric acid, which had the chirality 
shifted from the phosphorus to the backbone.15 This new 
ligand, DIOP (L4), showed comparable results to CAMP 
(L2). 
These results made Knowles and co-workers at Monsanto develop an 
improved version of their P-chiral ligands, i.e. DIPAMP (L3). This bidentate 
ligand showed even better results in the hydrogenation of the L-DOPA (6) 
precursor and the industrial process was converted to use it (Scheme 1.2). 
 The shift of chirality from the phosphorus to the backbone made the 
synthesis of these ligands much easier and literally hundreds of ligands 
have been designed and tested in the following years.16 In the next decades 
it was assumed that bidentate ligands are a conditio sine qua non to reach 


















































1.5   Monodentate ligands in asymmetric hydrogenations 
 
The widely held view that bidentate ligands are essential for high 
enantioselectivity in the rhodium-catalyzed asymmetric hydrogenation was 
turned down in 2000. Three groups reported, independently, the use of 
monodentate phosphonites18, phosphoramidites19 and phosphites20 in the 
hydrogenations of several benchmark substrates. Since then numerous 
reports have appeared on the use of monodentate ligands in rhodium-
catalyzed hydrogenations.21 
1.5.1   Structure of monodentate ligands 
1.5.1.1   P-chiral22 monodentate ligands   
The initially developed monodentate ligands were P-chiral.23 The results 
of these ligands in the rhodium-catalyzed hydrogenation of dehydroamino 
acids varied from almost non selective up to 90% e.e. for CAMP (L2).11 
Often a tedious synthesis is needed to obtain these ligands in 
enantiomerically pure form. This, in combination with the fact that the 
chirality could be shifted to the backbone (see §1.4.1) and the paradigm 
that ligands should be bidentate in nature, made that only a limited 
number of monodentate P-chiral ligands have been reported in literature.  
A few examples are given in Figure 1.5. 
Ligands 13, based on a menthyl backbone, were 
tested in the chemo- and enantioselective 
hydrogenation of (E)-3,7-dimethyl-2,6-dienoic acid 
(geranic acid) (7).24 The e.e.’s were modest, with a 
maximum of 45% for L13a. On the other hand, the chemoselectivity was 
excellent. The only product observed was the product with the double 
bond next to carboxylic acid moiety reduced. Monodentate phosphines 
L14 and L15 led to modest enantioselectivities in the hydrogenation of N-
acetyl dehydrophenylalanine (8), 62% and 10%, respectively. These two 
ligands were more successful in palladium-catalyzed allylic substitution 
reactions, where up to 95% e.e. has been obtained.25 Reetz and co-workers 
recently introduced ligands L16-L19, based on a BINOL backbone bearing 













phosphite ligands were formed as diastereomer mixtures and had to be 
separated by preparative HPLC.27 Many of these ligands induced excellent 
e.e.’s (> 95%) in the hydrogenation of dimethyl itaconate (19) and N-acetyl 
dehydroalanine methyl ester, both in diastereomerically pure form as in 
mixtures of diastereoisomers. Secondary phosphine oxide ligands L20 
proved to be versatile ligands in rhodium- and iridium-catalyzed 
hydrogenations of a broad range of substrates.28 Enantioselectivities up to 
85% were obtained in the hydrogenations of for example imines and β-
branched dehydroamino acids (§1.5.3.1). 
R1
R2
L13a: R1 = (S)-PPh, Me R2 = H
L13b: R1 = (R)-PPh, Me R2 = H
L13c: R1 = H, R2 = (S)-PPh, Me







L16a: R = C(O)Ph
L16b: R = CH3






L20a: R1 = t-Bu, R2 = Ph
L20b: R1 = i-Pr, R2 = Ph
L20c: R1 = t-Bu, R2 = 2-naphthyl
L20d: R1 = t-Bu, R2 = 2-MeO-Ph
L20e: R1 = t-Bu, R2 = 3,5-di-Me-Ph
L20f: R1 = t-Bu, R2 = 2,4,6-tri-Me-Ph
L20g: R1 = Ph, R2 = 2-naphthyl
L18a: R1 = C(O)Ph 
L18b: R1 = CH3 














L17a: R = CH3 
L17b: R = Ph 
L17c: R = SPh 
L17d: R = SiMe3 
L17e: R = SiPh3
















1.5.1.2   Non P-chiral  monodentate ligands 
The most abundant monodentate ligands are 
non P-chiral in nature. With the exception of a few 
monodentate phosphines, most of the monodentate 
non P-chiral ligands are based on chiral diols.21 
Ligands based on BINOL are easy to synthesize and 
have been highly successful (see also chapter 2). 
Furthermore, BINOL is commercially available at relative low cost. One of 
the most successful BINOL-based ligands is monodentate 
phosphoramidite L21. This ligand showed excellent results in the Rh-
catalyzed hydrogenation of a wide variety of substrates, such as α-
dehydroamino acids, enamides, itaconic acids, enol esters and enol 
carbamates.47a, 52 A drawback of BINOL is the rather difficult structural 
modification. This is one of the reasons why a wide variety of other 
backbones have been used in the recent years, such as biphenols,29 spiro 
based diols30, BICOL31 (see chapter 3) and catechol47 (see chapter 2). Most 
of these ligands showed excellent results in the hydrogenation of a variety 
of substrates. As was shown by Reetz et al. the chirality of the 
hydrogenation product is in most cases dictated by the chiral backbone.20 
The chirality of the other moiety is not important and as was shown 
before, one of the best ligands reported so far is bearing an achiral 
piperidine moiety. The remarkable beneficial effect of the piperidine moiety 
was also found in the other ligands. In the Rh-catalyzed hydrogenation of 
α,β-unsaturated acids and N-acyl β2-dehydroamino acids mixed ligands 
systems of chiral phosphoramidites and achiral phosphines were used (see 
chapters 5 and 6). The chiral phosphoramidite is based on a substituted 
BINOL and a piperidine moiety. 
1.5.2   Mixtures of monodentate ligands 
Reetz32 and Feringa / Minnaard / De Vries33 independently showed that 
the catalytically active species in the rhodium-catalyzed hydrogenation 
with monodentate ligands bears two of these monodentate ligands. This 
feature gives monodentate ligands the unique possibility to use two 
different monodentate ligands, instead of one bidentate ligand, for the 
formation of the chiral complex. By mixing a metal precursor with two 




























Scheme 1.3: The monodentate ligand combination approach. 
If the hetero-complex is more active and induces a higher 
enantioselectivity than the two homo-complexes, the e.e. of the product 
will be higher than up on use of the homo-complexes. A first attempt to 
use this approach was made by Chen and Xiao.35 Up to 75% e.e. was 
obtained in the rhodium-catalyzed hydrogenation of dimethyl itaconate  
(19) applying diastereomeric mixtures of biphenyl ligands. Unfortunately, 
formation of the hetero-complex in these mixtures was not observed by 
31P-NMR. Combining diastereomeric mixtures gave the average of the two 
diastereomeric mixture independently, which indicates that also in this 
case no hetero-complex formation takes place. 
The first successful experiments with combinations of monodentate 
ligands were reported by Reetz36 and Feringa / De Vries / Minnaard.37 
Combinations of chiral phosphites and phosphonites or phosphoramidites 
led in some cases to higher e.e.’s in the rhodium-catalyzed hydrogenation 
of dehydroamino acids or enamides than their corresponding homo-
combinations. This new strategy has been employed, not only in rhodium-
catalyzed hydrogenation,38 but also in rhodium-catalyzed additions of 
boronic acids39 and rhodium-catalyzed hydroformylations.40 In some cases, 
mixtures of chiral and achiral monodentate ligands gave significant higher 
e.e.’s than their corresponding homo-complexes (see chapter 5).38f An 
interesting effect was reported by Reetz and Mehler,38a where a 
combination of a chiral and an achiral ligand reversed the absolute 
configuration of the product compared to the corresponding homo-










enantioselectivities by nonchiral additives or by achiral and meso ligands 
has precedent and has been recently reviewed.41 
1.5.3   Substrates for Rh-catalyzed hydrogenation with monodentate 
ligands 
1.5.3.1   N-acyl α-dehydroamino acids and esters 
The most studied class of 
substrates in the rhodium-catalyzed 
asymmetric hydrogenation is the N-
acyl α-dehydroamino acids and esters. 
Hydrogenation of these molecules 
leads to the synthesis of α-amino 
acids, which are interesting molecules from an industrial point of view. A 
wide variety of newly developed chiral monodentate phosphites, 
phosphoramidites and phosphonites have proven to be excellent ligands in 
the hydrogenation of 8 and 9.21 A more difficult class of substrates is those 
with a tetra-substituted double bond. Only one example is known in the 
literature, in which a secondary phosphine oxide has been used in the 
hydrogenation of 10 in an Ir-catalyzed reaction.28a A good 













10 bar H2, 69 h
 
Scheme 1.4: Ir-catalyzed of substrate 10. 
1.5.3.2   N-acyl β-dehydroamino acids 
Less studied, but certainly not less interesting, is the hydrogenation of 
N-acyl β3-dehydroamino acids. A limited number of reports have been 




















monodentate ligands of these substrates. Although monodentate 
phosphites gave good results,42 so far, monodentate phosphoramidites 
gave the better results in the hydrogenation of N-acyl β3-dehydroamino 
acids (Scheme 1.5).43 Phosphoramidites L22 and L23 gave excellent 
results in the hydrogenation of N-acyl β3-dehydroamino acids with 
respectively an E- and Z-configuration.43a On the other hand, the Rh-
catalyst based on Zhou’s SIPHOS (L24) is able to hydrogenate mixtures of 
Z- and E-isomers in good yields. This saves a tedious separation of the 
isomers, since N-acyl β3-dehydroamino acids are normally obtained as 


















Rh / L, solvent, H2,
N-acyl-β3-amino acids
(S,R)-L22
(Z)-12: R1 = R2 = Me
i-PrOH, 10 bar, L22
2 mol% catalyst, 20 min
full conversion, 95% e.e.
(E)-12: R1 = R2 = Me
CH2Cl2, 10 bar, L23
2 mol% catalyst, 4 h
full conversion, 99% e.e.
(Z)-12 + (E)-12: R1= R2= Me
CH2Cl2, 100 bar, L24
2 mol% catalyst, 48 h
full conversion, 89% e.e.
(S)-L23 (S)-L24  
Scheme 1.5: Rh-catalyzed hydrogenation of N-acyl β3-dehydroamino acids 
with monodentate phosphoramidites. 
Only a few reports have been published on the 
hydrogenation of N-acyl β2-dehydroamino acids. 
Bidentate phosphine ligands have not been very 
successful so far and modest enantioselectivities have 
been obtained (see chapter 6).44 A new catalytic system, 
based on a mixture of an achiral phosphine and a 

















developed. This catalytic system gave good enantioselectivities (> 90%) in a 
series of substituted (E)-N-acyl β2-dehydrophenylalanine (see chapter 6). 
1.5.3.3   N-acyl enamides, enol esters and enol carbamates 
Enantiomerically pure amines, which are interesting 
building blocks for drug design and discovery, can be 
obtained by rhodium-catalyzed hydrogenation of N-acyl 
enamides with subsequent hydrolysis of the amide bond. 
The synthesis of these substrates is tedious (see chapter 
2), which might be the reason why this class of 
substrates is less studied compared to the class of α-
dehydroamino acids. 
Nevertheless, a number of monodentate phosphoramidites and 
phosphites are capable of hydrogenating a range of N-acyl enamides. 
Enantioselectivities up to 99% have been achieved in this class of 
substrates (see chapter 2).21 Two interesting and still challenging 
substrates, are 13 and 15. Limited reports have been published regarding 
these substrates, with in general disappointing results. Enantiomerically 
pure 14, or substituted derivatives thereof, are present in several 
biological active compounds.45  
Reasonable results for the rhodium-catalyzed hydrogenation of 13 have 
been obtained with a bidentate ligand, PennPhos (L26) (71% e.e.), 
developed by Zhang and co-workers (Scheme 1.6).46 So far, monodentate 
ligands have not been very successful in the hydrogenation of 13.47 The 
best result published is with BINOL-based phosphoramidite L25, which in 
the hydrogenation of 13 results in 34% e.e. with full conversion at 25 bar 
H2 at room temperature for 8h (Scheme 1.6). However, the best results 
obtained for the hydrogenation of 13 were published by Bruneau and co-
workers. They used a Ru / BINAP catalyst, which gave up to 90% e.e. Just 
recently, Jiang et al. published a remarkably breakthrough in the 
rhodium-catalyzed hydrogenation of 13. They were able to hydrogenate 13 
with 94% e.e. and full conversion employing a supramolecular catalyst, 







R1 = alkyl, or aryl,



















(S)-L25: 34% e.e. (R,S,R,S)-PennPhos (L26): 71% e.e.
13 14
 
Scheme 1.6: Rhodium-catalyzed hydrogenation of enamide 13. 
The hydrogenation of tetrasubstituted enamides with 
monodentate ligands is still challenging. As was observed 
in the hydrogenation of α-dehydroamino acids with 
tetrasubstituted double bonds, in general, low conversions 
and low enantioselectivities are obtained for the 
hydrogenation of 15 with monodentate 
ligands.47a,b,49 Although full conversion, only 27% 
e.e. has been achieved with L27.50 More successful 
were the bidentate phosphines BisP* and 
MiniPhos, developed by Imamoto and co-workers.51 
Catalysts based on these ligands were able to 
hydrogenate 15 with 99% and 98% e.e., 
respectively.  
An alternative for the Ru-catalyzed 
hydrogenation of ketones to alcohols 
is the Rh-catalyzed hydrogenation of 
enol acetates or enol carbamates to 
protected alcohols. In a recent 
published study, a series of aromatic 
enol acetates, alkyl and aromatic enol 
carbamates could be hydrogenation 
with e.e.’s up to 98% with PipPhos 

















R1 = alkyl, or aryl,
R2, R3 = alkyl, H
R1 = alkyl, or aryl,
R2, R3 = alkyl, H 












corresponding allyl carbamate. Allyl carbamate 17 was obtained with an 





Rh(COD)2BF4 / L21, (1 mol%)
10 bar, CH2Cl2, 16h, rt,
16 17; 97% e.e.  
Scheme 1.7: Selective hydrogenation of enol carbamate 16.52 
1.5.3.4   Unsaturated acids and esters 
The hydrogenation of itaconic acid (18) and its dimethyl 
ester 19 is considered, next to the hydrogenation of N-acyl α-
dehydroamino acids and esters, as a benchmark reaction. In 
the last 6 years a great number of monodentate ligands have 
been reported which can be used in the hydrogenation of 
these substrates in excellent enantioselectivities with high 
turn over frequencies.21 
Less studied is the hydrogenation of 
other unsaturated acids, such as α-
substituted cinnamic acids or tiglic acid 
(20). This is not surprising, since it is 
known that a secondary coordination of a 
suitable positioned carbonyl plays an 
important role in the hydrogenation (see also §1.5.4).53 Only a few reports 
have been published on the Rh-catalyzed hydrogenation of α-substituted 
cinnamic acids and 20 (see chapter 5).54 The best results obtained are 
with a catalyst based on a mixed ligand system of an achiral phosphine 
and a chiral monodentate phosphoramidite.38e The results are described in 






18: R = H



















1.5.4   Rh-substrate complexes in asymmetric hydrogenations 
As was mentioned before, the possibility of a secondary coordination by 
a carbonyl functionality of a substrate is believed to be essential for high 
enantioselectivity in the rhodium-catalyzed asymmetric hydrogenation.53 
The most relevant mechanism for the Rh-catalyzed hydrogenation is the 



























































Figure 1.6: Simplified representation of Halpern-mechanism (charges not 
indicated).56 
The initial step is the reversible coordination of the substrate to a 
cationic catalyst precursor (III), forming the diastereomeric complexes I 
and II. The two diastereomeric complexes are in equilibrium with each 
other. Whereas one of these complexes gives the product with a R-
configuration, the other complex gives the product with a S-configuration. 
The formation of these complexes is followed by oxidative addition of H2 (= 
r.d.s.)† and subsequently migratory insertion of the olefin into the Rh-H 
                                                     










bond. In the last step the product is released by reductive elimination and 
the original catalytic precursor (III) is recovered. 
The secondary coordination via the carbonyl reduces the rotational 
freedom of the substrate around the rhodium centre. The importance of 
this secondary coordination was shown by Vineyard et al., in a systematic 
study of substituents around the double bond (Table 1.1).53 




R1[Rh(COD)DIPAMP]BF4, 3 bar H2
50°C, methanol  
Entry R1 R2 E.e. of product 
(%) 
1 COOH NHAc 95 
2 COOMe NHAc 97 
3 C(O)NH2 NHAc 94 
4 CN NHC(O)Ph 88 
5 Ph NHAc 65 
6 Me NHAc 51 
7 COOH OC(O)Me 90 
8 Me COOH <1 
 
As can been seen from these data, the nature of the R1 substituent has 
not a major influence on the enantioselectivity of the products. Carboxylic 
acids, esters, amides and cyano groups give good enantioselectivities 
(entries 1-4). The e.e.’s drop when an alkyl group is introduced in the R1 
position (entries 5 and 6). Introduction of an enol ester at R2 gave the 
hydrogenated product with 90% e.e. This suggests that the nature of the 
carbonyl is of less importance. However, when R2 is changed from an 
amide to a carboxylic acid, the product was obtained in racemic form 
(entry 8). This, on the other hand, suggests that not only the presence of a 
carbonyl is important, but also the position of the carbonyl, i.e. the size of 
the formed chelate. This was shown by Vineyard and co-workers in the 
hydrogenation of itaconic acid dimethyl ester (19) and its analogue α-
methyleneglutaric acid dimethyl ester (21) (Scheme 1.8). Itaconic acid 
could be hydrogenated with an e.e. of 88%, whereas introduction of an 










reduced the enantioselectivity dramatically. This catalytic system, based 
on Rh and DIPAMP (L3) favors the formation of 6 membered chelates of 
the substrate, whereas other catalytic systems have proven to be able to 
hydrogenate substrates which form 5- or 7-membered chelate rings with 
the substrate. In general, bisphosphine ligands with a large bite angle, 
such as DIOP (L4) (96º), form strong complexes with substrates that form 
a small chelate ring with the substrate, whereas bisphosphines with a 
small bite angle, such as DIPAMP (L3) (82º), do not form characterizable 











22: n = 1, 88% e.e.
23: n = 2, 3%, e.e.
19: n = 1
21: n = 2  
Scheme 1.8: Rh-catalyzed hydrogenation of 19 and 21. 
Although to a lesser extent, the electronic properties of the carbonyl are 
also important. For example, the hydrogenations of unsaturated carboxylic 
acids are in general slower than the hydrogenations of enamides. This is 
attributed to the fact that carboxylic acids have a weaker coordination 
with Rh than amides. A similar effect was observed in our system; The 
hydrogenation of α-substituted cinnamic acids could be performed with 
high enantioselectivities, while the corresponding methyl ester could not 
be hydrogenated (see chapter 5). This might be also the reason why the 
hydrogenation of this class of substrates is less studied then other classes. 
The hydrogenation of unsaturated carboxylic acids demands a finely tuned 
catalytic system (see chapter 5). 
Whereas, amides form well-defined Rh/substrate complexes, carboxylic 
acids can form different types of Rh/substrate complexes as was shown by 
Brown et al.57 In general, four different kinds of Rh-complexes can be 
formed by carboxylic acids and carboxamides, depending on the ligand, 












As mentioned before, the structure of the ligand is of importance for the 
formation of the Rh-complexes. With seven-membered-ring ligand 
chelates, i.e. DIOP, formation of complex A is favored with sufficiently 
bulky acids, such as atropic or cinnamic acids. The formation takes 
places, preferentially in the presence of base. Unhindered acids, such as 
propenoic and 2-methyl propenoic acid also form complexes with structure 
A in the presence of base. However, in the absence of base, complexes 
with the structure of B are preferred, with a 2:1 stoichiometry of acid : Rh. 
The formation of B is relatively slow. A range of complexes are formed with 
itaconic acids and its esters with a range of Rh-DIPAMP complexes. 
Complexes A, C, and D have been observed. The authors conclude that 
there is little resemblance between the structure of the complexes, 
diastereomer ratios formed and the optimal enantioselectivity.58 It should 
be noted that, highest reactivities have been observed for complexes 
























A B C D
X = O-, NR2 R = H, Me X = OH, OMe R = H, Me  
Figure 1.7: Types of Rh / bisphosphine complexes formed with carboxylic 
acids and carboxamides. 
1.6   Monodentate phosphoramidites in other transition 
metal catalyzed reactions 
 
In addition to asymmetric hydrogenations, chiral monodentate ligands 
have proven to be very effective in the introduction of enantioselectivity in 
a broad range of other transition metal catalyzed reactions.59 In this 
paragraph an overview will be given of monodentate phosphoramidites in 










1.6.1   Conjugate additions  
The first successful application of chiral 
monodentate phosphoramidites has been in the Cu-
catalyzed conjugate additions of dialkylzinc 
derivatives to α,β-unsaturated ketones.60 The most 
successful ligand is L28, developed by Feringa and 
co-workers. In addition to enones,61 the conjugate 
addition to a variety of other unsaturated substrates 
has been reported in the last two years, i.e. lactams,62 malonates,63 
epoxides,64 imines65 and nitro olefins.66 A variety of other ligands have 
proven to be successful as well. In general, those ligands are derivatives of 
L28. Interesting is also that this chemistry has been applied as key-steps 
in syntheses of bio-active compounds. 61a,c,g 66a,c An attractive example is 











 Me2Zn, CH2Cl2, -25°C, 12h
2) Et3N, TMEDA, TMSOTf
    Et2Zn, rt, 2h
>99% e.e.;
>98% d.e.
apple leafminer pheromone  
Scheme 1.9: Synthesis of apple leafminer pheromone.61g 
The key-step in this synthesis is a Cu-catalyzed double conjugated 1,4-
addition of dimethylzinc to cycloocta-2,7-dienone (24). Van Summeren et 
al. were able to synthesize all 4 diastereoisomers in >99% e.e. and with 
d.e.’s of over 98%, by choosing the appropriate ligand in each step. The 
product of the second 1,4-addition was isolated as its TMS-enol ether, 
since quenching would afford the nonchiral meso-compound. 
Phosphoramidites have been applied, not only in the Cu-catalyzed 
conjugate addition of dialkylzinc reagents, but also in the Rh-catalyzed 
addition of boron compounds.67 Like in the Cu-catalyzed 1,4-additions, 














additions. A representative example is depicted in Scheme 1.10. A phenyl 
group could be introduced into a pyridone moiety with high 
enantioselectivities and good yields. The products are interesting 
intermediates for natural compounds or drug candidates, since the 










(3 mol% ) Rh(acac)(C2H4)2, (7.5 mol%) L29
(PhBO)3, dioxane / water, 100°C, 2h
86% yield, 99% e.e.(S)-L29 =
27 28
 
Scheme 1.10: Rh-catalyzed conjugate addition of phenylboroxine.67d 
1.6.2   Allylic substitutions 
After the initial reports by Hartwig and co-workers,68 a number of 
reports on the use of phosphoramidites in the Ir-catalyzed allylic 
amination or etherfication have been published.69 Helmchen and co-
workers applied this method in the synthesis of a variety of heterocycles. 
Excellent results have been obtained in the synthesis of substituted 
pyrolidines and pyridines with enantioselectivities of >99%. Again, the 
most successful ligand was L28 or derivatives thereof.  
The Ir-catalyzed alkylation with monodentate phosphoramidites has 
been reported before, but in contrast to the amination and etherification, 
the results were not very satisfactory.70  Enantioselectivities were low, 
regioselectivities covered a range between 30:70 to 91:9 for, respectively, 
the branched and linear products and reaction times were long. From 
earlier work it was known that an initial active catalyst was formed, when 
a base was added to a mixture of [{Ir(COD)Cl}2] and L28, which lost 
reactivity after several hours. 71 
The inactive catalyst was identified as 29 (Figure 1.8). The base is 










coordination of a second ligand satisfies the coordination places and 
deactivates the catalyst. A substantial improvement was reported by 
Lipowski et al.72 Complex 30 (Figure 1.8) was obtained after adding TBD‡ 

















Figure 1.8: Complexes 29 and 30. 
Complex 30 showed low catalytic activity,73 but an active catalyst was 
obtained after addition of CuI.74 The CuI acts as a scavenger by selective 
removal of the PPh3 from the complex. Removal of the PPh3 creates a free 
coordination place for the substrate. Streiff et al. applied this approach of 
catalyst activation in the synthesis of carbocycles (Scheme 1.11).75 
2) [Ir(COD)Cl]2, L30, TBD













33: n = 1; 77% yield, 96% e.e.
34: n = 2; 79% yield, 97% e.e.
31: n = 1
32: n = 2
(S,S,S)-L30 =
 
Scheme 1.11: Synthesis of 33 and 34 by intramolecular Ir-catalyzed 
allylic alkylation.75 
                                                     










Furthermore, Alexakis and co-workers reported the use of L30 in the 
Ir-catalyzed alkylation of series of benchmark substrates, with high 
enantioselectivities and good branched : linear regioselectivities.76 
In a comparative study of different 
phosphoramidites, it was shown that slight 
differences in the substitution pattern of the aryl 
group of the amine moiety of L28 strongly influences 
the activity of the ligand, whereas the e.e.’s of the 
different ligands were in a comparable range.76 The 
highest reactivity and enantioselectivities were 
observed for L31. 
A few reports have also been published on Cu-catalyzed77 and Pd-
catalyzed78 allylic substitutions with phosphoramidites. Whereas the 
results in Pd-catalyzed allylic substitution were modest, excellent results 
have been obtained in the Cu-catalyzed allylic alkylation with Grignard 
reagents (Scheme 1.12). For example, 36 could be isolated in 85% yield 
with 99 : 1 ratio of branched / linear product and an e.e. of 96%. 
Cl CuTC, (R, R, R)-L30, EtMgBr
85% yield
96% e.e.
CuTC = Copper(I) thiophene-2-carboxylate
35 36
 
Scheme 1.12: Cu-catalyzed allylic substitution with Grignard reagents.77a 
1.6.3   Hydrosilylations 
Zhou and co-workers reported a series of spiro phosphoramidites which 
have been used in different transition metal catalyzed reactions, e.g. Pd-
catalyzed hydrosilylation,79 Pd-catalyzed hydrovinylation (§1.6.6), Rh-
catalyzed asymmetric Pauson-Khand (§1.6.9), Cu-catalyzed ring opening 
(§1.6.7) and Rh-catalyzed asymmetric hydrogenations (§1.5.1.2). In the Pd-
catalyzed hydrosilylation of styrene derivatives enantioselectivities up to 
99% have been achieved. Oxidation of the obtained silanes afforded the 
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Scheme 1.13: Pd-catalyzed hydrosilylation with spiro phosphoramidites.79 
1.6.4   Hydroborations 
Biphenol–based ligands L33 and L34 showed reasonable results in the 
hydroboration of meso-bicyclic hydrazines (40) (Scheme 1.14).80 The 
chloride substituents proved to be important, since phosphoramidites with 
other substituents on these positions gave lower selectivities. BINOL-based 






















1) CatBH, 1% [IrCODCl]2,
    L33 or L34, THF, 0°C
2) H2O2




55% e.e.  











1.6.5   Hydroformylations 
Biphenol-based phosphoramidites have proven to be also versatile 
ligands for the Rh-catalyzed hydroformylation.61h Good enantioselectivities 
and very good regioselectivities could be obtained in the hydroformylation 
of allyl cyanide (42) (Scheme 1.15). L35 gave up to 80% e.e. with a b/l (= 
branched / linear) ratio of 96:4 at a temperature of 25°C. A drawback was 
the long reaction time of 74 h for full conversion. Increasing the 
temperature to 50°C gave full conversion in 5 h. In the latter case a slight 
drop of e.e. was observed (76%) with more unfavorable b/l ratio (92:8). 
Compound b-43 is particularly interesting, since it is an intermediate for 
















Scheme 1.15: Rh-catalyzed hydroformylation with biphenol-based 
phosphoramidites.61h 
1.6.6   Hydrovinylations 
As mentioned before, the spiro phosphoramidites developed by Zhou 
and co-workers have also been tested in the Pd-catalyzed hydrovinylation 
of styrene derivatives.81 Up to 92% e.e. has been obtained although the 
selectivity towards the desired product was only 10%. In the cases were 
the selectivity towards the product was better (up to 85%) the 












More interesting are the results obtained by Park et al.82 in the Ni-
catalyzed hydrovinylation of norborene (45). BINOL-based ligand (R,S,S)-
L28 gave 80% e.e. with a selectivity of 99% when NaBARF§ was used as an 
additive. Changing the additive to AgSbF6 gave the 2:1 adduct (46) 
selectively but with only 34% e.e. Perhaps more striking is the effect of the 
ligand. When the diastereomer (R,R,R)-L28 was used with NaBARF as an 









Ethene, CH2Cl2, 2.5 h, -50°C
>99%, 80% e.e.
>99%, 34% e.e.  
Scheme 1.16: Asymmetric Ni-catalyzed hydrovinylation of norborene with 
phosphoramidites.82 
1.6.7   Ringopening 
The groups of Pineschi and Zhou reported both the use of 
phosphoramidites in the ringopening reaction of cyclic derivatives 
employing either Grignard reagents, alkylzinc or alkylaluminium 
reagents.83 Both groups obtained excellent regioselectivities in favor of the 




                                                     










1.6.8   Cycloadditions 
Monodentate phosphoramidites have also proven to be versatile ligands 
in a series of cyclization reactions. Mezzetti and co-workers reported an 
asymmetric cyclopropanation of substituted styrenes with half-sandwich 
Ru-complexes. 84 The enantioselectivities obtained were reasonable, but 
the selectivity towards the cis or the trans product was bad. Another 






















Scheme 1.17: Cu-catalyzed ringopening reactions with 
phosphoramidites.83 
Böing et al. applied monodentate phosphoramidites in the Ni-catalyzed 
cycloisomerization of diethyl diallylmalonate (52).85 Unfortunately, whereas 
the selectivity towards the desired product was good, the obtained 
enantioselectivities were rather poor (Scheme 1.18). The e.e. could be 
increased using a Wilke’s bidentate azophospholene ligand.86 In the Co-
catalyzed [6+2] cycloaddition of cycloheptatriene with a terminal alkyne an 



























Scheme 1.18: Ni-catalyzed cycloisomerization with phosphoramidites.85 
1.6.9   Pauson-Khand reaction 
The earlier mentioned spiro phosphoramidites, developed by Zhou and 
co-workers, have also been successfully applied in the Rh-catalyzed 
asymmetric Pauson-Khand reaction.88 Respectable enantioselectivities 
have been obtained, with modest yields (Scheme 1.19). Konya et al. 
reported the Co-catalyzed Pauson-Khand reaction with a series of BINOL-
based monodentate phosphoramidites.89 The yields were modest whereas 








84% e.e.54 55  














1.6.10   1,2-Additions 
Woodward and co-workers reported a new and remarkably stable 
(Me3Al)·DABCO adduct.90 This new trialkylaluminium adduct has been 
employed successfully in the Ni-catalyzed 1,2-addition to aldehydes, using 
monodentate phosphoramidite (R,S,S)-L28 as a chiral ligand. Excellent 








[Ni(acac)2], (R,S,S,)-L28, -20°C, THF, 3h
90% yield
95% e.e.  
Scheme 1.20: Ni-catalyzed 1,2-addition.90  
1.7   Aim and outline of this thesis 
 
As described above, rhodium-catalyzed hydrogenation is a versatile, 
clean and atom economic method91 for the production of enantioselective 
compounds. In recent years monodentate phosphoramidite ligands have 
proven to be excellent ligands for this reaction. Although all benchmark 
substrates can be hydrogenated in high enantioselectivities and with high 
turn-over numbers, the demand for new ligands remains, since there are 
still classes of substrates which can not be hydrogenated with good 
enantioselectivities or high reaction rates. More interesting however is the 
study of new substrates. The aim of this thesis is the development of new 
ligands / catalysts as well as substrates for the rhodium-catalyzed 
hydrogenation. 
Chapter 2 describes the synthesis and application of new catechol-
based phosphoramidites. These new ligands were effective in the 
hydrogenation of a number of benchmark substrates. In chapter 3 the 
synthesis and application of a water-soluble phosphoramidite, PegPhos, is 
described. Good enantioselectivities were obtained in the hydrogenation of 
N-acetyl α-dehydroalanine (9). The synthesis of diamidophosphites has 










Low conversions and enantioselectivities have been obtained in the 
hydrogenation of a series of benchmark substrates. Chapter 5 describes 
the asymmetric hydrogenation of α,β-unsaturated acids using a mixed 
ligand system of a chiral phosphoramidite and an achiral phosphine. The 
powerful method of making libraries of phosphoramidites and screening 
those libraries has been used in the asymmetric hydrogenation of a new 
class of substrates, i.e. β2-dehydroamino acids. The results are described 
in chapter 6. Finally, the results of screening a new class of 
phosphoramidites, based on phenols, on benchmark substrates is 
described in chapter 7. 
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In this chapter the synthesis and application of catechol-based 
phosphoramidites in rhodium-catalyzed hydrogenations are described. Ee’s 
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2.1   Introduction 
2.1.1   Bidentate ligands for asymmetric rhodium-catalyzed 
hydrogenations 
The rhodium-catalyzed asymmetric hydrogenation of enamides is a key 
method to synthesize enantiomerically pure amino acids and amines.1 The 
majority of successful ligands used in this reaction is bidentate in nature,2 
e.g. DuPhos (L1)3, DiPAMP (L2)4, DIOP (L3)5, BINAP (L4)6, PennPhos (L5)7, 
and ferrocenyl-based ligands, such as JosiPhos (L6)8, and FerroPhos (L7)9 
(Figure 2.1). With the exception of CAMP (L8) 10 , limited success was 
obtained with monodentate ligands. These ligands were considered not 
particularly effective since they lack the possibility to form chelating 
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2.1.2   Monodentate ligands for asymmetric rhodium-catalyzed 
hydrogenations 
After nearly 30 years of asymmetric hydrogenation it was unequivocally 
demonstrated in 2000 that bidentate chiral ligands are not a conditio sine 
qua non to reach high enantioselectivities. Three groups showed that 
monodentate phosphonites (L9), 11  phosphites (L10) 12  and 
phosphoramidites (L11)13 can be applied successfully as chiral ligands in 
the rhodium-catalyzed asymmetric hydrogenation providing excellent 
enantioselectivities (Figure 2.2). A major advantage of these monodentate 
ligands is that they can be prepared in one or two steps at low costs, which 











Phosphonites (L9) Phosphites (L10) Phosphoramidites (L11)  
Figure 2.2: Monodentate Phosphonites, Phosphites and Phosphoramidites. 
Most successful monodentate ligands recently introduced consist of a 
chiral diol backbone, with another chiral or achiral moiety attached to 
phosphorus.14 The chirality of the backbone dictates in nearly all cases the 
chirality of the product.12 The chirality of the other moiety at phosphorus 
is found to be less important. Illustrative is that one of the most effective 
monodentate ligands for hydrogenation reactions, the commercially 
available15 phosphoramidite MonoPhos™ (L11), consists of only the chiral 
BINOL part an achiral N,N-dimethyl amine moiety. A few reports on 
alternative ligands using chiral backbones, such as biphenyls or spiro 












2.1.3   Goal of this research 
From earlier results it was evident, that in the case of BINOL derived 
phosphoramidites, a small amine moiety is favored for the hydrogenation 
of dehydroamino acids.13,14c Later results showed that the introduction of a 
piperidine moiety improved the enantioselectivity of the hydrogenation of a 
variety of substrates even further. 17  In this chapter a new class of 
monodentate phosphoramidites, based on an achiral catechol backbone is 
described. In this case the chirality of the products must be dictated solely 
by the chirality of the amine moiety. Not only is the chiral moiety an amine 
instead of the diol, but also the bulkiness of the diol backbone is reduced 
as a planar catechol is present whereas the size of the amine moiety is 
increased in the new ligand compared to MonoPhos™ (L11). 
2.2   Synthesis of phosphoramidites 
2.2.1   Synthesis of BINOL-based phosphoramidites 
In general three methods are used to synthesize monodentate 
phosphoramidites based on BINOL (1) (Scheme 2.1).17,18 In the first method 
BINOL (1) is reacted with PCl3 to yield the corresponding 
phosphorochloridite (2). The phosphorochloridite is then reacted with a 
primary or secondary amine to form the phosphoramidite. In some cases 
when sterically demanding amines are introduced the more reactive 
lithium amide of the amine is reacted with the phosphorochloridite (2).* 
The second method converts BINOL in MonoPhos™ (L11) by reacting it 
with HMPT † . Different phosphoramidites can be obtained by amine 
exchange with MonoPhos™ (L11).18 The third method is the so-called 
reversed synthetic approach.19 In the first step the amine is reacted with 
PCl3 to form the corresponding dichlorophosphino amine, which reacts 
subsequently with the diol to form the corresponding phosphoramidite. 
                                                     
* The Li-amides were prepared by reaction of the amine with n-BuLi. 



















































Scheme 2.1: Synthesis of Phosphoramidites.18 
2.2.2   Synthesis of catechol-based phosphoramidites 
Since o-phenylene phosphorochloridite (4) is commercially available, the 
choice was made to use the first method for synthesizing catechol-based 
phosphoramidites. Initial attempts using the Li-
amide of the corresponding amines afforded the 
ligands in low yield. A side product was obtained 
with a 31P signal at 128 ppm, independent of the 
amine that was used. Phosphoramidites in general have 31P signals 
between 140 and 150 ppm.17a It is assumed that the formed side-product 
is pyrophosphite 3, since it’s known from literature 20  that 
phosphorochloridites can react with water under basic conditions to form 
pyrophosphites. The reactions were performed in THF, which might have 
contained traces of water. When the solvent was switched to diethyl ether 
or methyl t-butyl ether and the base was replaced by Et3N, the desired 


















work up and column chromatography. The catechol-based ligands are in 
general more sensitive to hydrolysis than BINOL-based phosphoramidites. 
A considerable lost of product was observed after column chromatography 
on silica gel presumably due to hydrolysis during chromatography. A 
variety of easily accessible chiral amines, based on (S)-(-)-1-
phenylethylamine, were used in the preparation of ligands L12-L17. The 
cyclic analogue L20 of ligand L12 was obtained from the corresponding 
chiral amine 13, which could be synthesized in four steps from 
commercially available trans-1,2-dibenzoylethylene.21 For comparison also 
bidentate ligands L18 and L19 were examined (Scheme 2.2). All ligands 
were obtained as sticky colorless oils, with exception of L12 and L20, 
which were obtained as white powders. 31P-NMR spectra showed single 
peaks in the range of 140-150 ppm, typically for phosphoramidites. 






























(S,S)-5 and (S,S)-L12:R =
(S)-6 and (S)-L13:   R = benzyl
(R)-7 and (R)-L14:   R = i-propyl
(S)-8 and (S)-L15:   R = ethyl
(S)-9 and (S)-L16:   R = methyl























2.3   Catechol-based phosphoramidites in rhodium-
catalyzed hydrogenations 
2.3.1   Enantioselective hydrogenation of N-acyl 
dehydrophenylalanine methyl ester (14) 
As a benchmark reaction, the ligands were tested in the rhodium-
catalyzed asymmetric hydrogenation of N-acetyl dehydrophenylalanine 
methyl ester (14) under standard conditions. Standard conditions are: 0.2 
mmol of substrate, 1 mol% of catalyst (L:Rh = 2:1) in 4 ml CH2Cl2 at room 
temperature and 5 bar of H2 pressure. The results are depicted in Table 
2.1. 
Table 2.1: Asymmetric hydrogenation of N-acetyl dehydrophenylalanine 








H2, CH2Cl2, rt, 16h
14 15  
Entry Ligand Conversiona,b E.e.c 
1 L12 0 - 
2 L13 60 <3  
3 L14 45 <3 
4 L15 100 <3 
5 L16 60 <3 
6 L17 90 <3 
7 L18 100 5d 
8 L19 100 32 d 
9 L20 100 92 d 
a) Reactions performed under standard conditions; 0.2 mmol of substrate, 1 mol% catalyst 
(L:Rh = 2:1) in 4 ml CH2Cl2 at RT and 5 bar of H2 pressure; b) Conversions determined by 1H-
NMR, no side products were observed in addition to product and/or starting material; c) E.e. 
determined by chiral GC (CP Chiralsil-L-Val) d) Product has the R configuration, except when  
L18 is used (see experimental section for assignment). 
 
The catalysts based on ligands L13 to L17 gave modest to full 










surprisingly, gave no conversion at all. The enantiomeric excesses are in 
all cases disappointing (entries 1-6, Table 2.1). In sharp contrast however, 
is the excellent yield and enantioselectivity of >92% reached with ligand 
L20 (entry 9). Although L12 and L20 have a similar kind of structure, a 
remarkable difference in activity was observed by introduction of a ring 
structure in the ligand. The bidentate ligands L18 and L19 induced full 
conversion but rather poor e.e.’s although a longer spacer in the ligand 
resulted in a slightly higher e.e. (entries 7 and 8). 
2.3.2   Enantioselective hydrogenation of a variety of substrates 
A variety of substrates was tested to expand the scope of the catalytic 
hydrogenation employing L20. As shown in Table 2.2, other α-amino acid 
precursors gave full conversions with modest e.e.’s (entries 1 and 2, Table 
2.2). In contrast, β-amino acid precursor 18 gave no conversion at all 
using CH2Cl2 as the solvent (entry 3). When the reaction was performed in 
i-PrOH, 80% e.e. was obtained at 40% conversion (entry 4). In earlier 
studies it was shown that i-PrOH is the best solvent for the Rh-
phosphoramidite catalyst system in the hydrogenation of β-amino acid 
precursors with a Z-configuration.22 Elimination of the internal hydrogen 
bond by i-PrOH has been postulated as the origin of this change in 
reactivity.23 Enamides 19 and 20 were fully converted and the e.e.’s were 
good to excellent (entries 5 and 6). As expected, the imines 21 and 22 were 
not converted. Although carbamate 23 was hardly converted, the 
selectivity was negligible. 
This initial study revealed that L20 is 
comparable to MonoPhos™ (L11) with respect to 
selectivity in the hydrogenation of α-amino acid 
precursors. In the hydrogenation of enamides, 
however, higher enantioselectivities are observed 
with a remarkable 99% e.e. for the hydrogenation of 
20.13,14r Later results revealed that PipPhos (L21) gives in most cases 
almost perfect selectivity for the α-amino acid precursors as well as the 
enamides.17a So far no good results have been obtained for the 
hydrogenation of imines with monodentate phosphoramidites. 
Monodentate secondary phosphine oxides, on the other hand, have proved 














carbamate 23 are comparable to those obtained with MonoPhos™ (L11). It 
appeared that specifically in the hydrogenation of the carbamate the 
structure of the phosphoramidite is crucial. Introduction of a six-
membered ring at the amine moiety raised the rate of the reaction as well 
as the enantioselectivity.25 With these results in hand we decided to screen 
series of enamides. 
Table 2.2 : Asymmetric hydrogenation of a variety of substrates catalyzed 



















H2, CH2Cl2, rt, 16h
N N O N
O
21 22 23  
Entry Substrate Product Conversion a,b E.e.c, d 
1 16 24 100  89 
2 17 25 100 (>99) 66 
3 18 26 0 - 
4e 18 26 40 80 
5 19 27 100 (>98) 89 
6 20 28 100 (>99) 99 
7 21 29 0 - 
8 22 30 0 - 
9 23 31 33 6 
a) Reactions performed under standard conditions; b) Conversions determined by 1H-NMR, 
no side products were observed in addition to product and/or starting material; isolated 
yields between brackets; c) E.e.’s determined by chiral GC or HPLC (CP Chiralsil-L-Val, CP 
Chiralsil-Dex CB, Chiralcel OD); d) All products had the R configuration e) Reaction was 












2.3.3   Synthesis of enamides 
The substrates were synthesized, starting from the corresponding 
oxims, 26  using methods developed by Zhang7b and Burk (Scheme 
2.3). 27 , 28 Although easy synthesis and high yields are claimed, the 
purification of the compounds is not straightforward. For most compounds 






















OH 19 / 32 / 40 : R1 = p-ClPh, R2 = H, R3 = H
20 / 45 / 54 : R1 = Ph, R2 = Et, R3 = H
33 / 41 / 49 : R1 = t-Bu, R2 = H, R3 = H
34 / 42 / 50 : R1 = Ph, R2 = H, R3 = H
35 / 43 / 51 : R1 = p-MePh, R2 = H, R3 = H
36 / 44 / 52 : R1 = p-MeOPh, R2 = H, R3 = H
53 / 45 / 54 : R1 = Ph, R2 = H, R3 = Et
37 / 45 / 54 : R1 = Ph, R2 = Et/H, R3 = H/Et















57 58  
Scheme 2.3: Synthesis of enamides. 
In no case the reported yields could be reproduced. Substrate 54 was 
obtained as a 3:2 mixture of E- and Z-isomers which could be separated by 
column chromatography. Substrate 58 could be made in a one step 
procedure from the corresponding ketone with p-toluenesulfonic acid and 
acetamide in good yields.29 This method did not work for other substrates 










2.3.4   Asymmetric hydrogenations of enamides with a Rh-
phosphoramidite (L20) complex 
The series of enamides was screened in two solvents at 5 and 25 bar of 
hydrogen pressure to examine the scope of the asymmetric hydrogenation. 
The results are depicted in Table 2.3.  
Table 2.3 : Results of the asymmetric hydrogenation of enamides with Rh-
Phosphoramidite (L20) complex.a 
Entry Substrate Product E.e. 
b-e CH2Cl2  
5 bar 
E.e. b-e  CH2Cl2 
25 bar 
E.e.b-e  EtOAc 
25 bar 
1 49 59 63 70 26 
2 50 60f 92 93 96.5 
3 51 61 95 94 97 
4 52 62 97 97 97 
5 19 27 89 89 94 
6 20 28 99 >99 >99 
7 53 28 90 88 80 
8 54g 28 92 93 84 
9 55 63 9 (3.5) 20 (6) <3 (14) 
10 56 64 35 (48) 35 (95) 27 
11 58 65 4 (14) 9 (38) 35 (40) 
a) Reactions performed in 4 mL solvent with 0.2 mmol substrate and 1 mol% of catalyst at 
RT under a H2 atmosphere for 16 h; b) Conversions determined by 1H-NMR, no side 
products were observed in addition to product and/or starting material; c) E.e.’s 
determined by chiral GC (CP Chiralsil-Dex CB); d) Conversions are between brackets if 
reactions were not run to completion; e) In all cases the R configuration of the product was 
obtained, except for products 65 and 59; f) Isolated yield for 60 was >99% g) A mixture 
with a 3:2 ratio of E and Z alkene was used. 
 
With the exception of 55, containing a tetrasubstituted alkene, and the 
bicyclic systems 56 and 58 (entries 9-11, column 4, Table 2.3), all 
substrates gave full conversion. The enantioselectivity is lower when R1 is 
an alkyl group instead of an aryl group, (compare entries 1 and 2, column 
4). This can be due to an increase of steric hindrance, although this seems 
to be a common feature of this catalytic system, since similar results were 
observed in the hydrogenation of the α-amino acid precursors (compare 
entry 9, Table 2.1 and entry 2, Table 2.2). Favorable π-π interactions 
between the aromatic moiety of the substrate and the ligand might be 
another reason for this observation. Different substituents on the aromatic 










5, column 4). Tri-substituted alkenes gave good to excellent 
enantioselectivities. The best results were obtained with enamides with a 
Z-configuration (entries 6 and 7, column 4) while an E/Z mixture gave the 
calculated average of the enantioselectivities for both isomers (entry 8, 
column 4). Tetra-substituted alkenes and bicyclic systems are not suitable 
substrates for this new catalytic system. Low conversions and moderate 
enantioselectivities were obtained (entries 9-11, column 4). High 
enantioselectivities for these substrates have been obtained with a variety 
of bidentate phosphines.30 Reasonable enantioselectivities for alkene 56 
were obtained using MonoPhos™ (L11) at –20°C.31 
An increase of the pressure to 25 bar had no influence on the 
enantioselectivity although the conversion did increase.‡ Only in the case 
of the tetra-substituted alkene and the bicyclic systems derived from β-
tetralone the e.e. increased (entries 9 and 11).  
The use of EtOAc as solvent resulted in higher enantioselectivities for 
most of the substrates (Table 2.3, column 6). Surprisingly, the only 
exceptions are those with R1 is a t-Bu group (entry 1) or when R3 (Scheme 
2.3) is not hydrogen (entries 7-10). 
2.4   Catechol-based monodentate phosphoramidites in 
the copper-catalyzed conjugate addition of diethylzinc to 
cyclohexenone  
 
Ligand L12 has been reported to induce 78% e.e. in the copper-
catalyzed conjugate addition of Et2Zn to cyclohexenone (66).18 Ligands 
L13-L20 were also tested in this reaction. The results are depicted in Table 
2.4. 
 The results from Table 2.4 show that the bulkiness of the ligand is very 
important. Decreasing the size of the amine in the ligands lowers the e.e. 
dramatically. 
 
                                                     
‡ Reactions were run overnight, although in most cases reactions were completed in 4 h at 5 










Table 2.4: The copper-catalyzed conjugated 1,4-addition of diethylzinc to 




66 67  
Entry Ligand E.e.b   Entry Ligand E.e.b 
1 L12 78   5 L16 2 
2 L13 15   6 L17 1 
3 L14 48   7 L20 35 
4 L15 6      
a) Reactions were performed with 0.5 mmol of substrate, 2 mol% of Cu(OTf)2, 4 mol% of 
ligand and 1.1 equivalents of Et2Zn in 10 ml toluene b) E.e.’s were determined by chiral GC; 
Astec G-TA, 30 m x 0.25 mm, He-flow 1.0 ml / min, isocratic 95°C Tr = 25.8 min (S), Tr = 27.2 
min (R). 
2.5   A new series of catechol-based phosphoramidites 
2.5.1   Synthesis of ligands L22-26 
With these results in hand, a new series of catechol-based monodentate 
phosphoramidites was prepared. Ligand L22, with two n-propyl 
substituents on the catechol moiety, was synthesized to investigate the 
influence of steric hindrance due to alkyl groups at the ortho-positions. 
Catechol (68) was reacted with 2 equivalents of allyl bromide to form the 
corresponding diallylether (69). 32  The diallylether was subsequently 
rearranged to form 70 in only 23% yield.32 In addition to the desired 
product, a mixture of side-products was obtained, the composition of 
which has not been identified. Reduction of the double bonds of the allyl 

























Scheme 2.4: Synthesis of 71. 
L22 could be synthesized by refluxing 71 in PCl3 to provide the 
corresponding phosphorochloridite (not shown) (Scheme 2.5). The 
phosphorochloridite was reacted with amine 13 in the presence of Et3N to 
provide L22 in a very low 2.5% yield (not optimized). The low yield is 













Scheme 2.5: Synthesis of L22. 
A series of ligands based on proline esters was synthesized, as an 
alternative to the rather difficult to synthesize cyclic amine 13 (Scheme 
2.6). Amines 72-75 could be synthesized in a one pot procedure from the 
commercially available (S)-proline by a literature procedure.34 Ligands L23-
L26 were synthesized according the procedure described in Scheme 2.2 in 
30-60% yield. 31P-NMR spectra showed single peaks in the range of 140-
150 ppm, typically for phosphoramidites. Additional information was 










A difference between L20 and L23-L26 is the degree of symmetry. L20 
based on catechol and symmetrical 2,5-disubstituted pyrolidine is C2-
symmetric, while L23-L26 are based on non-symmetrical proline esters 









































(S)-L23 (S)-L24 (S,1R,2S,5R)-L25 (S,1S,2R,5S)-L26
(72-75)
72: R = methyl
73: R = benzyl
74: R = (1R,2S,5R)-menthyl
75: R = (1S,2R,5S)-menthyl
 
Scheme 2.6: Synthesis of ligands L23-L26. 
2.5.2   Hydrogenation of benchmark substrates using L22-L26 as 
ligands 
Monodentate phosphoramidites L22-L26 were tested in the rhodium-
catalyzed asymmetric hydrogenation of a set of 4 benchmark substrates 
i.e., 14, 17, 50 and 76 (vide infra). The reactions were run at 10 bar of 
hydrogen pressure with 1 mol % of catalyst for 16h. The results are 
depicted in Table 2.5. 
Introduction of n-propyl groups on the catechol moiety decreases the 
enantioselectivity as well as the conversion (compare entry 9, Table 2.1; 
entry 2, Table 2.2; entry 2, Table 2.3 vs. entry 1, Table 2.5). The e.e.’s 
obtained for the hydrogenation of substrate 76 with ligands L22-L26 are 
very low. In all cases incomplete conversion was obtained (entries 1-5, 
Table 2.5). The enantioselectivities obtained in the hydrogenation of amino 
acid derivatives 14 and 17 with ligands L23-L26 are rather poor compared 
to the results obtained with L20 (entries 2-5, Table 2.5 vs. entry 9, Table 










the hydrogenation of enamide 50, although the enantioselectivities are still 
lower than those with L20 (entries 2-5, Table 2.5 vs. entry 2, Table 2.3). 
Table 2.5: Rh-catalyzed asymmetric hydrogenation with L22-L26.a 
Substrate Product
Rh(COD)2BF4, L22-L26















17 50  
E.e. after hydrogenation of substrateb,c,d,e 
Entry Ligand 
14 17 50 76 
1 L22 18 (19) 20 (45) 14 (22) 7 (17) 
2 L23 27 42 69 3 (45) 
3 L24 38 3 65 15 (43) 
4 L25 6 22 69 7 (54) 
5 L26 35 31 60 12 (50) 
a) Reactions performed in 4 mL solvent with 0.2 mmol substrate and 1 mol% of catalyst at 
RT under a H2 atmosphere of 10 bar for 16 h b) Conversions determined by 1H-NMR, besides 
product and/or starting material no side products were observed c) E.e.’s determined by 
chiral GC d) Conversions are between brackets if reactions were not run to completion e) In 
all cases the R enantiomer was obtained, except for product of substrate 76. 
 
 The size of the R-group (Scheme 2.6) has hardly any influence on the 
enantioselectivity of the hydrogenation products. Neither does the 
introduction of additional stereocenters as in L25 and L26 have a 
significant effect. The e.e. of the products is mainly defined by the 
stereocenter of proline, since no pronounced matched/missmatched effect 
has been observed and the absolute configuration of the products is the 













2.6   Conclusion 
In this chapter a successful synthesis of catechol-based monodentate 
phosphoramidites has been described. These ligands showed good results 
in the rhodium-catalyzed asymmetric hydrogenation of a variety of pro-
chiral alkenes. In particular, ligand L20, based on catechol and 
enantiopure trans-2,5-diphenylpyrolidine, showed excellent results in the 
hydrogenation of enamides. Up to 99% of e.e. has been reached in the 
asymmetric hydrogenation of 20. L20, together with L21, are among the 
best ligands reported so far for the enantioselective hydrogenation of 
enamides. 14,17a  
The catechol-based ligands have also been tested in the Cu-catalyzed 
conjugate addition of diethylzinc. Modest e.e.’s have been obtained. The 
best ligand was L12, which induced an e.e. of 78%.  




All reactions were performed in a dry argon atmosphere using standard 
Schlenk techniques. Et2O (Na), CH2Cl2 (CaH), EtOAc (boiling chips), 
toluene (Na) and pentane (boiling chips) were distilled before use. 
Substrate 14 was made according a literature procedure.33 Substrates 17 
and 76 are commercially available. Michel van den Berg is gratefully 
acknowledged for substrate 16. Diego Peña is gratefully acknowledged for 
substrate 18. Xiao-Bin Jiang is gratefully acknowledged for substrates 21-
23. Leggy Arnold is gratefully acknowledged for ligand L12 and amines 7 
and 8. Amines 8, 9, 11-13 and 72-75 were made according literature 
procedures.34  Amine 10 is commercially available. Ketones 32-39 were 
commercially available.    
1H-NMR, 13C-NMR and 31P-NMR spectra were recorded on a Varian 
Gemini-200, Varian VXR-300 or a Varian Mercuri Plus. Chemical shifts 
are reported in δ units (ppm) relative to the residual deuterated solvent 
signals of CHCl3 (1H-NMR: δ 7.26; 13C-NMR: δ 77.0); DMSO (1H-NMR: δ 
2.49; 13C-NMR: δ 39.5) or relative to an external standard for 31P (H3PO4 at 
δ 0.0). The splitting patterns are designated as follows: s (singlet), d 
(doublet), t (triplet), q (quartet), b (broad). Optical rotations were measured 
with a Perkin Elmer 241 polarimeter. Column chromatography was 
performed using silica gel (Aldrich 60, 230-400 mesh).   Mass spectra 












General procedure for the synthesis of the ligands: 
 
To a solution of 1.5 g (8.60 mmol) of o-phenylenephosphorochloridite (4) 
and 0.87 g (8.60 mmol) of Et3N in 5 ml of Et2O was added a solution of 
8.60 mmol of the appropriate amine in 5 ml Et2O at 0°C. This suspension 
was warmed to RT and stirred for 1.5 h. The reaction mixture was filtered 
over Celite. The filtrate was concentrated. The ligand was purified by 
filtration over a short plug of silica gel (eluent n-pentane:EtOAc 10:1). 
 
(S,S)-Benzo[1,3,2]dioxaphosphol-2-yl-bis-(1-phenyl-
ethyl)-amine (L12): White solid. 1H-NMR (200 MHz, CDCl3) 
δ = 7.26-7.14 (m, 12H), 7.01-6.98 (m, 2H), 4.45 (m, 2H), 
1.79 (dd, J = 1.8 Hz, 7.1 Hz,  6H); 13C-NMR (50.32 MHz, 
CDCl3) δ = 146.8, 142.0, 129.1, 127.9, 127.7, 127.6, 126.9, 
121.7, 53.3, 53.0, 22.4, 22.2; 31P-NMR (81 MHz, CDCl3) δ = 
151.9; HRMS calcd. for C22H22NO2P 363.138 found 
363.138; [α]D20 = -264° (c= 0.79, CHCl3). 
 
(S)-Benzo[1,3,2]dioxaphosphol-2-yl-benzyl-(1-phenyl-
ethyl)-amine (L13): The ligand was obtained as a colorless 
sticky oil in 25% yield. 1H-NMR (200 MHz, CDCl3) δ =7.35-
7.13 (m, 10H), 6.96-6.78 (m, 4H), 4.34-4.29 (m, 1H), 3.69 
(ddd, J = 6.8 Hz, 15.7 Hz, 33.8 Hz, 2H), 1.43 (dd, J = 1.8 
Hz, 7.1 Hz, 3H); 13C-NMR (50.32 MHz, CDCl3) δ = 146.7, 
146.6, 146.5, 146.3, 141.9, 138.4, 128.5, 128.3, 128.1, 
127.3, 127.2, 121.7, 111.4, 56.2, 55.9, 47.2, 47.1, 22.3, 
22.1; 31P-NMR (81 MHz, CDCl3) δ =146.1; HRMS calcd. for C22H22NO2P 
349.123 found 349.122; [α]D20 = -21° (c= 1.17, CHCl3). 
 
(S)-Benzo[1,3,2]dioxaphosphol-2-yl-isopropyl-(1-phenyl-
ethyl)-amine (L14): The ligand was obtained as a colorless 
sticky oil in 37% yield. 1H-NMR (200 MHz, CDCl3) δ =7.42-
7.22 (m, 5H), 7.04-6.95 (m, 2H), 6.90-6.81 (m, 2H), 4.43-
4.37 (m, 1H), 3.18-3.05 (m, 1H), 1.54 (dd, J = 0.5 Hz, 7.1 
Hz, 3H), 1.35 (d, J = 6.8 Hz, 3H), 0.96 (d, J = 6.8 Hz, 3H); 
13C-NMR (50.32 MHz, CDCl3) δ = 146.7, 128.2, 127.6, 127.0, 121.6, 111.4, 
52.5, 52.4, 46.5, 46.1, 26.3, 26.1, 25.1, 24.9, 20.7, 20.6; 31P-NMR (81 
MHz, CDCl3) δ = 152.5; HRMS calcd. for C17H20NO2P 301.123 found 



























ethyl)-amine (L15): The ligand was obtained as a colorless 
sticky oil in 36% yield. 1H-NMR (200 MHz, CDCl3) δ = 7.45-
7.28 (m, 5H), 7.06-6.89 (m, 4H), 4.73-4.65 (m, 1H), 2.79-
2.64 (m, 2H), 1.69 (dd, J = 1.6 Hz, 7.2 Hz, 3H), 0.89 (t, J = 
7.1 Hz, 3H); 13C-NMR (50.32 MHz, CDCl3) δ =146.7, 146.6, 
146.4, 142.3, 142.3, 128.4, 127.1, 121.6, 111.2, 55.7, 55.1, 37.2, 37.1, 
21.5, 21.2, 17.0, 16.9; 31P-NMR (81 MHz, CDCl3) δ =149.5; HRMS calcd. 
for C16H18NO2P 287.108 found 287.108; [α]D20 = -65° (c= 1.36, CHCl3). 
 
(S)-Benzo[1,3,2]dioxaphosphol-2-yl-methyl-(1-phenyl-
ethyl)-amine (L16): The ligand was obtained as a colorless 
sticky oil in 44% yield. 1H-NMR (200 MHz, CDCl3) δ = 7.42-
7.26 (m, 5H), 7.05-6.97 (m, 2H), 6.94-6.87 (m, 2H), 4.79-
4.71 (m, 1H), 2.20 (d, J = 6.1 Hz, 3H), 1.59 (dd, J = 0.6 Hz, 
7.0 Hz, 3H); 13C-NMR (50.32 MHz, CDCl3) δ = 146.7, 141.0, 128.4, 127.1, 
121.6, 111.1, 55.0, 54.4, 26.2, 26.1, 18.8, 18.6; 31P-NMR (81 MHz, CDCl3) 
δ =147.0; HRMS calcd. for C15H16NO2P 273.092 found 273.091; [α]D20 = -
28° (c= 1.09, CHCl3). 
 
(S)-Benzo[1,3,2]dioxaphosphol-2-yl-(1-phenyl-ethyl)-
amine (L17): The ligand was obtained as a colorless sticky 
oil in 38% yield. 1H-NMR (200 MHz, CDCl3) δ = 7.36-6.78 
(m, 9H), 4.21-4.06 (m, 1H), 3.84 (m, 1H), 1.86 (d, J = 6.8 
Hz, 3H); 13C-NMR (50.32 MHz, CDCl3) δ = 146.0, 144.5, 
128.3, 126.9, 125.6, 121.8, 121.7, 111.6, 11.3, 50.0, 25.2, 25.2; 31P-NMR 
(81 MHz, CDCl3) δ =137.6; HRMS calcd. for C14H14NO2P 259.076 found 




diamine (L18): The ligand was obtained as a 
colorless sticky oil in 21% yield. 1H-NMR (200 
MHz, CDCl3) δ = 7.40-7.15 (m, 10H), 7.00-6.84 
(m, 8H), 4.24-4.13 (m, 2H), 2.74-2.43 (m, 4H), 1.26 (d, J = 7.1 Hz, 6H); 
13C-NMR (50.32 MHz, CDCl3) δ = 146.6, 141.7, 128.3, 127.2, 121.8, 111.5, 
111.3, 55.2, 54.8, 44.5, 44.3, 20.5, 20.3; 31P-NMR (81 MHz, CDCl3) δ 
=150.1; HRMS calcd. for C30H30N2O4P2 544.168 found 544.168; [α]D20 = -




diamine (L19): The ligand was obtained as a 
colorless sticky oil in 29% yield. 1H-NMR (200 







































(m, 8H), 4.40-4.29 (m, 2H), 2.32-2.15 (m, 4H), 1.49 (dd, J = 1.7 Hz, 7.0 Hz, 
6H), 1.53-1.21 (m, 4H); 13C-NMR (50.32 MHz, CDCl3) δ = 146.0, 141.8, 
128.4, 127.2, 127.1, 121.7, 111.2, 55.5, 55.0, 40.3, 40.2, 31.8, 21.5, 21.2; 
31P-NMR (81 MHz, CDCl3) δ =148.5; HRMS calcd. for C31H32N2O4P2 
558.184 found 558.184; [α]D20 = +79° (c= 1.41, CHCl3). 
 
(S,S)-1-Benzo[1,3,2]dioxaphosphol-2-yl-2,5-diphenyl-
pyrrolidine (L20): The ligand was obtained as colorless 
crystals in 46% yield. 1H-NMR (200 MHz, CDCl3) δ = 7.26-
7.11 (m, 10H), 6.97 (d, J = 7.7 Hz, 1H), 6.75 (dt, J = 1.1 
Hz, 7.7 Hz, 1H), 6.51 (dt, J = 1.1 Hz, 7.7 Hz, 1H), 5.95 (d, J 
= 7.7 Hz, 2H), 2.36-2.25 (m, 2H), 1.67-1.57 (m, 2H); 13C-
NMR (50.32 MHz, CDCl3) δ =145.0, 128.1, 126.8, 126.1, 
121.6, 121.2, 111.5, 110.3, 63.2, 63.1, 33.7; 31P-NMR (81 
MHz, CDCl3) δ =143.9; HRMS calcd. for C22H20NO2P 361.122 found 
361.123; Anal. Calc. for C22H20NO2P: C, 73.12 %; H, 5.58 %; N, 3.88 %, 
found: C, 73.09 %; H, 5.58 %; N, 3.89 %; [α]D20 = -104° (c= 0.79, CHCl3). 
 
General procedure for the synthesis of oximes: 
 
A mixture of 10 g ketone and 10 g (144 mmol) hydroxylamine (HCl salt) in 
100 ml EtOH and 10 ml pyridine was refluxed overnight. The reaction 
mixture was concentrated and poured into 100 ml ice/water. The cooled 
(0°C) mixture was stirred for 45 min and filtered. The white precipitate was 
dissolved in 100 ml EtOAc and dried over Na2SO4. The mixture was filtered 
and concentrated to yield the corresponding oxime in 73-95% yield. The 
product was used in the next step without any purification. 
 
1-(4-Chloro-phenyl)-ethanone oxime (40): The oxime was 
obtained as a white solid in 92% yield. 1H-NMR (200 MHz, 
CDCl3) δ = 9.58 (bs, 1H), 7.56 (d, J = 9.0 Hz, 2H), 7.36 (d, J 
= 9.0 Hz, 2H), 2.29 (s, 3H); 13C-NMR (50.32 MHz, CDCl3) δ 
=155.1, 135.3, 134.8, 128.7, 127.3, 12.2; HRMS calcd. for C8H8ClNO 
162.029 found 162.028. 
 
3,3-Dimethyl-butan-2-one oxime (41): The oxime was obtained 
as a white solid in 73% yield. 1H-NMR (200 MHz, CDCl3) δ = 
9.39 (bs, 1H), 1.88 (s, 3H), 1.13 (s, 9H); 13C-NMR (50.32 MHz, 
CDCl3) δ =163.9, 37.2, 27.4, 10.0; MS m/z 116 (M+1), 133 
(M+18). 
 
1-Phenyl-ethanone oxime (42): The oxime was obtained as a 
white solid in 95% yield. 1H-NMR (200 MHz, CDCl3) δ = 10.09 
(bs, 1H), 7.72-7.63 (m, 2H), 7.49-7.35 (m, 3H), 2.36 (s, 3H); 


















126.0, 12.4; HRMS calcd. for C8H9NO 135.068 found 135.069. 
 
1-(4-Chloro-phenyl)-ethanone oxime (43): The oxime was 
obtained as a white solid in 94% yield. 1H-NMR (200 MHz, 
CDCl3) δ = 9.42 (bs, 1H), 7.48 (d, J = 8.1 Hz, 2H), 7.15 (d, J = 
8.1 Hz, 2H), 2.33 (s, 3H), 2.25 (s, 3H); 13C-NMR (50.32 MHz, 
CDCl3) δ =155.7, 139.1, 133.5, 129.1, 125.8, 21.1, 12.2; 
HRMS calcd. for C9H11NO 149.084 found 149.085. 
 
1-(4-Methoxy-phenyl)-ethanone oxime (44): The oxime 
was obtained as a white solid in 75% yield. 1H-NMR (200 
MHz, CDCl3) δ = 10.01 (bs, 1H), 7.60 (d, J = 9.0 Hz, 2H), 
6.92 (d, J = 9.0 Hz, 2H), 3.82 (s, 3H), 2.30 (s, 3H); 13C-
NMR (50.32 MHz, CDCl3) δ =160.4, 155.3, 128.9, 127.3, 
113.8, 55.2, 12.2; HRMS calcd. for C9H11NO2 165.079 found 165.081.  
 
1-Phenyl-butan-1-one oxime (45): The oxime was obtained 
as a white solid in 95% yield. 1H-NMR (200 MHz, CDCl3) δ = 
8.92 (bs, 1H), 7.57-7.54 (m, 2H), 7.37-7.21 (m, 3H), 2.75 (t, J 
= 7.7 Hz, 2H), 1.63-1.47 (m, 2H), 0.94 (t, J = 7.3 Hz, 3H); 13C-
NMR (50.32 MHz, CDCl3) δ = 159.4 (s), 135.8 (s), 129.0 (d), 128.4 (d), 
126.2 (d), 28.1 (t), 19.7 (t), 14.2 (q); HRMS calcd. for C10H13NO 163.100 
found 163.105. 
 
2-Methyl-1-phenyl-propan-1-one oxime (46): The oxime was 
obtained as a white solid in 79% yield as an 1:1 mixture of syn 
and anti isomers. 1H-NMR (200 MHz, CDCl3) δ = 9.19 (bs, 1H), 
7.45-7.21 (m, 10H), 3.56 (m, 1H), 2.80 (m, 1H), 1.18 (d, J = 7.0 
Hz, 6H), 1.14 (d, J = 7.0 Hz, 6H); 13C-NMR (50.32 MHz, CDCl3) δ = 
164.539, 162.9, 135.6, 133.6, 128.4, 128.3, 128.2, 128.0, 127.6, 127.4, 
34.4, 27.6, 20.0, 19.2; HRMS calcd. for C10H13NO 163.100 found 163.100. 
 
3,4-Dihydro-2H-naphthalen-1-one oxime (47): The oxime 
was obtained as a brown solid in 92% yield. 1H-NMR (400 
MHz, CDCl3) δ = 10.0 (bs, 1H), 7.89 (d, J = 7.7 Hz, 1H), 7.29-
7.19 (m, 2H), 7.15 (d, J = 7.3 Hz, 1H), 2.86 (t, J = 6.5 Hz, 2H), 
2.75 (t, J = 6.0 Hz, 2H), 1.86 (m, 2H); 13C-NMR (50.32 MHz, 
CDCl3) δ = 155.2 (s), 139.8 (s), 130.3 (s), 129.2 (d), 128.6 (d), 126.4 (d), 






















General procedure for the synthesis of enamides: 
 
Method A: A mixture of 55.6 mmol of oxime, 12 ml (166 mmol) acetic 
anhydride, 6.2 g (111 mmol) Fe-powder (325 mesh) and 9.5 ml (166 mmol) 
acetic acid in 40 ml toluene was stirred for 4 h at 70°C. The mixture was 
cooled and filtered through Celite© and the residue was washed with 
toluene. The filtrates were washed with 2M NaOH(aq), dried over Na2SO4, 
filtered and concentrated. The crude enamides were purified by column 
chromatography and thoroughly washing with hexane. 
 
Method B: A mixture of 13.2 mmol oxime, 2.20 g (39.4 mmol) Fe-powder 
(325 mesh) and 0.95 ml (16.6 mmol) acetic anhydride in 100 ml DMF was 
stirred at RT for 6 h. The reaction was initiated by a few drops of TMSCl. 
The reaction mixture was diluted with water and extracted with 200 ml of 
ether. The organic layer was washed with water (2x 200 ml), brine (1x 200 
ml), dried over Na2SO4, filtered and concentrated. The crude enamides 
were purified by column chromatography and thoroughly washing with 
hexane. 
 
N-[1-(4-Chloro-phenyl)-vinyl]-acetamide (19): The 
enamide was obtained as a white solid in 17% yield. 1H-
NMR (200 MHz, CDCl3) δ = 7.32-7.28 (m, 5H), 5.71 (s, 1H), 
5.07 (s, 1H), 2.06 (s, 3H) ;13C-NMR (50.32 MHz, CDCl3) δ = 
169.5 (s), 139.6 (s), 136.5 (s), 134.3 (s), 128.6 (d), 127.3 
(d), 103.6 (t), 24.2 (q); HRMS calcd. for C10H10ClNO 
195.045 found 195.044. 
 
N-(1-Phenyl-but-1-enyl)-acetamide (20): The Z-isomer was 
isolated from a 3:2 mixture of E- and Z-isomers by column 
chromatography. (SiO2, pentane / EtOAc, (4:1), Rf = 0.13). 
The Z-enamide was obtained as a white solid in a 3:1 mixture 
of rotamers in 21% yield. 1H-NMR (200 MHz, CDCl3) δ = 
7.41-7.19 (m, 5H), 7.10 (bs, 0.75H), 6.89 (bs, 0.25H), 5.93 (t, J = 7.2 Hz, 
0.25H), 5.80 (t, J = 7.1 Hz, 0.75H), 2.31-2.09 (m, 2H), 2.08 (s, 2.25H), 1.76 
(s, 0.75H), 1.11-1.01 (m, 3H); 13C-NMR (50.32 MHz, CDCl3) δ = 173.6, 
168.7, 137.9, 134.1, 132.4, 129.3, 128.6, 128.4, 128.2, 128.1, 127.5, 
125.4, 125.3, 23.1, 21.7, 21.2, 20.5, 13.4; HRMS calcd. for C12H15NO 
189.115 found 189.116. 
 
N-(2,2-Dimethyl-1-methylene-propyl)-acetamide (49): The 
enamide was obtained as colorless crystals in 36% yield. 1H-
NMR (300 MHz, CDCl3) δ = 6.38 (bs, 1H), 5.61 (s, 1H), 4.79 (s, 
1H), 2.08 (s, 3H), 1.11 (s, 9H); 13C-NMR (50.32 MHz, CDCl3) δ = 
168.8, 148.0, 98.9, 35.1, 28.1, 24.5; HRMS calcd. for C8H15NO 














N-(1-Phenyl-vinyl)-acetamide (50): The enamide was 
obtained as a white solid in 17% yield. 1H-NMR (300 MHz, 
CDCl3) δ = 7.38 (m, 5H), 7.06 (bs, 1H), 5.83 (s, 1H), 5.08 (s, 
1H), 2.08 (s, 3H); 13C-NMR (50.32 MHz, CDCl3) δ = 169.5, 
140.6, 138.0, 128.3, 125.9, 102.7, 24.0; HRMS calcd. for 
C10H11NO 161.084 found 161.088. 
 
N-(1-p-Tolyl-vinyl)-acetamide (51): The enamide was 
obtained as a white solid in 44% yield. 1H-NMR (200 MHz, 
CDCl3) δ = 7.31 (d, J = 8.1 Hz, 2H), 7.20 (d, J = 8.1 Hz, 2H), 
6.99 (bs, 1H), 5.79 (s, 1H), 5.05 (s, 1H), 2.35 (s, 3H), 2.09 
(s, 3H); 13C-NMR (50.32 MHz, CDCl3) δ = 169.1 (s), 140.4 
(s), 138.5 (s), 135.5 (s), 129.2 (d), 125.8 (d), 101.8 (t), 24.4 (q), 21.1 (q); 
HRMS calcd. for C11H13NO 175.100 found 175.100. 
 
N-[1-(4-Methoxy-phenyl)-vinyl]-acetamide (52): The 
enamide was obtained as a yellow solid in 39% yield. 1H-
NMR (200 MHz, CDCl3) δ = 7.32 (d, J = 8.4 Hz, 2H), 7.12 
(bs, 1H), 6.85 (d, J = 8.4 Hz, 2H), 5.69 (s, 1H), 4.99 (s, 
1H), 3.79 (s, 3H), 2.06 (s, 3H); 13C-NMR (50.32 MHz, 
CDCl3) δ = 169.1 (s), 159.8 (s), 140.1 (s), 130.8 (s), 127.2 
(d), 113.8 (d), 101.4 (t), 55.2 (q), 24.3 (q); HRMS calcd. for C11H13NO2 
191.095 found 191.096. 
 
N-(1-Phenyl-but-1-enyl)-acetamide (53): The E-isomer was 
isolated from a 3:2 mixture of E and Z by column 
chromatography. (SiO2, pentane / EtOAc, (4:1), Rf = 0.0.26). 
The E-enamide was obtained as a white solid in 28% yield. 1H-
NMR (400 MHz, CDCl3) δ = 7.42 (bs, 1H), 7.34-7.23 (m, 5H), 
6.11 (t, J = 7.8 Hz, 1H), 2.11-1.96 (m, 2H), 1.76 (s, 3H), 0.96 (t, J = 7.4 Hz, 
3H); 13C-NMR (50.32 MHz, CDCl3) δ = 167.7, 135.5, 131.9, 127.1, 126.7, 
126.3, 120.9, 22.4, 20.0, 13.3; HRMS calcd. for C12H15NO 189.115 found 
189.116. 
 
N-(2-Methyl-1-phenyl-propenyl)-acetamide (55): The 
enamide was obtained as a white solid in 42% yield as a 3:1 
mixture of rotamers. 1H-NMR (400 MHz, CDCl3) δ = 7.30-7.14 
(m, 5H), 6.91 (bs, 0.75H) 6.86 (bs, 0.25H), 1.94 (s, 2.25H), 
1.81 (0.75H), 1.78 (s, 0.75H), 1.72 (s, 4.50H), 1.67 (s, 0.75H); 
13C-NMR (50.32 MHz, CDCl3) δ = 173.8 (s), 168.2(s), 138.7 (s), 
130.0 (s), 129.0 (d), 128.1 (d), 127.8 (d), 127.4 (d), 127.0 (d), 23.1 (q), 21.1 




















Mixture of rotamers (3:1); 1H-NMR (400 MHz, CDCl3) δ = 7.21-
7.11 (m, 4H), 6.76 (bs, 0.75H), 6.65 (bs, 0.25H), 6.46 (bt, 
0.75H), 5.97 (bt, 0.25H), 2.87-2.73 (m, 2H), 2.43-2.33 (m, 2H), 
2.18 (s, 2.25H), 1.96 (s, 0.75H); 13C-NMR (50.32 MHz, CDCl3) 
δ = 169.2 (s), 136.7 (s), 131.5 (s) 127.8 (d), 127.5 (d), 126.3 (d), 120.6 (d), 




A solution of 3.69 g (25.2 mmol) of β-tetralone, 7.45 g (126 
mmol) acetamide and 0.96 g (5.04 mmol) p-toluenesulfonic 
acid in 150 ml toluene was refluxed under Dean-Stark 
conditions under an inert atmosphere for 20h. After cooling to RT, 250 ml 
of saturated NaHCO3(aq) was added, and the mixture was warmed to 60°C 
for 30 min. After cooling to RT, the organic layer was extracted and washed 
with water (3x 150 ml), dried over Na2SO4, filtered and concentrated. The 
enamide was purified by column chromatography (SiO2, ether/pentane 
(1:2)). The enamide was obtained as a white solid,  3.74g (20.0 mmol; 
80%);  1H-NMR (300 MHz, CDCl3)29 δ = 7.12-7.02 (m, 5H), 6.61 (bs, 1H), 
2.89 (dd, J = 8.4 Hz, 7.7 Hz, 2H), 2.44 (dd, J = 8.4 Hz, 7.7 Hz, 2H), 2.12 (s, 
3H); 13C-NMR (50.32 MHz, CDCl3)29 δ = 113.7, 100.2, 100.0, 99.2, 96.9, 
96.8, 96.5, 96.4, 90.7, 57.4, 57.1, 56.0; HRMS calcd. for C12H13NO 
187.100 found 187.101. 
 
1,2-Bis-allyloxy-benzene (69): A solution of 22.0 g (0.20 
mol) catechol 68, 34.8 ml (0.40 mol) allylbromide and 60.8 
g (0.45 mol) in 300 ml acetone was refluxed overnight. The 
reaction mixture was diluted with water and extracted with ether. The 
combined organic layers were washed with water, 5% NaOH(aq) and dried 
on Na2SO4. The solution was filtered and concentrated. The product was 
purified by distillation. Yield 33.1 g (0.17 mol; 85%).  1H-NMR (200 MHz, 
CDCl3) δ 6.92 (s, 4H), 6.11 (ddt, J = 17.3 Hz, 10.5 Hz, 5.2 Hz, 2H), 5.44 
(ddt, J = 10.5 Hz, 2.9 Hz, 1.5 Hz, 2H), 5.29 (ddt, J = 17.3 Hz, 3.3 Hz, 1.5 
Hz, 2H), 4.62 (ddd, J = 5.2 Hz, 1.5 Hz, 1.5 Hz, 4H); 13C-NMR (50.32 MHz, 
CDCl3) δ = 148.5, 133.4, 121.1, 117.4, 114.2, 69.8; HRMS calcd. for 
C12H14O2 190.099 found 190.100. 
 
3,6-Diallyl-benzene-1,2-diol (70): 33.1 g (0.17 mol) of 
69 was heated at 200°C for 4 h. The dark red reaction 
mixture was distilled. A yellow oil was obtained at 88-
90°C and 0.3 mbar. The oil was purified by column 
chromatography (SiO2; CH2Cl2) to obtain a yellowish oil, which solidified in 
a white solid after standing. Yield: 7.5 g  (39.5 mmol; 23%) 1H-NMR (200 
















4H), 3.44-3.42 (m, 4H); 13C-NMR (50.32 MHz, CDCl3) δ = 142.0, 136.5, 
124.1, 121.4, 116.0, 34.6; HRMS calcd. for C12H14O2 190.099 found 
190.101. 
 
3,6-Dipropyl-benzene-1,2-diol (71): A mixture of 6.6 
g (34.7 mmol) of 70 and 0.73 g 10% Pd/C in 70 ml of 
EtOH was stirred under H2 (1 bar) for 2 d. The reaction 
mixture was filtered and the remaining solution was 
dried on Na2SO4 and concentrated to give a grey solid. Yield: 6.7 g (34.7 
mmol: 100%). 1H-NMR (200 MHz, CDCl3) δ 6.60 (s, 2H), 5.15 (bs, 2H), 2.50 
(t, J = 7.7 Hz, 4H), 1.63-1.57 (m, 4H), 0.94 (t, J = 7.3 Hz, 6H); 13C-NMR 
(50.32 MHz, CDCl3) δ = 141.4, 126.2, 121.0, 31.7, 22.9, 14.0; HRMS calcd. 
for C12H18O2 194.131found 194.130. 
 
(S,S)-1-(4,7-Dipropyl-benzo[1,3,2]dioxaphosphol-2-yl)-
2,5-diphenyl-pyrrolidine (L22): 0.93 g (4.80 mmol) of 71 
was refluxed in 5 ml of PCl3 overnight. The excess PCl3 was 
removed by distillation. The resulting oil was dissolved in 5 
ml of Et2O and 0.65 ml (4.80 mmol) Et3N. To the cooled 
solution (0°C) was added dropwise a solution of 1.07 g 
(4.80 mmol) 13 in 5 ml Et2O. The mixture was stirred for 
2h at RT. The suspension was filtered over Celite and the filtrate was 
concentrated. The remaining oil was purified by column chromatography. 
(Si2O; pentane:EtOAc 10:1). The obtained solid was recrystallized to give 
colorless crystals. Yield 55 mg (0.12 mmol; 2.6%). 1H-NMR (200 MHz, 
CDCl3) δ = 7.34-7.15 (m, 10H), 6.60 (d, J = 7.7 Hz, 1H), 6.38 (d, J = 7.7 Hz, 
1H), 4.89 (d, J = 7.1 Hz, 2H), 2.82-2.60 (m, 2H), 2.39-2.23 (m, 2H), 1.86-
1.51 (m, 6H), 1.31-1.13 (m, 2H), 1.07 (t, J = 7.3 Hz, 3H), 0.73 (t, J = 7.1 
Hz, 3H); 13C-NMR (50.32 MHz, CDCl3) δ = 145.6, 145.5, 128.9, 128.1, 
127.8, 126.7, 126.1, 124.6, 121.8, 121.2, 63.0, 62.9, 62.5, 52.5, 48.0, 
33.4, 33.4, 32.0, 30.6, 23.2, 22.1, 18.6, 14.1, 13.9; 31P-NMR (81 MHz, 
CDCl3) δ =143.2; HRMS calcd. for C28H32NO2P 445.217 found 445.216; 
[α]D20 = -29° (c= 0.43, CHCl3). 
 
(S)-1-Benzo[1,3,2]dioxaphosphol-2-yl-pyrrolidine-2-
carboxylic acid methyl ester (L23): The ligand was 
obtained as a colorless sticky oil in 30% yield. 1H-NMR 
(200 MHz, CDCl3) δ = 7.05-6.87 (m, 4H), 4.28-4.24 (m, 
1H), 3.70 (s, 3H), 3.06-2.98 (m, 2H), 2.09-2.01 (m, 2H), 
1.84-1.73 (m, 2H); 13C-NMR (50.32 MHz, CDCl3) δ = 174.1, 145.9, 145.8, 
121.8, 121.7, 111.3, 111.1, 59.4, 59.1, 52.3, 44.6, 44.5, 30.7, 30.6, 24.8; 
31P-NMR (81 MHz, CDCl3) δ =141.8; HRMS calcd. for C12H14NO4P 267.066 























carboxylic acid benzyl ester (L24): The ligand was 
obtained as a colorless sticky oil in 60% yield. 1H-NMR 
(200 MHz, CDCl3) δ = 7.42-7.33 (m, 5H), 7.05 (dd, J = 
2.4 Hz, 6.8 Hz, 1H), 6.97-6.87 (m, 3H), 5.19 (d, J = 
12.1 Hz, 1H), 5.12 (d, J = 12.1 Hz, 1H), 4.34-4.30 (m, 
1H), 3.12-3.00 (m, 2H), 2.16-2.00 (m, 2H), 1.80-0.88 
(m, 2H); 13C-NMR (50.32 MHz, CDCl3) δ = 173.4, 146.0, 145.9, 145.8, 
145.7, 135.4, 128.4, 128.2, 128.1, 121.8, 121.7, 111.2, 111.1, 66.9, 59.4, 
59.2, 44.5, 44.4, 30.6, 30.5, 24.6; 31P-NMR (81 MHz, CDCl3) δ =141.9; 





cyclohexyl ester (L25): The ligand was obtained as a 
colorless sticky oil in 36% yield. 1H-NMR (200 MHz, 
CDCl3) δ = 6.97-6.94 (m, 1H), 6.92-6.89 (m, 1H), 6.84-
6.80 (m, 2H), 4.62 (dt, J = 4.4 Hz. 10.6 Hz, 1H), 4.21-
4.17 (m, 1H), 2.99-2.88 (m, 2H), 2.07-1.82 (m, 4H), 
1.73-1.62 (m, 5H), 1.58-1.42 (m, 2H), 1.16-0.90 (m, 2H), 0.86 (dd, J = 4.4 
Hz, 5.7 Hz, 6H), 0.70 (d, J = 7.0 Hz, 3H);13C-NMR (50.32 MHz, CDCl3) δ = 
173.2, 146.2, 146.1, 146.0, 145.9, 121.7, 121.6, 111.2, 111.1, 60.1, 59.8, 
46.9, 44.2, 44.2, 40.6, 34.1, 31.3, 30.8, 30.7, 26.0, 24.7, 23.1, 21.9, 20.8, 
15.9; 31P-NMR (81 MHz, CDCl3) δ =142.5; HRMS calcd. for C21H30NO4P 




cyclohexyl ester (L26): The ligand was obtained as a 
colorless sticky oil in 47% yield. 1H-NMR (200 MHz, 
CDCl3) δ = 7.06-6.86 (m, 4H), 4.70 (dt, J = 4.4 Hz. 10.8 
Hz, 1H), 4.28-4.24 (m, 1H), 3.01-2.90 (m, 2H), 2.09-
1.85 (m, 3H), 1.84-1.67 (m, 6H), 1.51-1.40 (m, 2H), 
1.26-0.95 (m, 2H), 0.91 (d, J = 6.2 Hz, 6H), 0.76 (d, J = 7.0 Hz, 3H); 13C-
NMR (50.32 MHz, CDCl3) δ = 173.2, 146.2, 146.1, 146.0, 145.9, 121.7, 
121.6 111.2, 111.0, 60.0, 59.8, 46.8, 44.1, 40.6, 34.1, 31.3, 30.6, 30.6, 
26.1, 24.6, 23.2, 22.0, 20.8, 16.1; 31P-NMR (81 MHz, CDCl3) δ =142.7; 


































General procedure for hydrogenations: 
 
In a glass tube, 0.81 mg (2 µmol) of Rh(COD)2BF4, 4 µmol of ligand (2 µmol 
in case of the bidentate ligands L8 and L9), 200 µmol of the substrate and 
4 ml of solvent, was added. This small glass tube was placed in a semi-
automated autoclave with eight reactors (Endeavor™) that was purged 4 
times with nitrogen and once with hydrogen. Then, the autoclave was 
pressurized with 5 or 25 bar of hydrogen. The reaction mixture was stirred 
for 16 h. A sample of the resulting mixture was filtered over a silica plug 
and subjected to conversion (1H-NMR) and e.e. determination (capillary 
GC). Full conversion was observed in most cases. As typical examples the 
isolated yields for 25, 27, 28 and 59 were determined. The complete 
reaction mixtures were filtered over a short silica plug (EtOAc) to yield the 
corresponding products in 99% yield. Absolute configurations were 
determined by comparison with reference compounds (59, 60, 64), 
literature values (GC or HPLC injections; 15, 24, 25, 26, 27, 28, 62), 
optical rotation (61) or assigned by analogy through chiral GC elution 
order (63, 65). 
Table 2.6: E.e. determination for compounds 15, 24-31, 59-65 and 77. 
Entry Compound Method Retention time (min) Retention time (min) 
1 15 A 6.7 (R) 7.1 (S) 
2 24 B 12.8 (R)  14.9 (S) 
3 25 C 3.4 (R) 3.9 (S) 
4 26 D 11.5 (S) 11.7 (R) 
5 27 E 15.8 (S) 16.7 (R) 
6 28 F 39.4 (S) 41.0 (R) 
7 29 K 11.6 (R) 14.1 (S) 
8 30 B  6.9a 8.1a 
9 31 L 10.9 (R) 13.6 (S) 
10 59 G 12.8 (S) 13.9 (R) 
11 60 H 15.8 (S) 16.7 (R) 
12 61 H 13.5 (S) 14.6 (R) 
13 62 E 9.0 (S) 9.5 (R) 
14 63 I 12.1 (S) 12.7 (R) 
15 64 E 14.0 (S) 15.4 (R) 
16 65 E 17.0 (S) 17.6 (R) 
17 77 J 13.0 (S) 13.9 (R) 
a) Absolute configuration is not known 
 
Method A: CP Chiralsil-L-Val from Chrompack (30m x 0.25mm x 0.12µm), 160°C 
Method B: Chiralcel-OD (0.46 cm x 25 cm), i-PrOH: heptane 1:9 










Method D: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 160°C 
Method E: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 170°C 
Method F: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 130°C 
Method G: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 100°C 
Method H: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 140°C 
Method I: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 150°C 
Method J:  CP Chiraldex G-TA from Altrack (30m x 0.25 mm x 0.125 µm), 80°C 
Method K: Chiralcel-OD (0.46 cm x 25 cm), i-PrOH: heptane 5:95 
Method L: CP Chiralsil-L-Val from Chrompack (30m x 0.25mm x 0.12µm), 100°C 
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In this chapter, the results of a study on the rhodium-catalyzed asymmetric 
hydrogenation of N-acyl dehydroalanine with a chiral water-soluble 
monodentate phosphoramidite ligand are described. Enantioselectivities up 
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3.1   Introduction 
3.1.1   Organic synthesis in water 
Water is a very attractive solvent for organic synthesis from an 
economical as well as an environmental point of view.1 Extensive research 
has been done on the use of water as solvent for (stereoselective) organic 
reactions, such as Diels-Alder reactions, oxidations and reductions, 
Claisen rearrangements, and aldol condensations. Also the field of 
transition metal catalyzed reactions, applying water as a solvent, has been 
studied extensively. Examples of these reactions are: cross-coupling 
reactions, Diels Alder reactions, Heck reactions, carbonylations, 
hydroformylations and hydrogenations.  
3.1.2   Hydrogenations in water 
Although hydrogenation reactions in water are well documented,2 only a 
limited number of reports have appeared describing asymmetric 
hydrogenations in an aqueous environment. In general, the low water 
solubility of many catalysts and substrates causes a decrease in reaction 
rate. The obvious way to avoid this problem is to make these ligands 
water-soluble. In most cases, chiral ligands used for these reactions are 
water-soluble analogues of well-known bidentate phosphines (e.g. BINAP, 
DIOP, BDPP and BIFAP)3 as well as ligands based on carbohydrates4 or 
amino acids (Figure 3.1).5   
The use of biphasic systems makes it possible to recycle these water 
soluble ligands.6 In a series of articles, Sinou and co-workers report the 
use of sulphonated phosphines in a mixed solvent system of water and 
ethylacetate.7 The product and the catalyst could be obtained separately by 
a simple phase-separation. The aqueous phase, containing the catalyst, 
could be reused. Uemera et al. applied the same strategy as described 
before, using a water-soluble catalyst based on sugar derivatives.4d,e They 
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Figure 3.1: Water-soluble phosphorus ligands. 
An alternative method to increase the efficiency of catalysts in aqueous 
media is by adding surfactants. In 1992, Oehme and co-workers reported 
that the asymmetric hydrogenation of a variety of α-dehydroamino acids in 
aqueous media could be promoted by the addition of surfactants.8 In the 
following years, a variety of surfactants were introduced by Oehme and 
Selke for the rhodium-catalyzed asymmetric hydrogenation of different 
substrates.9 Whereas the increase of reaction rates is a concentration 
effect, the reason for the increase in enantioselectivity is still not fully 
understood.9n,o Concentration of the substrate and catalyst in a 
hydrophobic surrounding might be an explanation, although there is a 
range of factors which play a role, e.g. solubility of substrate, cmc,10 











3.1.3   BICOL 
The number of C2-symmetric biaryl ligands for transition metal 
catalyzed reactions has steadily increased since the introduction of BINAP 
by Noyori in the early 80’s.11 Most of these ligands are based on BINOL,12 
although other backbones have been used as well, for example DuPhos,13 
SpiroPhos14 or the TunaPhos family of ligands of Zhang and co-workers.15 
Modification in the BINOL backbone is still a tedious and time- 
consuming work. An alternative for the BINOL backbone was developed by 
Hiemstra and co-workers e.g., the dibenzofuran-based diphosphine BIFAP 
(L7) (Figure 3.2).3e Advantage of the dibenzofuran backbone is the high 
regioselectivity in the sulphonation of BIFAP (L7) to obtain its water-
soluble equivalent BIFAPS (L3) (Figure 3.1). The two ligands showed 
excellent results in the asymmetric Ru-catalyzed hydrogenation of several 
substrates in both organic solvents and in aqueous media.3e The nitrogen 
analogue of BIFAP (L7), BICAP (L8) (Figure 3.2) showed excellent results in 
the asymmetric hydrogenation of methyl acetoacetate and dimethyl 
itaconate.16, 17 The presence of the amine functionality in the backbone 
makes it easy to substitute the BICOL, which is the precursor of BICAP 



















(S)-BIFAP (L7)  
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3.1.4   Goal of this research 
The goal of this research is the design and synthesis of a water-soluble 
monodentate phosphoramidite, and application of this as a ligand in 
rhodium-catalyzed hydrogenation. It was decided to use BICOL (7) as a 
backbone due to the possibility of easy modification. To increase the 
solubility of the ligand in water, BICOL (7) was equipped with polyethylene 
glycol chains. 
The project is a co-operation between the groups of Van Maarseveen / 
Hiemstra and Minnaard / Feringa. The synthesis described in the following 
paragraphs has been performed by Dr. Stephane Leleu and Drs. Vanessa 
A. M. Appelman. 
3.2   Synthesis of PegPhos 
3.2.1   Synthesis of 3-hydroxycarbazole 
The synthesis of BICOL (7) has been carried out according to a route 
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The initial tetrahydrocarbazole 3 was synthesized by a method 
developed by Rogers and Corson.18 The Fisher indole reaction of 
cyclohexanone (1) and p-methoxyphenylhydrazine (2) proceeded smoothly 
and gave the tetrahydrocarbazole 3 in a moderate yield. Dehydrogenation 
of 3 on 10% Pd/C, deactivated by water, gave 4 in almost quantitative 
yield. Deactivation of the catalyst appeared to be essential. The yield of 
demethoxylated side-product 5 was much higher when the catalyst was 
not deactivated.  Use of the deactivated catalyst gave only traces (≈1%) of 
the unwanted side-product. Deprotection of the methoxy group by 48% 
HBr(aq) in acetic acid yielded 3-hydroxycarbazole (6) in good yield. 
3.2.2   Oxidative coupling 
The key step in the synthesis of BICOL (7) is the oxidative dimerization of 
3-hydroxycarbazole (6) (Scheme 3.2). It was chosen to perform the reaction 
with VO(acac)2 as a catalyst, although other catalysts gave similar 
results.17  The reaction was monitored by TLC and stopped after complete 
disappearance of the starting material. Immediate removal of the catalyst 
by filtration after completion appeared to be necessary to avoid 
overoxidation of the diol to, probably, quinone-like products. The reaction 
could be performed on a 2 g scale. Attempts to perform the reaction on a 












VO(acac)2, O2, 2-4 h
(42-46%)
 
Scheme 3.2: Oxidative coupling of 3-hydroxycarbazole (6). 
3.2.3   Resolution of (±)-BICOL 
Resolution of the enantiomers of (±)-BICOL (7) was done using (R) or (S)-
menthyl chloroformate as resolving agent (Scheme 3.3). Reaction of 7 with 
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(R)-menthyl chloroformate gave diastereomers 8, which could be separated 
by column chromatography. Removal of the resolving agents by reduction 




















































































3.2.4   Synthesis of PegPhos 
(S)-(+)-PegPhos (L9) could be synthesized in three steps starting from 
















































1) TBAF, THF, 1h






Scheme 3.4: Synthesis of (S)-(+)-PegPhos (L9). 
Protection of the hydroxy groups with TBDMSCl proceeded smoothly 
and (S)-9 was obtained in 90% yield. Alkylation of (S)-9 with bromoacetic 
acid derivative 1019 was troublesome. Product 11 was obtained in a poor 
yield of 20%. Deprotecting of the TBDMS diether by TBAF and 
subsequently reaction of the dihydroxy compound (not shown) with HMPT 
gave the monodentate phosphoramidite L9 in 77% yield over two steps. 
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The 31P-NMR showed a single peak at 148 ppm, which is typically for 
phosphoramidites.20 Furthermore, no traces of amines were detected in the 
1H- and 13C-NMR spectra. Also the characteristic IR-absorption of the 
carbonyl was observed at 1750 cm-1. 
3.3   Hydrogenations with PegPhos  
 
The catalytic performance of PegPhos (L9) as a 
ligand was compared with MonoPhos which has proven 
to be highly effective in the asymmetric hydrogenation 
of dehydroamino acids.21 The catalyst was obtained by 
reaction of two equivalents of the ligand with 
Rh(COD)2BF4 in CH2Cl2 and subsequent removal of the 
solvent. N-acyl dehydroalanine (12) was chosen as a representative and 
reasonably water-soluble substrate,. The hydrogenation reactions were 
performed in a semi-automated eight reactors Endeavor™ autoclave 
pressurized with 10 bar of hydrogen. The results are depicted in Table 3.1. 









1 mol% Rh(L)2(COD)BF4, solvent




E.e.a,b T.O.F. E.e.a,b T.O.F. 
1 DCM 57 133 90 (82) 400 (133) 
2 MeOH 90 1200 95 (94) 600 (600) 
3 MeOH / H2O 89 1200  65 (54)  20 (55) 
4 H2O 82 55 16 (0) 20 (25) 
5 MeOH + 10% SDS 74 2000 89 (83) 63 (300) 
6 MeOH / H2O + 10% SDS 82 750 80 (47) 20 (92) 
7 H2O + 10% SDS 89 600 83 (79) 50 (44) 
(a) E.e’s in % obtained by chiral GC (b) Products were analyzed as their corresponding methyl 















Initial experiments in CH2Cl2 with 1 mol% of catalyst gave full 
conversion and e.e.’s of 57% and 90% for PegPhos (L9) and MonoPhos 
(L10), respectively, both in favor of the R-product and with T.O.F.’s of 133 
h-1 and 400 h-1 (entry 1). By switching to the more polar solvent MeOH, 
especially PegPhos (L9) showed a remarkable 9-fold reaction rate increase 
and also the e.e. now reached 90% (entry 2). The addition of water slowed 
down the activity of MonoPhos (L10) drastically (30-fold) together with a 
significant drop in e.e., in sharp contrast with PegPhos (L9) that fully 
maintained its high rate and enantioselectivity (entry 3). In pure water 
PegPhos (L9) still gave a respectable 82% e.e. but at the expense of a 22-
fold rate decrease while under the same conditions MonoPhos (L10) almost 
lost most of its enantioselectivity and activity (entry 4). These results show 
that the phosphoramidite moiety is compatible with water, which has been 
observed before in for example Rh-catalyzed boronic acid additions.22 
The addition of surfactants is known to influence the activity and 
selectivity of homogeneous catalysts in highly polar solvents (vide supra). 
Regarding the e.e., no beneficial effect could be seen after addition of SDS* 
to MeOH (entry 5) or a water/MeOH mixture (entry 6). By adding SDS to 
water, the e.e. obtained with MonoPhos (L10) increased from 16% to 83% 
together with a more than 2-fold increase of the T.O.F. Under these 
conditions PegPhos (L9) clearly outperformed MonoPhos by reaching an 
e.e. of 89% as well as a 12-fold higher rate. 
3.4   Conclusion 
 
It has been shown that the versatile biscarbazole-based BICOL skeleton 
can be functionalized with polyethylene glycol units at the nitrogen atoms 
to render this highly apolar moiety soluble in water. The resulting PegPhos 
was superior to the parent MonoPhos (L10) ligand, in activity as well as in 
selectivity, in the enantioselective Rh-catalyzed hydrogenation of N-acyl 
dehydroalanine (12) in polar solvents, especially in water. Whereas there 
are a number of bidentate phosphine ligands which give better 
enantioselectivities (> 99%)23 in the hydrogenation of dehydroamino acids,1-
4 to the best of our knowledge, this is the first monodentate ligand 
                                                     
* SDS = Sodium Dodecyl Sulphate 
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providing high e.e.’s in the Rh-catalyzed enantioselective hydrogenation of 
N-acyl dehydroalanine (12) in water. 




Unless noted otherwise, chemicals were purchased from commercial 
suppliers and used without purification. DMF was distilled from KOH and 
stored over mol sieves (4Å). CH2Cl2 was freshly distilled from calcium 
hydride. THF, toluene and diethyl ether were freshly distilled from sodium 
and benzophenone as indicator. MeCN was dried over Na2SO4. Et3N was 
stored over KOH pallets. PE 60-80 was freshly distilled. All reactions were 
performed under inert atmosphere and using flame dried glassware. 
Column chromatography was performed using silica gel (Aldrich 70-230 
mesh, 60 Å). Rf values were obtained by using thin layer chromatography 
(TLC) on silica gel-coated plastic sheets (Merck silica gel 60 F254). 1H- and 
13C-NMR spectra were determined with a Bruker ARX 400 (400 and 100.6 
MHz respectively). Chemical shifts (δ) are given in ppm downfield from 
tetramethylsilane. 31P nuclear magnetic resonance spectra were 
determined with a Varian Mercury-VX (121.5 MHz). Chemical shifts (δ) are 
given in ppm downfield from 85% H3PO4. Coupling constants (J) are given 
in Hertz. IR spectra were obtained from NaCl plates using a Perkin-Elmer 
1310 spectrophotometer and wavelengths (ν) are in cm-1. 
 
2-Methoxy-6,7,8,9-tetrahydrocarbazole (3): To a 
mixture of 90.2 g (0.92 mol) of freshly distilled 
cyclohexanone (1) and 330 ml of acetic acid was added in 
portions 100 g (0.92 mol) of p-methoxyphenylhydrazine (2) 
at room temperature. After refluxing for 3 h, the mixture was cooled to 0°C 
for 5 h. The mixture was filtered to obtain a brown powder. The product 
was obtained in 55% yield after recrystallization from a 5:1 mixture of 
water/ethanol. Spectroscopic data were according to the literature 
values.24 
 
2-Methoxycarbazole (4): To a solution of 1 g (4.96 mmol) 
of 3 in 10 ml of p-cymene and 2 ml of water, was added 
0.5 g of 10 % Pd on carbon. The resulting suspension was 
refluxed for 48 h, cooled to room temperature and filtered. 
The residue was washed with boiling ethyl acetate. The collected filtrates 
were concentrated in vacuo to yield a 99:1 mixture of 4 and 5. (0.96 g; 4.95 

















2-Hydroxycarbazole (6): To a solution of 30 g (0.15 mol) 
of 4 in 140 ml of AcOH was added a solution of 138.5 ml, 
(1.21 mol) of 48 % HBr(aq). After 2 h refluxing the mixture 
was cooled to 0°C. The product precipitated and was 
collected by filtration. The product was obtained as grey crystals. (20.4 g; 
0.11 mol; 73 %) Spectroscopic data were according the literature values.26 
 
 (Rac)-(9H,9'H-[4,4']-Bicarbazolyl-3,3'-diol (BICOL) (7): 
To a solution of 2 g (10.8 mmol) of 3-hydroxycarbazole (6) 
in 80 ml of acetonitrile was added 140 mg (0.5 mmol) of 
VO(acac)2. The solution was stirred at room temperature 
while the progress of the reaction was monitored by TLC. 
The reaction was immediately stopped by filtration on 
celite/silica gel (80/20) after disappearing of the starting 
material. The residue was washed with 50 ml of 
acetonitrile. The solution was concentrated in vacuo. The obtained dark 
solid was purified by column chromatography (PE/EtOAc, 80/20 → 60/40) 
affording 0.91 g (2.50 mmol; 46%) of 7 as a brown powder. M.p. 327-
328°C; Rf = 0.24; 1H-NMR (CDCl3): δ = 10.14 (bs, 2H), 7.53 (d, J = 8.6 Hz, 
2H), 7.35 (d, J = 8.1 Hz, 2H), 7.22 (d, J = 8.6 Hz, 2H), 7.12 (m, 4H), 6.71 
(d, J = 8.0 Hz, 2H), 6.56 (dt, J = 7.2, 0.9 Hz, 2H; 13C-NMR (CDCl3): δ = 
147.9, 140.4, 134.1, 124.4, 123.0, 122.0, 121.1, 117.2, 116.6, 114.9, 
110.3, 110.1. 
 
Resolution of BICOL (7): To a stirred solution of 10 g 
(27.5 mmol) of racemic BICOL 7 and 19.1 ml of 
triethylamine in 250 ml of acetonitrile was added dropwise 
13.6 ml (63 mmol) of (-)-(1R)-menthyl chloroformate. The 
solution was stirred for 1 h at room temperature. The 
reaction was quenched by addition of 300 ml of ethyl 
acetate and 100 ml of water. The layers were separated 
and the aqueous layer was extracted with ethyl acetate (2 x 150 ml). The 
combined organic layers were dried over Mg2SO4, filtered and concentrated 
under reduced pressure.  
Purification and separation of diastereomers by chromatography 
(PE/CH2Cl2, 80/20 → 40/60 → CH2Cl2) afforded 3 fractions : the first 
fraction was the diastereomer (-)-(aS)-8 (2.40 g, 12 % out of maximum 
50%), the second fraction was a mixture of  (-)-(aS)-8 and (-)-(aR)-8 in 3:1 
ratio (7.20 g) and the third fraction was the diastereomer (-)-(aR)-8 (6.80 g, 
34 % out of maximum 50%).  
The third fraction was recrystallized from refluxing diisopropyl ether 
yielding 6.2 g (8.52 mmol; 31% out of maximum 50%) of (-)-(aR)-8 as a 
white solid. 
The first and the second fraction (9.60g, 13.2 mmol) were dissolved in 250 
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portions over 10 min. The reaction mixture was stirred for an additional 1 
h at room temperature. The reaction was carefully quenched by adding 
water, ethyl acetate and 1M aqueous HCl. The layers were separated and 
the aqueous layer was extracted with EtOAc (3 x 100 ml). The combined 
organic layers were dried over MgSO4, filtered and concentrated under 
reduced pressure. Purification by column chromatography (PE/EtOAc, 1:1) 
afforded a mixture of (S)-BICOL and (R)-BICOL as a white solid (3.08 g, 
8.46 mmol, 64%). This mixture was reacted with (+)-(1S)-
menthylchloroformate according to the procedure described above, yielding 
a mixture of (+)-(aS)-8 and (+)-(aR)-8. Purification and separation of the 
diastereomers was done by column chromatography (PE/CH2Cl2, 80/20 → 
40/60 → CH2Cl2). The second fraction recrystallized from diisopropyl ether 
yielding 4.41g (6.06 mmol; 72% out of maximum 75%) of (+)-(aS)-8 as a 
white solid. 
Both diastereomerically pure (-)-(aR)-8 and (+)-(aS)-8 were treated with 
LiAlH4 according to the procedure described above, yielding 
enantiomerically pure (R)-(+)- and (S)-(-)-BICOL, respectively, in 65 % yield 
after purification by chromatography (PE/EtOAc, 50/50). Spectroscopic 
data were according the literature values.17 
 
(S)- 3,3'-Bis-(tert-butyl-dimethyl-silanyloxy)-
9H,9'H-[4,4']-bicarbazolyl (9): A solution of 0.5 g 
(1.37 mmol) of BICOL 7, 0.33 g (4.80 mmol) of 
imidazole and 0.54 g (3.57 mmol) of TBDMSCl in 14 
ml of MeCN was heated at 65 ºC for 4 h. After cooling 
to room temperature the reaction was quenched with 
H2O, EtOAc and NaHSO4. The product was extracted 
with EtOAc and the water layer was extracted twice 
with EtOAc. The organic layers were washed with brine, dried over MgSO4, 
filtered and concentrated in vacuo. Purification by column chromatography 
(PE/EtOAc, 60/40) afforded 0.69 g (1.23 mmol; 90%) of 9 as an off-white 
foam. Rf = 0.57. 1H-NMR (CDCl3): δ = 7.93 (s, 2 H), 7.37 (d, J = 8.8 Hz, 2 
H), 7.26 (d, J = 7.2 Hz, 2 H),  7.18 (t, J = 7.2 Hz, 2 H), 7.01 (d, J = 8.8 Hz, 2 
H), 6.91 (d, J = 8.0 Hz, 2 H), 6.69 (t, J = 7.2 Hz, 2 H), 0.5 (s, 18 H), -0.01 
(s, 6 H), -0.20 (s, 6 H); 13C-NMR (CDCl3): δ = 146.8, 140.2, 134.5, 124.9, 
123.9, 123.5, 122.3, 121.7, 118.4, 117.4, 109.6, 109.5, 25.0, 17.5, -4.7, -
4.9; IR (NaCl, cm-1) 3422, 2954, 2929, 2886, 2856, 1507, 1478, 1435, 
1287, 1265, 952, 832. 
 
Bromo- acetic acid 2-{2-[2-(2-methoxy-ethoxy)-
ethoxy]-ethoxy}-ethyl ester (10): To a stirred solution of 
2.58 g (18.5 mmol) of bromoacetic acid and 1.9 ml (22.2 
mmol) of SOCl2 in 185 ml of CH2Cl2, was added dropwise 5.0 g (24 mmol) 
tetraethylene glycol monomethylether and the resulting reaction mixture 





















under reduced pressure and the product was purified using column 
chromatography on silica gel (eluens PE/EtOAc, 1:3) yielding 4.98 g (15.6 
mmol, 82%) of a yellow liquid. Rf-value: 0.15 (PE/EtOAc, 50/50); 1H-NMR 
(CDCl3): δ = 4.31 (t, J = 4.7 Hz, 2H), 3.85 (s, 2H), 3.71 (t, J = 4.8 Hz, 2H), 
3.64 (m, 10H), 3.53 (t, J = 4.9 Hz, 2H), 3.36 (s, 3H); 13C-NMR (CDCl3): δ =  
166.95,  71.64, 70.35, 70.32, 70.31, 70.28, 70.21, 68.45, 65.03, 58.72, 




silanyloxy)-9H,9’H-[4,4’]-bicarbazole (11): To a 
solution of 722 mg (1.22 mmol) of 9 in 12.2 ml of THF 
and 12.2 ml of DMF, was added dropwise 6.4 ml (2.81 
mmol) of KHMDS at 0ºC and the solution was stirred 
at room temperature for 1 h. Next 1.9 g (4.88 mmol) 
of 10 was added dropwise and the resulting reaction 
mixture was stirred at room temperature for 4 h. 
After this time a two-phase separation was carried 
out using EtOAc, water, brine and NH4Cl. The organic 
phase was washed 4 times with water and brine, dried over MgSO4, filtered 
and concentrated under reduced pressure. The product was further 
purified using column chromatography on silica gel (PE/EtOAc, 4/1 – 
0/1/5% MeOH) yielding 260 mg (0.24 mmol; 20%) of a brown oil. Rf-value: 
0.24 (EtOAc); 1H-NMR (CDCl3): δ = 7.26 (d, J = 4.0 Hz, 2H), 7.13 (d, J = 3.6 
Hz, 2H), 7.05 (d, J = 8.4 Hz, 2H), 6.80 (d, J = 8.0 Hz, 2H), 6.64 (m, 2H), 
5.01 (s, 4H), 4.24 (m, 4H), 3.58 (m, 24H), 3.47 (m, 4H), 3.29 (d, J = 6.8 Hz, 
6H), 0.38 (s, 18H), -0.11 (s, 6H), -0.31 (s, 6H); 13C-NMR (CDCl3): δ = 
168.63, 147.16,  141.10, 135.70, 125.20, 123.64, 123.24, 122.52, 121.90, 
118.76, 117.41, 107.43, 76.68,  70.56, 68.77, 65.29, 64.43, 61.01, 58.98, 
44.75, 30.88, 25.78, 25.06, 17.56, -4.60; IR (NaCl, cm-1) :  1754 ; [α]D20 
(S)-11 = - 77º (c = 0.55, CHCl3). 
 
(S)-N-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy}-ethyl 
ester- 9H,9’H-[4,4’]-bicarbazole-3,3’-diol (14): To a 
solution of 260 mg (0.23 mmol) of 11 in 5 ml of THF, 
was added 0.48 ml (0.47 mmol) of TBAF. The resulting 
reaction mixture was stirred at room temperature for 
10 min. After this time a two-phase separation was 
carried out using EtOAc, water, brine and 0.5 M 
NaHSO3. The organic phase was washed once with 
water and brine, dried over MgSO4, filtered and 
concentrated under reduced pressure. The product 
was further purified using column chromatography on 
silica gel (PE/EtOAc, 0/1) yielding 169 mg (0.20 mmol; 
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(CDCl3): δ = 7.40 (d, J = 8.8 Hz, 2H), 7.30 (d, J = 8.7 Hz, 2H), 7.20 (m, 4H), 
6.76 (d, J = 7.8 Hz, 2H), 6.71 (m, 2H), 5.03 (s, 4H), 4.27 (m, 4H), 3.57 (m, 
18H), 3.47 (m, 10H), 3.28 (s, 6H); 13C-NMR (CDCl3): δ = 168.47,  148.32, 
141.00, 135.50, 125.61, 122.48, 121.92, 121.56, 119.14, 115.17, 113.46, 
109.67, 107.87, 71.65, 70.23, 68.57, 64.63, 60.19, 58.73, 53.58, 44.59, 




ethyl ester- 9H,9’H-[4,4’]-Bicarbazole-3,3’-O2PNMe2 
(L9): To a solution of 169 mg (0.19 mmol) of 15 in 2 
ml of MeCN, was added 37 µl (0.19 mmol) of HMPT 
and the resulting reaction mixture was refluxed at 70 
ºC for 4 h. After this time the solvent was removed 
under reduced pressure to obtain 160 mg (0.17 mmol; 
90%) of a yellow oil. Rf-value: 0.04 (EtOAc); 31P-NMR 
(CDCl3): δ = 148.05; 1H-NMR (CDCl3): δ = 7.47 (d, J = 
1.6 Hz, 2H), 7.40 (d, J = 8.7 Hz, 1H), 7.33 (d, J = 8.7 
Hz, 1H), 7.24 (m, 4H), 6.85 (d, J = 8.0 Hz, 1H), 6.76 
(d, J = 8.0 Hz, 1H), 6.51 (m, 2H), 5.14 (m, 4H), 4.34 (m, 4H), 3.63 (m, 4H), 
3.54 (m, 20H), 3.49 (m, 4H), 3.35 (d, J = 1.2 Hz, 12H), 2.55 (d, J = 8.9 Hz, 
6H); 13C-NMR (CDCl3): δ = 168.24, 168.20, 144.87, 144.75, 140.99, 
140.94, 137.68, 137.13, 125.65, 122.63, 122.50, 122.43, 122.21, 119.63, 
118.80, 118.76, 108.85, 108.75, 107.63, 107.57, 71.72, 70.39, 70.32, 
70.29, 68.64, 68.61, 64.57, 64.48, 58.82, 44.60, 35.93, 35.72 ; IR (NaCl, 
cm-1) : 1751 ; [α]20D (S)-12 = + 297º (c = 0.1, CH3Cl). 
 
Preparation of the catalysts: 
  
 The Rh complex was prepared in situ by dissolving 0.083 mmol of 
Rh(COD)2BF4 and 0.17 mmol of the appropriate ligand in 3.2 ml of CH2Cl2. 
The yellow solution was stirred for 30 min and subsequently concentrated 
under reduced pressure, yielding a yellow powder which was used without 
purification.  
 
General procedure for hydrogenation: 
 
 In a glass tube, 0.002 mmol of the preformed Rh-complexes, 36 mg 
(0.2 mmol) of the substrate and 4 ml of solvent, were mixed. This small 
glass tube was placed in a semi-automated autoclave with eight reactors 
(Endeavor™) that was purged 4 times with nitrogen and once with 
hydrogen. Then, the autoclave was pressurized with 10 bar of hydrogen. 
The reaction mixture was stirred for 8 h. The solvents were removed under 
vacuum. The residue was dissolved in 2 ml of MeOH and 0.3 ml of a 2M 






















was filtered over a silica plug and subjected to conversion and e.e. 
determination (capillary GC; CP Chiralsil-L-Val from Chrompack (30m x 
0.25mm x 0.12µm), 110°C; 3.4 (R), 3.9 (S)).  
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In this chapter the synthesis and application of monodentate 
diamidophosphites ligands in rhodium-catalyzed asymmetric hydrogenation 
























4.1   Introduction 
4.1.1   Diamidophosphites1 
Phosphines are the most abundantly used chiral ligands in asymmetric 
hydrogenation.2  To change the electronic properties of the phosphorus 
atoms of these ligands, electron donating or withdrawing groups can be 
introduced on the R moieties (Figure 4.1). Another method to tune these 
properties is to replace the carbon atom in the first coordination sphere3 of 
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Figure 4.1: Phosphorus ligands. 
A number of successful ligands with heteroatoms in the first 
coordination sphere of phosphorus are the monodentate phosphonite, 4 
phosphite5 and phosphoramidite6 ligands introdced by, respectively, the 
groups of Pringle, Reetz and Feringa, De Vries and Minnaard. These 
ligands led to excellent results in the rhodium-catalyzed asymmetric 
hydrogenation of a wide variety of prochiral substrates. 7  All of these 
ligands were based on BINOL (2).  
Hardly any research has been done on the synthesis and application of 
chiral diamidophosphites. It is expected that these compounds have 
different properties compared to phosphoramidites or phosphites when 
applied as ligands in asymmetric catalysis. For example, introducing 
nitrogen substituents at the phosphorus creates more steric bulk around 
the phosphorus, compared to oxygen, due to the higher degree of 
substitution of nitrogen.8 Furthermore, diamidophosphites are assumed to 
have a more electron-rich phosphorus compared to phosphoramidites or 
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phosphites. The combination of these factors could result in a catalyst 
with different activities or/and enantioselectivities. 
4.1.2   Application of diamidophosphites 
Only a few examples are known of diamidophosphites in asymmetric 
catalysis. Gavrilov and co-workers introduce in a series of articles different 
diamidophosphites, which all have an additional amine functionality as an 
extra coordination site. 9  These ligands gave modest to good e.e.’s in 
asymmetric allylic substitution reactions.  
The most versatile diamidophospite has been 
developed by Buono and co-workers. 10  QUIPHOS has 
proved to be a versatile ligand for a variety of transition 
metal catalyzed asymmetric reactions, such as: 
palladium-catalyzed allylic substitutions, 11  copper-
catalyzed Diels-Alder reactions 12  and copper-catalyzed 
conjugate addition reactions.13 
An example of a diamidophosphite in an iridium-catalyzed allylic 
alkylation has been reported by Helmchen and co-workers. The obtained 
results were rather poor.14 Reetz and co-workers have reported a series of 
diamidophosphites which have been tested in the rhodium-catalyzed 
asymmetric hydrogenation (see also §4.2.4, Figure 4.3).15 The results were 
rather poor with a maximum of 30% e.e. in the hydrogenation of dimethyl 
itaconate (39). 
Börner et al. and van Leeuwen et al. reported independently the use of 
diamidophosphites in the Rh-catalyzed hydroformylation of alkenes,16 with 
modest results. 
4.1.3   Goal of this research 
The goal of this research is to synthesize a library of new monodentate 
diamidophosphites based on 1,1’-binaphthyl-2,2’-diamine. The option to 
introduce different substituents on the nitrogens makes it possible to 
create a library with a lot of structural variation. These new ligands will be 















4.2   Synthesis of 1,1’-binaphthyl-2,2’-diamine 
4.2.1   Literature procedures 
We anticipated to make a library of ligands based on 1,1’-binaphthyl-
2,2’-diamine (1). Unfortunately, the price of the diamine is distinctly higher 
than the price of BINOL (2,2’-dihydroxy-1,1’-binaphthyl) (2).17 Since the 







Figure 4.2: 1,1’-Binaphthyl-2,2’-diamine (1) and BINOL (2). 
4.2.1.1   Coupling of 2-naphthol 
 
The shortest route to 1 is by a method reported by Clemo and 
Dawson 18 . 2-Naphthol (3) and hydrazine hydrate are heated in an 
autoclave to 170°C and stirred for 48 h (Scheme 4.1). The reaction is 
thought to proceed via a benzidine rearrangement, 19  with 4 as an 
intermediate, although the exact mechanism of this reaction is still under 
debate. The reaction can be performed on large scale with good yields. A 
disadvantage of this method is that the diamine is obtained as a racemic 
mixture which makes it necessary to perform a resolution afterwards, 
which has been described in literature.20  
Unfortunately, several attempts to perform this synthesis failed. The 
reaction was performed on small scale in a Pyrex tube or on large scale in 
an autoclave. In all cases mixtures of 2-naphthol and the highly toxic 2-
naphthylamine were obtained (see also § 4.2.1.2).21 No further attempts 
were made to reproduce the reaction.22 
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Scheme 4.1: Synthesis of 1,1’-binaphthyl-2,2’-diamine (1) via benzidine 
rearrangement.18 
4.2.1.2   Coupling of 2-naphthylamine 
 
Another well known procedure is the homo-coupling of 2-
naphthylamine.23 As mentioned before, 2-naphthylamine is a highly toxic 
compound, which can cause cancer. The toxicology of 2-naphthylamine is 
described as follows in the material safety data sheets (MSDS):24 “A series 
of studies of workers with occupational exposure to it has shown clear 
evidence of a link between exposure and bladder cancer. In the UK it 
appears in Schedule 2 of the Control of Substances Hazardous to Health 
Regulations (COSHH) 1999 which prohibits its "manufacture and use for all 
purposes".”21 Due to the health risks it was decided to relinquish this 
strategy. 
4.2.2   BINOL as starting material 
As mentioned before, BINOL (2) is a cheap starting material, of which 
both enantiomers can be obtained in pure form. With these features BINOL 
(2) would be an ideal starting material for the synthesis of 1. But, to the 
best of our knowledge, there are no successful reactions known in which 
BINOL (2) is transformed into 1,1’-binaphthyl-2,2’-diamine (1). 
4.2.2.1   Bucherer reaction 
 
The most classical method to transform naphthols into the 
corresponding naphthyl amines is the Bucherer reaction, 25  in which a 
naphthol reacts with sodium bisulfite and ammonia to form the 










naphthyl amine reacts with sodium bisulfite and water to form the 
corresponding naphthol.  
Unfortunately, attempts to perform this reaction with BINOL (2) failed 
(Scheme 4.2). Only starting material was recovered. In the 1H-NMR 
spectrum, traces of another aromatic system were observed, which 







rac-2 rac-1  
Scheme 4.2: Attempted Bucherer reaction on BINOL (2). 
4.2.2.2   Buchwald-Hartwig chemistry 
 
A very elegant method to transfer BINOL (2) into 1,1’-binaphthyl-2,2’-
diamine (1)  would be a palladium-catalyzed coupling of an amine and a 
BINOL derivative. Buchwald and Hartwig developed a wide variety of Pd-
catalysts to aminate aromatic systems.26 
In a standard reaction an aryl compound with a good leaving group and 
an amine react under influence of a catalytic palladium source, a ligand 






RPd / Ligand, Base+
LG = Leaving Group  
Scheme 4.3: Buchwald-Hartwig amination. 
Frequently used leaving groups for these kinds of reactions are halides, 
and in particular bromides. Unfortunately, 2,2’-dibromo-1,1’-binaphthyl is 
not commercially available and should be synthesized. This can be achived 
from BINOL (2), but the disadvantage is that the temperature at which this 
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reaction is performed is 320°C. At these elevated temperatures BINOL (2) 
racemizes, which makes a resolution step necessary afterwards. Another 
frequently used leaving group is a triflate. The bistriflate of BINOL (2) can 
be synthesized in a straightforward reaction, with good yields. 
Unfortunately, attempts by Singer and Buchwald to substitute the 
bistriflate of BINOL (2) with an ammonia equivalent failed.28 
4.2.2.3   Curtius Rearrangement 
 
A classical method to introduce amine moieties on an aromatic system 




NH2∆, -N2 H2O, base
765  
Scheme 4.4: Curtius Rearrangement. 
Starting from the acyl azide 5, the isocyanate 6 is formed with evolution 
of N2 when the acyl azide 5 is heated. Acyl azides can be explosive if 
isolated. To diminish the risks of explosions, acyl azides should preferably 
be kept in solution. 30  Hydrolysis of the isocyanate 6 forms a unstable 
carbamic acid, which decomposes in the primary amine 7. Reaction of the 
isocyanate with an alcohol or an amine would form respectively the 
corresponding carbamate or urea. The Curtius rearrangement of 1,1'-
binaphthalenyl-2,2'-dicarboxylic acid (16) has been reported. 
Unfortunately, 16 is not commercially available and must be synthesized 
in a multistep synthesis.31 
4.2.2.4   Other methods 
 
Another method to transform hydroxy groups on an aromatic ring into 
an NH2 group is by converting the hydroxy group first into an aryl diethyl 
phosphate. Treatment of this diethyl phosphate compound with potassium 
amide (K in liquid NH3) and an iron catalyst (Fe(NO3)3·9H2O) yields the 
corresponding primary aromatic amines (Scheme 4.5).32  The formation of 










Unfortunately, the second reaction, the transformation of 10 into 1 did not 















Scheme 4.5: Attempted synthesis of 1,1’-binaphthyl-2,2’-diamine. 
4.2.3   Multistep synthesis of (±)-1 
Since all previous mentioned methods failed or were not suitable, a 
multistep synthesis was designed based on a Curtius rearrangement. The 
synthesis is depicted in Scheme 4.6. 
In the first step, commercially available 2-methylnaphthalene (11) was 
brominated, according to a procedure described by Adams and Binder.33 
The reaction proceeded by slow addition of the bromine (>7 h for 1 mol) 
under exclusion of light. A modest yield was obtained, probably due to 
side-reactions, such as overbromination. 
The 1-bromo-2-methylnaphthalene (12) was oxidized to the 
corresponding carboxylic acid, by a Co(OAc)2·4H2O mediated oxidation 
reaction with molecular oxygen, as described by Bringmann et al.34 The 
product was obtained in a good yield. Refluxing 12 in acetone with K2CO3 
and MeI resulted in formation of 1-bromo-2-naphthoic acid methyl ester 
(13).  
Coupling of 13, under the standard Ullmann coupling conditions, 
according to a method described by Seki et al.,35 gave the corresponding 
binaphthalene in good yield. Besides the desired product, 14% of the 
dehalogenated substrate was isolated, which is a common side-product of 
the Ullmann coupling (not shown). 36 Direct coupling of 13 to form 16 is 
not possible under standard Ullmann conditions. Attempts to perform the 
coupling reaction under the milder conditions developed by Lin et al.37 
were unsuccessful. 
Monodentate Diamidophosphite Ligands 
 
 






Diacid 16 was obtained almost quantitatively after saponification of 15 
in refluxing 2M KOH. Refluxing of 16 in SOCl2 with pyridine gave the 
corresponding diacid dichloride (not shown). A subsequent nucleophilic 
substitution with NaN3 gave the dicarboxylic azide (not shown), which was 
subjected to a Curtius rearrangement under aqueous conditions to give 
1,1’-bisnaphthyl-2,2’-diamine 1 in 42% yield over three steps.31  
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1) SOCl2, pyridine, ∆
2) NaN3, 
    acetone / H2O










Scheme 4.6: Synthesis of 1,1’-bisnaphthyl-2,2’-diamine (1). 
A shorter route to 1 would be the direct coupling of 12, followed by 
oxidation of 17. A Curtius rearrangement of 16 would then give the 
desired 1,1’-bisnaphthyl-2,2’-diamine (1) in only four steps from 2-methyl-
naphthalene (11). The coupling of 12 went smooth via the NiCl2(PPh3)2 
catalyzed homo-coupling of 12 with its corresponding Grignard reagent. 
Unfortunately, attempts to oxidize 17 failed. No conversion was observed 










under more harsh conditions, using KMnO4 as an oxidant, no product 
could be isolated. 
4.2.4   Attempts to make 1,1’-bisnaphthyl-2,2’-diamine (1)-based 
diamidophosphites 
Racemic 1,1’-bisnaphthyl-2,2’-diamine (1) was used to study the 
synthesis and stability of 1,1’-bisnaphthyl-2,2’-diamine (1) based 
diamidophosphites.  Racemic 1 was alkylated at the amine moieties using 
two different approaches. Compounds 19 and 21 were synthesized in a 
two step procedure via the corresponding acyl amide or aldimine / 
ketimine. Subsequent reduction of these compounds gave the N,N’-







































(rac)-22: 34%    R = i-Pr        (rac)-24:  34%















Scheme 4.7: Synthesis of N,N-alkylated 1,1’-binaphthyl-2,2’-diamines. 
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Kočovskỳ and co-workers reported a one-pot reaction for the alkylation 
of 1, in which different alkyl groups were introduced in good yields.38 
Several attempts to repeat these reactions, never led to the same yields. In 
addition to the desired dialkylated products, large amounts of 
monoalkylated products were obtained. The mixture of mono- and 
dialkylated products could be separated by column chromatography (see 
§4.5). Furthermore, the total yield was rather disappointing (Scheme 4.7c). 
Unfortunately, attempts to synthesize diamidophosphites from the N,N’ 
-dialkylated products failed. In all cases hydrolyzed or oxidized products 
were obtained. For example, the attempted synthesis of 26 is shown in 
Scheme 4.8. Bulky amines react in general slowly with 
phosphoro(di)chloridites. To make them more reactive, the Li-amide was 
formed with n-BuLi. The amide reacts then with the corresponding 









1) n-BuLi, THF, 0°C
2) PhOPCl2, toluene
(rac)-26  
Scheme 4.8: Attempted synthesis of diamidophosphites. 
During our research an article by Reetz and co-workers was 
published,15 in which the synthesis and application of diamidophosphites 
were reported. They isolate the ligands as their corresponding BF3-
adducts. Attempts to deprotect the ligands and to purify them failed. The 
ligands were deprotected in situ and used as obtained. Only ligand a in 
Figure 4.3 led to a reasonable conversion (80%) and a modest e.e. (30%) in 
the rhodium-catalyzed asymmetric hydrogenation of dimethyl itaconate 
(39) (1.3 bar H2; CH2Cl2; 20 h).15 All other tested ligands gave conversions 
of only 2-10%. Based on our own experience and the results reported by 















a) R = CH3; X = OCH3
b) R = CH3; X = NEt2
c) R = Ph; X = OCH3
d) R = Ph; X = CH3
e) R = Ph; X = CH(CH3)2
f) R = Ph; X = c-C6H11
g) R = Ph; X = C(CH3)3
 
Figure 4.3: Diazaphospholidines synthesized by Reetz and co-workers.15 
4.3   Diamidophosphites based on α-phenylethylamine 
4.3.1   Synthesis of ligands 
To study the properties of monodentate diamidophosphite ligands, 
simplified model compounds were synthesized. These compounds were 
based on diamines 30 and 31. The synthesis of these diamines is 
straightforward, with the cheap α-phenylethylamine (27) and the 
corresponding dihaloalkanes 28 and 29 as starting materials (Scheme 
4.9).  
The reaction of amines 30 and 31 with dichlorophosphites gave the 
desired diamidophosphites 32-35. The crude products were used as 
obtained. All ligands were pure according to 31P-NMR. The values of the 31P 
signals are in the range of 122-125 ppm. This is in the same range of those 
of phosphites and about 20 ppm smaller than phosphoramidites.39 On the 
other hand, traces of free (up to 5%) amine were observed in the 1H- and 
13C-NMR spectra. Any attempt to purify the products failed. The 
compounds are unstable on silica as well as on Al2O3.40 Purification by 
distillation has not been attempted, since distillation under reduced 
pressure of structural similar compounds resulted in violent explosions.41 
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28 : n = 1, X = Cl
29 : n = 2, X = Br
(S,S)-30 : n = 1 (73%)





Scheme 4.9: Synthesis of ligands 32-35. 
4.3.2   Hydrogenation experiments 
Ligands 32-35 were tested in the rhodium-catalyzed asymmetric 
hydrogenation of four benchmark substrates. The results are depicted in 
Table 4.1.  
All reactions were run for 16 h with a H2-pressure of 10 bar and 1 mol% 
of catalyst. In general the ligands performed disappointingly. No full 
conversion has been obtained and the enantioselectivities were low to 
modest. The best results were obtained for substrate 38 with ligands 32 
and 33; 31% and 12% e.e., at 30% and 46% conversion, respectively. 
Surprisingly, despite the fact that both ligands have the same 
configuration, opposite configurations of the products were obtained. 
Although no hard conclusion can be drawn from the results, a small trend 
can be observed. Introduction of a phenol group in the ligands increases 
the reaction rate. Higher conversions have been observed for ligands 33 










is also the fact that the best results (t.o.n. and e.e.’s) were obtained with 
substrate 38. As already mentioned in chapter 2, turnover numbers of the 
hydrogenation of enamides are in general lower than those for α-
dehydroamino acids. 
Table 4.1: The rhodium-catalyzed hydrogenation of benchmark substrates 













36 37 38 39
Substrate Product
Rh(COD)2BF4, 32-35




36 37 38 39 
1 32 10 (17) 0 (5) 31 (30) 9 (2) 
2 33 0 (72) 0 (19) 12 (46) 5 (6) 
3 34 0 (6) 0 (6) 0 (10) 0 (5) 
4 35 6 (20) 0 (2) 0 (13) 5 (5) 
(a) Reaction conditions: 0.2 mmol of substrate in 4 ml of solvent with 0.002 mmol of 
Rh(COD)2BF4 and 0.004 mmol of diamidophosphite (b) Reactions were run for 16 h (c) E.e.’s 
were determined by chiral GC (for details see experimental section), conversion are indicated 
in brackets (d) In all cases the R enantiomer of ligand gave the S enantiomer of products. 
 
The poor results obtained for ligands 32-35 are most likely caused by 
the sensitivity of these ligands. Since purification was troublesome, crude 
ligands have been used. These ligands might have contained traces of free 
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4.4   Conclusion 
 
A successful synthesis of 1,1’-binaphthyl-2,2’-diamine (1) is described, 
in which the desired product can be obtained in 6 steps. The reactions 
could be performed on multigram scale with reasonable to excellent yields. 
Unfortunately, attempts to make diamidophosphites ligands based on 1 
failed.  
The synthesis of diamidophosphites based on α-phenylethylamine (27) 
was successful. Purification of these ligands was not possible and the 
crude ligands were used as obtained. The ligands were tested in rhodium-
catalyzed asymmetric hydrogenation of four benchmark substrates. The 
results were disappointing. Low conversions, and only in a few cases 
optically active products were obtained.  
The high instability towards hydrolysis makes it difficult to isolate and 
purify diamidophosphites. The high instability is probably caused by the 
basic character of the nitrogens. It is known that the nitrogen of a P-N 
bond in a phosphoramidite has a strong sp2-character.42 Presumably, in a 
diamidophospite, one of the nitrogens has a strong sp2-character, while the 
other has a strong sp3-character. The sp3-hybridized nitrogen will be more 
basic then the sp2-hybridized one. A possibility to stabilize these ligands 
might be the introduction of electron-withdrawing groups on the nitrogens, 
since these groups stabilize the nitrogen phosphorus bond.16a,b The 
disappointing results obtained so far in hydrogenation reactions might be 
caused by the impurities in the ligands. The stability, easy synthesis and 
excellent results obtained, makes phosphoramidites and phosphites a 
more versatile and interesting class of ligands compared to the 


















For general remarks see Chapter 2.  
 
General procedure hydrogenations: 
 
In a glass tube, 0.81 mg (2 µmol) of Rh(COD)2BF4, 4 µmol of ligand (2 eq.), 
200 µmol of the substrate and 4 ml of solvent, were added. This small 
glass tube was placed in a semi-automated autoclave with eight reactors 
(Endeavor™) that was purged 4 times with nitrogen and once with 
hydrogen. Then, the autoclave was pressurized with 10 bar of hydrogen. 
The reaction mixture was stirred for 16 h. A sample of the resulting 
mixture was filtered over a silica plug and subjected to conversion (1H-
NMR) and e.e. determination (capillary GC). Absolute configurations were 
determined by comparison with reference compounds (36, 38 and 39) or 
compared to literature values (GC injection; 37).43  
 
1-Bromo-2-methyl-naphthalene (12).33 To a cooled (0°C) 
solution of 142 g (1.00 mol) 2-methylnaphthalene (11) in 300 
ml of CCl4 was added a catalytic amount of Fe powder and I2. 
The solution was shielded from light. To this solution was 
added 162 g (1.01 mol) Br2 in 300 ml of CCl4 over a period of 7 h. The 
temperature was not allowed to rise above 5°C. The mixture was stirred 
overnight at rt after the last addition. The reaction mixture was washed 
with 10% NaOH(aq) (5x 200 ml), water (2x 200 ml) and brine (200 ml). The 
organic layer was separated and dried over CaCl2, filtered and 
concentrated in vacuum. The crude mixture was purified by vacuum 
distillation. The product was obtained as yellow oil at 126-128°C (4 mbar). 
Yield: 119.3 g (0.54 mol; 54%) 1H-NMR (300 MHz, CDCl3):44 δ 8.26 (d, J = 
8.4 Hz, 1H), 7.75 (d, J = 8.1 Hz, 1H), 7.66 (d, J = 8.4 Hz, 1H), 7.53 (t, J = 
7.0 Hz, 1H), 7.42 (d, J = 7.0 Hz, 1H), 7.30 (d, J = 8.4 Hz, 1H), 2.59 (s, 3H); 
13C-NMR (75.48 MHz, CDCl3): δ 136.0 (s), 133.0 (s), 132.5 (s), 128.7 (d), 
128.0 (d), 127.0 (d), 126.9 (d), 125.6 (d), 124.0 (s), 24,2 (q); HRMS for 
C11H9Br: calcd. 219.989 found 219.989. 
 
1-Bromo-naphthalene-2-carboxylic acid (13).34 A mixture of 26.3 g (0.12 
mol) 12, 5.90 g (24.0 mmol) Co(OAc)2·4H2O, 3.20 ml (36 
mmol) 2-butanone in 100 ml acetic acid was heated in an 
autoclave to 120°C. The mixture was stirred overnight under 
a constant pressure of 4 bar O2. The autoclave was cooled to 
room temperature and the pressure was released. The mixture was poured 
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and dried in a vacuum oven at 60°C. The product was obtained as a 
slightly brown solid. Yield: 26.3 g (0.10 mol; 87%) 1H-NMR (300 MHz, 
DMSO-d6):45 δ 13.59 (bs, 1H), 8.28 (d, J = 8.4 Hz, 1H), 8.02-7.98 (m, 2H), 
7.73-7.62 (m, 3H); 13C-NMR (75.48 MHz, DMSO-d6):45 δ 168.0 (s), 133.9 (s), 
133.0 (s), 130.8 (s), 128.1 (d), 128.0 (d), 127.7 (d), 127.5 (d), 126.9 (d), 
124.9 (d), 119.4 (s); HRMS for C11H7BrO2: calcd. 249.963 found 249.964. 
 
1-Bromo-naphthalene-2-carboxylic acid methyl ester 
(14).35 A suspension of 6.35 g (25.3 mmol) 13, 10.9 g (79.0 
mmol) K2CO3 and 8.00 ml (128 mmol) MeI in 70 ml acetone 
was refluxed for 6 h. The mixture was filtered and the 
filtrate was concentrated in vacuo. The product was purified 
by column chromatography (SiO2; hexane/EtOAc 6:1; Rf = 0.50). The 
product was obtained as a yellow solid. Yield 5.88 g (22.2 mmol; 88%). 1H-
NMR (300 MHz, CDCl3):46 δ 8.36 (d, J = 8.4 Hz, 1H), 7.72 (d, J = 8.1 Hz, 
2H), 7.61-7.46 (m, 3H), 3.94 (s, 3H); 13C-NMR (75.48 MHz, CDCl3): δ 167.7 
(s), 135.0 (s), 132.0 (s), 131.0 (s), 128.4 (d), 128.0 (d), 128.0 (d) (2x), 127.7 
(d), 125.6 (d), 122.5 (s), 52.6 (q); HRMS for C12H9BrO2: calcd. 263.979 
found 263.979. 
 
(±)-[1,1']Binaphthalenyl-2,2'-dicarboxylic acid dimethyl 
ester  (15).35 A mixture of 26.7 g (0.10 mol) 14 and 40.0 g 
activated Cu-powder in 250 ml freshly distilled DMF was 
refluxed overnight (16 h) under an argon atmosphere. The 
mixture was filtered and the residue was boiled in toluene. 
The organic layers were combined, washed with 2M HCl(aq), 
water and dried on Na2SO4. After removal of Na2SO4 by filtration, the 
organic layer was concentrated. The product was purified by column 
chromatography (SiO2; hexane/EtOAC 10:1; Rf = 0.21). The product was 
obtained as a white solid. Yield: 14.4 g (38.9 mmol; 77%). 1H-NMR (300 
MHz, CDCl3):46 δ 8.15 (d, J = 8.8 Hz, 2H), 7.98 (d, J = 8.8 Hz, 2H), 7.90 (d, 
J = 8.1 Hz, 2H), 7.47 (dd, J = 7.7 Hz, 7.3 Hz, 2H), 7.19 (dd, J = 8.1 Hz, 7.3 
Hz, 2H), 7.05 (d, J = 8.8 Hz, 2H), 3.46 (s, 6H); 13C-NMR (75.48 MHz, 
CDCl3): δ 167.0 (s), 140.3 (s), 134.8 (s), 132.8 (s), 127.9 (d), 127.8 (d), 
127.6 (d), 127.2 (d), 127.0 (s), 126.6 (d), 125.8 (d), 51.8 (q); HRMS for 
C24H18O4: calcd. 370.120 found 370.120. 
 
As a side product, naphthalene-2-carboxylic acid methyl 
ester was isolated as a white solid. (SiO2; hexane/EtOAc 
10:1; Rf = 0.50). Yield: 2.79 g (15 mmol; 15%).   1H-NMR 
(300 MHz, CDCl3): δ 8.62 (s, 1H), 8.07 (dd, J = 8.8 Hz, 1.46 
1H), 7.95 (d, J = 7.7 Hz, 1H), 7.88 (d, J = 8.4 Hz, 2H), 7.62-
7.51 (m, 2H), 3.99 (s, 3H); 13C-NMR (75.48 MHz, CDCl3): δ 167.2 (s), 135.4 
















126.6 (d), 125.2 (d), 52.2 (q); HRMS for C12H10O2: calcd. 186.068 found 
186.067. 
 
(±)-[1,1']Binaphthalenyl-2,2'-dicarboxylic acid (16). A 
suspension of 14.4 g (38.9 mmol) 15 in 500 ml 2M KOH(aq) 
was heated at reflux overnight. The mixture was cooled 
and extracted with CH2Cl2 (200 ml). The aqueous layer was 
acidified with conc. HCl(aq) and the white precipitate was 
collected and dried in the air. The product was obtained as 
a white solid. Yield: 13.0 g (38.0 mmol; 98%). 1H-NMR (300 MHz, DMSO-
d6):47 δ 12.42 (bs, 2H), 8.10 (s, 4H), 8.04 (d, J = 8.4 Hz, 2H), 7.54 (dd, J = 
7.7 Hz, 7.3 Hz, 2H), 7.27 (dd, J = 8.1 Hz, 7.0 Hz, 2H), 6.89 (d, J = 8.4 Hz, 
2H); 13C-NMR (75.48 MHz, DMSO-d6):47 δ 167.2 (s), 139.0 (s), 133.8 (s), 
132.0 (s), 127.6 (s), 127.5 (d), 127.1 (d), 127.0 (d), 126.2 (d) (2x), 125.6 (d); 
HRMS for C22H14O4: calcd. 342.089 found 342.090. 
 
(±)-[1,1']Binaphthalenyl-2,2'-diamine (1).31 13.0 g (38.0 
mmol) 16, was refluxed in 120 ml SOCl2 and 4.60 ml 
pyridine. The solution was concentrated and the remaining 
oil was dissolved in 100 ml CCl4. The precipitate was 
removed by filtration and the filtrate was concentrated to 
yield a yellow solid. The solid was dissolved in 80 ml 
acetone. 13.2 g (0.20 mol) NaN3 in 35 ml water was added dropwise to this 
solution. The solution was cooled in an ice-bath and 120 ml water was 
added. The mixture was stored in the refrigerator over the weekend. The 
precipitate was collected after warming to room temperature. The solid was 
dissolved in 200 ml toluene and the solution dried over CaCl2. The solution 
was filtered and the organic solution was heated at 50°C for 30 min and 
then 90 min at reflux. 50 ml of a 50% KOH(aq) solution was added to the 
hot stirred solution. The mixture was refluxed for an additional 90 min. 
The toluene layer was separated, 200 ml 6M HCl(aq) was added and the 
resulting mixture heated for 15 min. The acidic aqueous layer was 
separated, filtered and neutralized with concentrated NaOH. The 
precipitate was collected and dried in air. The product was obtained as off 
white solid after recrystallization from EtOH/acetone. Yield 4.53 g (16 
mmol; 42%). 1H-NMR (300 MHz, CDCl3):50 δ 7.78-7.75 (m, 4H), 7.23-7.02 
(m, 8H), 3.60 (bs, 4H); 13C-NMR (75.48 MHz, DMSO-d6): δ 142.6 (s), 133.6 
(s), 129.4 (d), 128.4 (s), 128.1 (d), 126.8 (d), 123.9 (d), 122.4 (d), 118.3 (d), 
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 (±)-2,2'-Dimethyl-[1,1']binaphthalenyl (17).48 To 2.00 g (83.3 
mmol) Mg in 10 ml ether was added dropwise a solution of 
16.3 g (13.8 mmol) 12 in 60 ml ether/benzene (1:1). The 
mixture was stirred at reflux for 1 h after the addition was 
completed. To the solution of Grignard reagent was added 0.50 
g (0.76 mmol) NiCl2(PPh3)2. To this mixture was added dropwise a solution 
of 14.8 g (67.0 mmol) 16 in 30 ml ether. The reaction mixture was refluxed 
overnight. The reaction was quenched with 2M HCl(aq). The layers were 
separated and the aqueous layer was extracted twice with ether. The 
organic layers were washed with water, brine and dried on Na2SO4. The 
solution was concentrated after removal of the Na2SO4. The crude product 
was purified by bulb-to-bulb distillation. The product was obtained as a 
yellow sticky gum. (250-300°C / 0.5 mbar). Yield: 14.0 g (49.6 mmol; 74%). 
1H-NMR (300 MHz, CDCl3):49 δ 7.87 (d, J = 8.1 Hz, 2H), 7.86 (d, J = 8.4 Hz, 
2H), 7.49 (d, J = 8.4 Hz, 2H), 7.37 (dd, J = 8.1 Hz, 7.0 Hz, 2H), 7.18 (dd, J 
= 8.1 Hz, 7.0 Hz, 2H), 7.04 (d, J = 8.4 Hz, 2H), 2.02 (s, 6H); 13C-NMR 
(75.48 MHz, CDCl3): δ 135.1 (s), 134.3 (s), 132.7 (s), 132.2 (s), 128.7 (d), 
127.9 (d), 127.4 (d), 126.1 (d), 125.6 (d), 124.9 (d), 20.0 (q); HRMS for 
C22H18: calcd. 282.141 found 282.141. 
 
 (±)-N-(2'-Acetylamino-[1,1']binaphthalenyl-2-yl)-
acetamide (18).50 1.20 g (4.23 mmol) 1 and 1.00 ml (14.0 
mmol) acetyl chloride were dissolved in 8 ml pyridine and 
40 ml benzene. The mixture was stirred overnight at room 
temperature. The reaction was quenched with 10% 
NaOH(aq) (100 ml). The solid was removed by filtration. The 
aqueous solution was extracted with benzene (2x 50 ml). The combined 
organic layers were washed with brine, dried on MgSO4, filtered and 
concentrated. The remaining solid was crystallized from EtOH/hexane. The 
product was obtained as an off-white powder. Yield 0.50 g (1.36 mmol; 
32%). 1H-NMR (300 MHz, CDCl3):50 δ 8.33 (d, J = 8.8 Hz, 2H), 8.04 (d, J = 
9.2 Hz, 2H), 7.95 (d, J = 8.1 Hz, 2H), 7.46 (dd, J = 8.1 Hz, 7.0 Hz, 2H), 7.33 




(19).50 A suspension of 0.50 g (1.35 mmol) 18 and 0.30 g 
LiAlH4 in 35 ml freshly distilled THF was refluxed for 3 h. 
The reaction mixture was cooled to room temperature and 
quenched with 5 ml water and 5 ml 15% NaOH(aq). The 
white precipitate was removed by filtration and the residue 
was washed thoroughly with ether. The combined organic layers were 
washed with water, brine, dried on Na2SO4, filtered and concentrated. The 
crude product was purified with column chromatography (SiO2; 




















Yield: 150 mg (0.44 mmol; 33%). 1H-NMR (300 MHz, CDCl3):50 δ 7.87 (d, J 
= 8.8 Hz, 2H), 7.75 (d, J = 8.3 Hz, 2H), 7.10-7.23 (m, 6H), 6.95 (d, J = 7.7 
Hz, 2H), 3.59 (bs, 2H), 3.20 (q, J = 7.1 Hz, 4H), 1.09 (t, J = 7.1 Hz, 6H); 
13C-NMR (75.48 MHz, CDCl3): δ 144.6 (s), 133.9 (s), 129.5 (d), 128.0 (d), 
127.6 (s), 126.6 (d), 123.8 (d), 121.8 (d), 114.2 (d), 112.1 (s), 38.6 (t), 12.2 
(q); HRMS for C24H24N2: calcd. 340.194 found 340.193.  
 
General procedure for the synthesis of 22 and 23:38 
To a solution of 14 mmol of the corresponding ketone in 10 ml THF and 
20% H2SO4(aq) was added over a period of 10 min, simultaneously, a 
solution of 284 mg (1 mmol) 1 in 10 ml THF and 530 mg (14 mmol) solid 
NaBH4. The mixture was stirred for an additional 15 min at room 
temperature. The mixture was poured into 100 ml 2% KOH(aq) and 
extracted with EtOAc (3x 20 ml). The combined organic layers were washed 
with brine, dried over Na2SO4, filtered and concentrated. The remaining 
crude mixtures were purified by column chromatography (SiO2; toluene). 
The products were obtained as white solids. 
 
 (±)-N,N'-Diisopropyl-[1,1']binaphthalenyl-2,2'-diamine 
(22). Rf = 0.51. Yield 125 mg (0.34 mmol; 34%). 1H-NMR 
(300 MHz, CDCl3):38 δ 7.85 (d, J = 8.8 Hz, 2H), 7.74 (d, J = 
7.7 Hz, 2H), 7.24 (d, J = 8.8 Hz, 2H), 7.21-7.08 (m, 4H), 
6.90 (d, J = 8.1 Hz, 2H), 3.77 (m, 2H), 3.38 (bs, 2H), 1.04 
(d, J = 6.2 Hz, 6H), 0.95 (d, J = 6.2 Hz, 6H); 13C-NMR 
(75.48 MHz, CDCl3):38 δ 143.1 (s), 134.0 (s) (2x), 129.5 (d), 127.9 (d), 127.6 
(s), 126.5 (d), 124.0 (d), 121.8 (d), 115.0 (d), 44.6 (d), 23.2 (q); HRMS for 
C26H28N2: calcd. 368.225 found 368.224. 
 
(±)-N'-Isopropyl-[1,1']binaphthalenyl-2,2'-diamine (24). 
Rf = 0.29. Yield 112 mg (0.34 mmol; 34%). 1H-NMR (300 
MHz, CDCl3):38 δ 7.88-7.76 (m, 4H), 7.29-6.96 (m, 8H), 
3.78 (q, J = 6.2 Hz, 1H), 3.49 (bs, 3H), 1.05 (d, J = 6.2 Hz, 
3H), 0.98 (d, J = 6.2 Hz, 3H); 13C-NMR (75.48 MHz, 
CDCl3):38 δ 143.9 (s), 142.5 (s), 133.9 (s), 133.6 (s), 129.4 
(d) (2x), 128.3 (s), 128.0 (d) (2x), 127.2 (s), 126.6 (d) (2x), 124.0 (d),123.8 
(d), 122.3 (d), 121.9 (d), 118.2 (d), 115.2 (d), 113.0 (s), 112.1 (s), 44.7 (d), 
23.2 (q), 23.1 (q); HRMS for C23H22N2: calcd. 326.178 found 326.179. 
 
 (±)-N,N'-Dicyclohexyl-[1,1']binaphthalenyl-2,2'-
diamine (23). Rf = 0.71. Yield 125 mg (0.28 mmol; 28%).  
1H-NMR (300 MHz, CDCl3):38 δ 7.81 (d, J = 9.2 Hz, 2H), 
7.72 (d, J = 7.7 Hz, 2H), 7.23 (d, J = 9.2 Hz, 2H), 7.15-
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3.38-3.32 (m, 2H), 2.13-1.78 (m, 4H), 1.60-1.49 (m, 6H), 1.31-1.14 (m, 4H), 
1.04-0.92 (m, 4H), 0.88-0.71 (m, 2H); 13C-NMR (75.48 MHz, CDCl3):38 δ 
143.9 (s), 134.0 (s), 129.3 (d), 127.5 (s), 127.9 (d), 126.4 (d),124.0 (d), 
121.7 (d), 115.0 (d), 112.2 (s), 52.0 (d), 33.6 (t), 25.7 (t), 25.0 (t); HRMS for 
C32H36N2: calcd. 448.288 found 448.289. 
 
 (±)-N'-Cyclohexyl-[1,1']binaphthalenyl-2,2'-diamine 
(25). Rf = 0.28. Yield 98 mg (0.27 mmol; 27%).  1H-NMR 
(300 MHz, CDCl3):38 δ 7.82 (d, J = 9.2 Hz, 1H), 7.78-7.73 
(m, 3H), 7.28 (d, J = 8.8 Hz, 1H), 7.21-7.08 (m, 5H), 6.99 
(d, J = 8.1 Hz, 1H), 6.94 (d, J = 7.7 Hz, 1H), 3.60 (bs, 3H), 
3.38-3.29 (m, 1H), 1.92-1.78 (m, 2H), 1.59-1.48 (m, 3H), 
1.30-1.12 (m, 2H), 1.05-0.72 (m, 3H); 13C-NMR (75.48 MHz, CDCl3):38 δ 
143.8 (s), 142.9 (s), 133.9 (s), 133.8 (s), 129.4 (d), 129.4 (d) (2x), 128.4 (s), 
128.0 (d) (2x), 128.0 (d) (2x), 127.5 (s), 126.6 (d), 126.6 (d), 124.1 (d), 123.7 
(d), 122.3 (d), 121.8 (d), 118.2 (d), 115.2 (d), 112.6 (s), 112.3 (s), 52.1 (d), 
33.8 (t), 33.6 (t), 25.6 (t), 25.0 (t), 24.9 (t); HRMS for C26H26N2: calcd. 
366.210 found 366.208. 
 
(±)-N,N'-Bis-[1-phenyl-meth-(Z)-ylidene]-
[1,1']binaphthalenyl-2,2'-diamine (20). Diamine 1 (1.01 g 
(3.56 mmol) was dissolved in 20 ml EtOH. 0.90 ml (8.92 
mmol) benzaldehyde was added and the resulting mixture 
was stirred overnight at room temperature. The mixture 
was concentrated and the remaining solid was washed 
with pentane. The product was obtained as a white solid. 
Yield: 1.26 g (2.74 mmol; 77%). 1H-NMR (300 MHz, CDCl3): 
δ 8.15 (s, 2H), 7.90 (d, J = 8.4 Hz, 2H), 7.86 (d, J = 8.4 Hz, 
2H), 7.41-6.99 (m, 18H); 13C-NMR (75.48 MHz, CDCl3): δ 160.6 (d), 148.9 
(s), 136.3 (s), 133.5 (s), 131.5 (s), 130.8 (d), 129.0 (d), 128.4 (d), 128.3 (d), 
127.9 (d), 126.7 (d), 126.3 (d), 126.1 (s), 124.6 (d), 119.2 (d); HRMS for 
C34H24N2: calcd. 460.193 found 460.193. 
 
(±)-N,N'-Dibenzyl-[1,1']binaphthalenyl-2,2'-diamine (21). 
To a suspension of 57.0 mg (1.50 mmol) LiAlH4 in 5 ml 
Et2O was added dropwise a solution of 301 mg (0.65 mmol) 
20 in 10 ml Et2O/CH2Cl2 (1:1). The mixture was stirred 
overnight at room temperature. The reaction was 
quenched with concentrated HCl until a clear solution was 
obtained. The aqueous layer was separated. Concentrated 
NaOH was added and the layer was extracted with CH2Cl2. 
Organic layers were washed with brine, dried on Na2SO4, filtered and 
concentrated. The crude product was purified by column chromatography 
(SiO2; toluene (drop of Et3N)). The product was obtained as a white solid. 



















(m, 4H), 7.20-7.03 (m, 18H), 4.38 (s, 4H), 4.20 (bs, 2H); 13C-NMR (75.48 
MHz, CDCl3): δ 144.2 (s), 139.8 (s), 133.8 (s), 129.6 (d), 128.4 (d), 128.1 (d), 
127.7 (s), 126.9 (d), 126.7 (d), 126.7 (d), 123.9 (d), 122.0 (d), 114.1 (d), 
112.0 (s), 47.5 (t); HRMS for C34H28N2: calcd. 464.225 found 464.225. 
 
(±)-[2'-(Diethoxy-phosphoryl)-[1,1']binaphthalenyl-2-
yl]-phosphonic acid diethyl ester (10). 51  (+/-)-Bis-β-
naphthol (2) (10.0 g (35.0 mmol) was dissolved in 300 ml 
ether and the solution was cooled to 0°C. To this 
solution was added simultaneously dropwise 11.0 ml 
(76.0 mmol) diethyl chlorophosphate and 10 ml 20% 
NaOH(aq). The resulting mixture was stirred for 1 h at 0°C and then slowly 
warmed to room temperature where upon the mixture was stirred for an 
additional 3 h. The organic layer was washed with 10% NaOH(aq) (2x 50 ml), 
water (50 ml), brine (50 ml) and dried on Na2SO4. The mixture was filtered 
and concentrated in vacuo. The remaining yellow solid was recrystallized 
from EtOAc/hexane. The product was obtained as a white solid. Yield: 9.6 
g (17.2 mmol: 49%).  1H-NMR (300 MHz, CDCl3): δ 7.89 (d, J = 8.8 Hz, 1H), 
7.80 (d, J = 8.1 Hz, 1H), 7.10 (d, J = 8.8 Hz, 1H), 7.35-7.30 (m, 1H), 7.21-
7.19 (m, 2H), 3.69-3.56 (m, 2H), 3.45-3.35 (m, 2H), 0.96 (t, J = 7.0 Hz, 3H), 
0.74 (t, 7.0 Hz, 3H); 31P-NMR (161.9 MHz, CDCl3): δ -7.96; 13C-NMR (101.0 
MHz, CDCl3): δ 146.5(s, JP-C = 6.11 Hz), 133.3 (s), 130.6 (s), 129.8 (d), 
127.7 (d), 126.7 (d), 125.9 (d), 125.2 (d), 121.3 (s, JP-C = 8.43 Hz), 119.0 (d), 
64.1 (t, JP-C = 18.3 Hz), 64.0 (t, JP-C = 19.5 Hz), 15.5 (q, JP-C = 15.9 Hz), 15.4 
(q, JP-C = 14.7 Hz); HRMS for C28H32O8P: calcd. 558.157 found 558.156. 
 
(S,S)-N,N'-Bis-(1-phenylethyl)-ethane-1,2-diamine 
(30).52 40.5 g (0.33 mol) (S)-(-)-α-phenylethylamine (27) 
was heated to 90°C. 1,2-dichloroethane (28) (9.0 ml 
(0.11 mol) was added dropwise  over a period of 3 h. 
The mixture was stirred overnight at 90°C. The mixture 
was cooled to 60°C, 100 ml KOH(aq) (sat) was added and stirred while 
cooling to room temperature. The aqueous layer was extracted with CH2Cl2 
(3x 75 ml). The combined organic layers were washed with brine and dried 
on Na2SO4. The organic solution was filtered and concentrated in vacuo. 
The excess (S)-(-)-α-phenylethylamine was removed by vacuum distillation. 
The crude product was purified by bulb-to-bulb distillation. The product 
was obtained as slightly yellow oil (bp. = 165-170°C / 0.6 mbar). Yield: 
21.6 g (80.6 mmol; 73%). [α]D20 = -63.1° (c= 1.08, CHCl3)52; 1H-NMR (300 
MHz, CDCl3):52 δ 7.31-7.15 (m, 10H), 3.62 (q, J = 6.6 Hz, 2H), 2.49 (s, 4H), 
1.44 (bs, 2H), 1.30 (d, J = 6.6 Hz, 6H); 13C-NMR (75.48 MHz, CDCl3):52 δ 
145.8 (s), 128.3 (d), 126.7 (d), 126.5 (d), 58.1 (d), 47.3 (t), 24.4 (q); HRMS 
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diamine (31).52 Similar procedure as for 30. Starting 
from 29.3 g (0.24 mol) (R)-(+)-α-phenylethylamine (27) 
and 8.5 ml (83.7 mmol) 1,3-dibromopropane (29), 
the product was obtained as a slightly yellow oil by bulb-to-bulb 
distillation (bp. = 171°C / 0.6 mbar). Yield: 18.6 g (66.0 mmol; 79%). [α]D20 
= 59.0° (c= 1.16, CHCl3);52 1H-NMR (300 MHz, CDCl3):52 δ 7.29-7.15 (m, 
10H), 3.66 (q, J = 6.6 Hz, 2H), 2.50-2.37 (m, 4H), 1.56 (m, 2H), 1.28 (d, J = 
6.6 Hz, 6H); 13C-NMR (75.48 MHz, CDCl3):52 δ 145.8 (s), 128.3 (d), 126.7 
(d), 126.5 (d), 58.4 (d), 46,4 (t), 30,4 (t), 24.4 (q); HRMS for C19H26N2: calcd. 
282.210 found 282.209.  
 
2-propyl phosphorodichlorite.53 To a cooled (0°C) solution of 
14.1 ml (0.15 mol) PCl3 was added dropwise 8.1 ml (0.11 mol) 2-
propanol. The mixture was warmed to room temperature and stirred 
overnight. The solution was distilled under reduced pressure. The product 
was obtained as a colorless liquid (bp. = 84°C; 18 mbar). Yield: 8.6 g (71 
mmol; 67%). 1H-NMR (200 MHz, CDCl3): δ 5.14-4.97 (m, 1H), 1.38 (d, J = 
6.1 Hz, 6H); 31P-NMR (80.96 MHz, CDCl3): δ 173.87; 13C-NMR (75.48 MHz, 
CDCl3): δ 74.8 (d), 22.5(q). 
 
Phenyl phosphorodichlorite.54 To 8.08 g (86.0 mmol) phenol 
was added dropwise 42 ml (0.48 mol) PCl3. The solution was 
refluxed overnight. The excess PCl3 was removed by distillation. The 
resulting crude liquid was purified by vacuum distillation. The product 
was obtained as a colorless liquid (bp. = 53°C; 0.6 mbar). Yield: 11.8 g 
(60.4 mmol; 77%). 1H-NMR (200 MHz, CDCl3): δ 7.42-7.22 (m, 5H); 31P-
NMR (80.96 MHz, CDCl3): δ 176.58; 13C-NMR (75.48 MHz, CDCl3): δ 129.5 
(d), 126.1 (d), 126.7 (d, JP-C = 4.96). 
 
General procedure for the synthesis of 32-35: 
 
To a cooled solution of 5.33 mmol diamine and 1.31 ml (17.5 mmol) Et3N 
in 15 ml ether (double Schlenk vessel) was added 5.33 mmol of the 
corresponding dichlorophosphite. The reaction mixture was allowed to 
warm slowly to room temperature and stirred for 2 h and then filtered. The 
clear solution was transferred under argon to another Schlenk vessel and 
concentrated under reduced pressure. The remaining yellow oils were used 
as obtained. The ligands were pure according to 31P-NMR spectroscopy. In 

















[1,3,2]diazaphospholidine (32). 1H-NMR (400 MHz, 
CDCl3): δ 7.38-7.15 (m, 10H), 4.41-4.37 (m, 1H), 4.21-
4.19 (m, 1H), 4.18-4.06 (m,1H), 3.07-3.00 (m, 1H), 
2.74-2.68 (m, 2H), 1.63 (d, J = 6.6 Hz, 3H), 1.60 (d, J = 
7.0 Hz, 3H), 1.23 (d, J = 6.2 Hz, 3H); 31P-NMR (161.9 
MHz, CDCl3): δ 121.71; 13C-NMR (101.0 MHz, CDCl3): δ 
145.3 (d, JP-C = 6.9 Hz), 144.8 (d, JP-C = 4.6 Hz), 128,3 (d), 128,1 (d), 126.9 
(d), 126.7 (d), 126.7 (d), 126.6 (d), 65.9 (dd, JP-C = 17.6 Hz), 57.7 (dd, JP-C = 
15.3 Hz), 56.5 (dd, JP-C = 23.0 Hz), 48.4 (dt, JP-C = 8.4 Hz), 46.5 (dt, JP-C = 
9.2 Hz), 24.9 (dq, JP-C = 2.3 Hz), 23.8 (dq, JP-C = 15.3 Hz), 22.2 (dq, JP-C = 
13.0 Hz); HRMS for C21H29NO2P: calcd. 356.201 found 356.202; [α]D20 = -
7.5° (c= 1.01, CHCl3).  
 
 (S,S)-2-Phenoxy-1,3-bis-(1-phenylethyl)-
[1,3,2]diazaphospholidine (33). 1H-NMR (400 MHz, 
CDCl3): δ 7.40-7.21 (m, 12H), 7.04-6.98 (m, 3H), 4.50-
4.46 (m, 1H), 4.24-4.21 (m, 1H), 3.21-3.14 (m,2H), 
2.93-2.77 (m, 2H), 1.64 (d, J = 6.6 Hz, 3H), 1.63 (d, J = 
5.5 Hz, 3H); 31P-NMR (161.9 MHz, CDCl3): δ 125.25; 
13C-NMR (101.0 MHz, CDCl3): δ 155.6 (s), 144.8 (d, JP-C 
= 6.9 Hz), 144.2 (d, JP-C = 4.70 Hz), 129.3 (d), 128.4 (d), 128.2 (d), 126.9 (d), 
126.9 (d), 126.6 (d), 121.7 (d), 120.3 (d), 120.2 (d), 57.8 (dd, JP-C = 14.6 Hz), 
56.5 (dd, JP-C = 21.5 Hz), 48.5 (dt, JP-C = 8.4 Hz), 46.95 (dt, JP-C = 9.2 Hz), 
24.1 (dq, JP-C = 16.1 Hz), 22.2 (dq, JP-C = 13.8 Hz); MS: m/z 297; 100%; 
[α]D20 = -9.5° (c= 1.07, CHCl3). 
 
(R,R)-2-Isopropoxy-1,3-bis-(1-phenylethyl)-
[1,3,2]diazaphosphinane (34). 1H-NMR (400 MHz, 
CDCl3): δ 7.44-7.20 (m, 10H), 4.59-4.54 (m, 1H), 
4.27-4.23 (m, 1H), 4.11-4.04 (m,1H), 3.15-3.01 (m, 
2H), 2.59-2.41 (m, 1H), 2.40-2.36 (m, 1H), 1.61 (dd, 
J = 7.0 Hz, 1.5 Hz, 3H), 1.54 (d, J = 7.0 Hz, 3H), 1,51-1.43 (m, 2H), 1.27 (d, 
J = 5.9 Hz, 1.5 Hz, 3H), 1.24 (d, J = 6.2 Hz, 3H); 31P-NMR (161.9 MHz, 
CDCl3): δ 122.39; 13C-NMR (101.0 MHz, CDCl3): δ 145.5 (d, JP-C = 6.1), 
144.3 (d, JP-C = 10.0), 128,0 (d), 127.8 (d), 127.2 (d), 127.0 (d), 126.5 (d), 
126.4 (d), 65.7 (dd, JP-C = 16.9 Hz), 60.4 (dd, JP-C = 29.1 Hz), 58.3 (dd, JP-C = 
3.9 Hz), 41.4 (dt, JP-C = 4.8 Hz), 37.8 (dt, JP-C = 4.6 Hz), 25.9 (t), 24.5 (dq, JP-
C = 3.8 Hz), 24.4 (dq, JP-C = 3.1 Hz), 21.9 (dq, JP-C = 18.4 Hz), 17.7 (dq, JP-C = 
6.1 Hz); HRMS for C22H31N2OP: calcd. 370.217 found 370.216; [α]D20 = 
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[1,3,2]diazaphosphinane (35). 1H-NMR (400 MHz, 
CDCl3): δ 7.46-7.15 (m, 15H), 4.63-4.56 (m, 1H), 
4.28-4.23 (m, 1H), 3.24-3.14 (m, 2H), 2.62-2.42 (m, 
2H), 1.67-1.58 (m, 2H), 1.56 (dd, J = 7.0 Hz, 2.2 Hz, 
3H), 1.43 (d, J = 7.0 Hz, 3H); 31P-NMR (161.9 MHz, 
CDCl3): δ 124.80; 13C-NMR (101.0 MHz, CDCl3): δ 157.5 (s), 144.7 (d, JP-C = 
6.9), 143.6 (d, JP-C = 10.7), 129.3 (d), 128.1 (d), 128.0 (d), 127.0 (d), 127.0 
(d), 126.6 (d), 126.6 (d), 120.2 (d), 120.1 (d), 60.7 (dd, JP-C = 30.7 Hz), 58.6 
(dd, JP-C = 41.4 Hz), 41.6 (dt, JP-C = 4.6 Hz), 37.8 (dt, JP-C = 4.6 Hz), 26.1 (t), 
21.8 (dq, JP-C = 19.2 Hz), 17.4 (dq, JP-C = 5.4 Hz); MS (CI; 329 (M+H+); 347 
(M+NH4+); [α]D20 = 6.6° (c= 1.00, CHCl3). 
 
Table 4.2: E.e.-determination methods of hydrogenation products of 
substrates 36-39. 
Entry Substrate Method Retention time (min) Retention time (min) 
1 36 A 3.4 (R) 3.9 (S) 
2 37 B 6.7 (R) 7.1 (S) 
3 38 C 15.8 (S) 16.7 (R) 
4 39 D 13.0 (S) 13.9 (R) 
Method A: CP Chiralsil-L-Val from Chrompack (30m x 0.25mm x 0.12µm), 110°C  
Method B: CP Chiralsil-L-Val from Chrompack (30m x 0.25mm x 0.12µm), 160°C           
Method C: CP Chiralsil-Dex CB from Chrompack (25m x 0.25mm x 0.25µm), 140°C            
Method D: CP Chiraldex G-TA from Altrack (30m x 0.25mm x 0.125µm), 80°C 
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In this chapter the rhodium-catalyzed asymmetric hydrogenation of a series 
of unsaturated carboxylic acids is described, using a mixed ligand system of 
a chiral phosphoramidite and an achiral phosphine. Enantioselectivities up 
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5.1   Introduction 
5.1.1   Monodentate ligands 
The field of asymmetric hydrogenation has developed rapidly since the 
initial experiments by Knowles and Horner. 1  In the last 35 years 
thousands of ligands have been synthesized which, in combination with a 
variety of transition metals, can be employed in the hydrogenation of a 
broad range of prochiral olefins. 2  The most studied substrates in 
asymmetric hydrogenation are α-dehydroamino acids. Besides these, 
several other substrates have been examined such as: enamides, 
substituted itaconic acids, enol acetates, β-dehydroamino acids and 
unsaturated carboxylic acids. 
Since Pringle,3a Feringa / De Vries / Minnaard3b and Reetz3c reported 
independently the use of monodentate ligands in the rhodium-catalyzed 
asymmetric hydrogenation, the number of reports on the use of 
monodentate ligands has been increasing exponentially.4 The fact that two 
monodentate ligands are coordinating to Rh in the catalytic active species, 
was exploited by the groups of Reetz5 and Feringa6 to show that mixtures 
of (a)chiral monodentate ligands can be used to hydrogenate different 
substrates with enhanced selectivities (see chapter 1). This new strategy 
was also employed in the rhodium-catalyzed addition of boronic acids and 
the rhodium-catalyzed hydroformylation.7  
5.1.2   Dihydrocinnamic acids 
Dihydrocinnamic acids are an important class of compounds. They are 
key intermediates in the synthesis of a variety of bio-active compounds, 
including renin inhibitors, 8  γ-secretase inhibitors, 9  enkephalinase 
inhibitors, 10  endothelin receptor antagonists 11  or opioid antagonists. 12 
These intermediates are not only interesting from a synthetic point of view, 
but also for industrial applications they can be very useful. For example, 
dihydrocinnamic acid 2, which is an intermediate for renin inhibitor 
SPP100 (3), could be obtained on 39 mol scale (>12 kg) with 95% e.e., after 
hydrogenation of cinnamic acid derivative 1 (see Scheme 5.1).8a 
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Scheme 5.1: Published asymmetric hydrogenation as part of the synthesis 
of Renin inhibitor SPP100 3.8a 
5.1.3   Hydrogenation of unsaturated carboxylic acids 
Relatively limited research has been done in the asymmetric 
hydrogenation of unsaturated carboxylic acids compared to for example α-
amino acids. In the next two paragraphs an overview will be given of the 
relevant literature on the asymmetric hydrogenation of unsaturated 
carboxylic acids. The most frequently used benchmark substrates for this 
class of compounds are depicted in Figure 5.1.  
5.1.3.1   Rhodium-catalyzed hydrogenations 
 
Yamashita and co-workers developed carbohydrate based monodentate 
phosphines and phosphonites. 13  These ligands induced modest 
enantioselectivities (65%) in the rhodium-catalyzed hydrogenation of tiglic 
acid (6). A carbohydrate based bidentate phosphine, synthesized by 

















a-methylcinnamic acid (4) a-phenylcinnamic acid (5) tiglic acid (6)  
Figure 5.1: Benchmark unsaturated carboxylic acids. 
Better results for the hydrogenation of unsaturated acids have been 
obtained with ferrocenyl-based ligands.8a, 15  In the hydrogenation of 4, 
enantioselectivities of 82% have been obtained when a Mandiphos 
derivative was used.8a A dramatic increase of enantioselectivity was 
observed when 4 was derivatized with a bulky i-propyl group on the α-
position of the carboxylic acid moiety (Scheme 5.1).  
The best results obtained, so far, are 
with bidentate ligands containing an amine 
moiety, which participates in the 
coordination to the metal centre. 16  For 
example, complex 7, developed by 
Yamagishi and co-workers, could 
hydrogenate substrates 4 and 6 in, 
respectively, 92% and 75% e.e.16a,b Thomas 
and co-workers developed a Rh-catalyst based on diamine 8.16d This 
catalyst induced 93% e.e. in the hydrogenation of substrate 5, at 77% 
conversion. An improvement of the enantioselectivity was observed when 
this diamine was anchored to silica. The ee could be increased up to 96% 
with this heterogeneous catalyst at 80% conversion.16d  
Rhodium-catalyzed hydrogenations of unsaturated acids are in general 
slower compared to dehydroamino acids and harsher conditions are 
required, e.g. high pressures, high temperatures and long reaction times. 
For example, the hydrogenation of 5 with a Rh-complex of 8 was 
performed with 20 bar of hydrogen pressure and a reaction time of 24 
hours at 40°C. Only 74% conversion was obtained, with a chemoselectivity 
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products, such as 2,2- and 3,3-diphenylpropionic acids, were found as 
well in this reaction. 
An interesting new development occurred when J. Boogers at DSM was 
screening catalyst for the asymmetric hydrogenation of 1. He found that 
addition of triarylphosphines not only increased the enantioselectivity in 
the Rh/MonoPhos (L1) catalyzed hydrogenation of 1, but also had the 
effect of enhancing the rate. This eventually has led to a process for 2 as 











55°C, 80 bar H2
90% e.e.
 
Scheme 5.2: Asymmetric hydrogenation of 1 using a mixed ligand base 
catalyst.17 
5.1.3.2   Ruthenium-catalyzed hydrogenations 
 
The ruthenium-catalyzed hydrogenation of tiglic 
acid (6) with (functionalized) BINAP complexes has 
been extensively studied. 18  Excellent 
enantioselectivities were obtained under relatively mild 
reaction conditions. For example, complex 9, based on 
8H-BINAP ligand, hydrogenated 6 with an 
enantiomeric excess of 97%, in 20 hours with 1.5 bar 
of H2 pressure.18h Furthermore, 9 also performed well in the hydrogenation 
of substrates 4 and 5. The reduced products could be obtained in 89% and 
74% e.e., respectively. Higher pressures and longer reaction times were 























In addition to the BINAP systems, 
a variety of other ruthenium 
complexes has been studied. 19  
Almost perfect stereo control was 
obtained in the hydrogenation of 
6 with biphenyl-based ligand 
10,19d and spirofluorene-based 
ligand 11a.19i On the other hand, 
ligand 11b gave good e.e.’s in the 
hydrogenation of substrate 4. 
5.1.4   Goal of this research 
Chiral carboxylic acids are important building blocks for a range of bio-
active compounds (see §5.1.2). The majority of ligands which are 
successful in the Rh- or Ru-catalyzed hydrogenation of unsaturated 
carboxylic acids, is bidentate in nature. In general, a lengthy synthesis is 
required to obtain these ligands, which makes it difficult to modify them. 
Alternatively, monodentate phosphoramidites can be synthesized in one or 
two steps. The easy synthesis makes it possible to use these ligands in a 
high throughput screening, as developed by DSM and in our group. 20  
The goal of this research was to extend the scope and further 
investigate the mixed ligand system that was originally found at DSM for 
the rhodium-catalyzed asymmetric hydrogenation of α,β-unsaturated 
carboxylic acids. 
5.2   Reaction conditions 
5.2.1   Initial Screening and ligand optimization 
An initial screening of monodentate phosphoramidites ligands in the 
rhodium-catalyzed asymmetric hydrogenation of α-methylcinnamic acid (4) 
gave rather poor results (Table 5.1, odd entries). Addition of an equivalent 
of achiral triphenylphosphine, i.e. employing a 2:1 ratio of 





BIPHEMP 10 a) Ar = 3,5-Me2C6H3b) Ar = 3,4,5-Me3C6H211
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conversion and in enantioselectivity, compared to the corresponding homo-
complexes of the phosphoramidites (Table 5.1, even entries).  
Table 5.1: Screening of phosphoramidites in the rhodium-catalyzed 











25 bar H2, 60°C, i-PrOH
4 12
L1: R = NMe2
L2: R = morpholine
L3: R = piperidine
L4: R = (R)-α-methylbenzyl amine
L5: R = NMe2
L6: R = morpholine
L7: R = piperidine
L8: R = pyrrolidine  
Entry Ligand Conversion E.e.c 
1 L1 43 8 
2 L1 + PPh3 100 43  
3 L2 72 0 
4 L2 + PPh3 100 55 
5 L3 76 0 
6 L3 + PPh3 100 63 
7 L4 91 0 
8 L4 + PPh3 100 37 
9 L5 91 10 
10 L5 + PPh3 100 80 
11 L6 82 3 
12 L6 + PPh3 100 80 
13 L7 81 2 
14 L7 + PPh3 100 85 
15 L8 86 16 
16 L8 + PPh3 100 76 
(a) Reaction conditions: 1 mmol of substrate in 4 ml of solvent with 0.01 mmol of 
Rh(COD)2BF4, 0.02 of mmol phosphoramidite and 0.01 of mmol PPh3 (b) Reactions were run 
for 5 h. (c) E.e.’s were determined by chiral GC after conversion of product to the 
corresponding methyl ester (for details see experimental section) (d) In all cases the R 











For example, the use of L3 in combination with triphenylphosphine 
resulted in an enhancement of the conversion from 72% to 100% and e.e. 
from 0% to 63% (entries 5 and 6). It was observed that phosphoramidites 
based on 3,3’-dimethyl-BINOL induced distinctly higher e.e.’s than the 
phosphoramidites based on BINOL (entries 1-8 vs. 9-16). The use of 
piperidine-based phosphoramidite L7 further improved the 
enantioselectivities. For the catalyst based on L7 the addition of 
triphenylphosphine increased the e.e. from 2% to 85% (entries 13 and 14). 
5.2.2   Optimization of solvent, temperature and pressure 
5.2.2.1   Solvent effect 
 
Screening of a series of protic solvents in the rhodium-catalyzed 
hydrogenation of α-methylcinnamic acid (4) showed that i-propanol is the 
best solvent for these hydrogenations, although the results with methanol 
and ethanol were almost the same (entries 1-3, Table 5.2). Furthermore, 
addition of water as a co-solvent with i-propanol gave a slight increase in 
e.e. (entries 4-7). In the presence of water at higher temperatures the 
ligands were stable, as long as they were bound to rhodium. Similar 
observations were made in the rhodium-catalyzed addition of boronic acid 
to enones.21 Free phosphoramidites, on the other hand, hydrolyze in the 
presence of water at higher temperatures within 5 hours.22 
5.2.2.2   Temperature effect 
 
Decreasing the temperature from 60°C to 30°C led to an increase of 
enantioselectivity from 81% to 84% (entries 5 and 8-10, Table 5.2). The e.e. 
stayed constant when the temperature was lowered to 25°C, but in this 
case no full conversion was obtained.  
5.2.2.3   Pressure effect 
 
The effect of hydrogen pressure was examined under optimized 
conditions, i.e. ligand L7, a temperature of 30°C and a 4:1 mixture of i-
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propanol and water as solvent. Lowering the pressure from 25 to 1 bar led 
to a decrease in enantioselectivity. No full conversion was obtained at 1 bar 
of hydrogen pressure. The drop in selectivity is attributed to a combination 
of a lower reaction rate and partial decomposition of the catalyst. In some 
cases rhodium black formation was observed, which causes an undesired 
and unselective side reaction. 
Table 5.2: Screening of solvent, temperature and pressure in the rhodium-





Rh(COD)2BF4, L5 or L7/ PPh3 (2:1)
 H2, T, solvent
4 12  






1 L5 MeOH 60 25 79 
2 L5 EtOH 60 25 79 
3 L5 i-PrOH 60 25 80 
4 L5 i-PrOH / 10% H2O 60 25 80 
5 L5 i-PrOH / 20% H2O 60 25 81 
6 L5 i-PrOH / 30% H2O 60 25 81 
7 L5 i-PrOH / 40% H2O 60 25 81 
8 L5 i-PrOH / 20% H2O 50 25 82 
9 L5 i-PrOH / 20% H2O 40 25 83 
10 L5 i-PrOH / 20% H2O 30 25 84 
11 L5 i-PrOH / 20% H2O 25 25 84 (93) 
12 L7 i-PrOH / 20% H2O 30 25 88 
13 L7 i-PrOH / 20% H2O 30 20 88 
14 L7 i-PrOH / 20% H2O 30 15 85 
15 L7 i-PrOH / 20% H2O 30 10 84 
16 L7 i-PrOH / 20% H2O 30 5 81 
17 L7 i-PrOH / 20% H2O 30 1 79 (87) 
(a) Reaction conditions: 1 mmol of substrate in 4 ml of solvent with 0.01 of mmol 
Rh(COD)2BF4, 0.02 mmol of phosphoramidite and 0.01 of mmol PPh3 (b) Reactions were run 
for 16 h (c) E.e.’s were determined by chiral GC after conversion of the product to the 
corresponding methyl ester  (for details see experimental section); full conversion was 
obtained otherwise indicated in brackets (d) In all cases the R enantiomer of ligand led to the 










5.2.3   Phosphine optimization 
5.2.3.1   Ratio of phosphoramidite / phosphine 
 
A rather poor e.e. of 10% was obtained in the hydrogenation of 4 with a 
L5 to Rh(COD)2BF4 ratio of 2. Also in the case of 3 equivalents of L5 the 
selectivity remained low. Addition of 1 equivalent of PPh3, relative to L5, 
increased the e.e. dramatically (entries 1-3, Table 5.3). The amount of 
phosphine could be decreased to 0.5 equivalent with respect to L5 (L5 : 
PPh3 = 4:1) without any loss of selectivity. On the other hand, further 
reduction of the phosphine amount to 0.2 equivalents led to a decrease in 
e.e. (entries 3-5). Nevertheless, addition of even a small amount of achiral 
PPh3 increases the e.e. dramatically compared to the use of solely the 
chiral phosphoramidite L5. Using 1:1 ratios of L5 and PPh3 gave slightly 
lower enantioselectivities (entries 3, 6 and 7). Surprisingly, the 
hydrogenation even proceeded when 4 equivalents of ligand were used 
compared to the rhodium precursor. Earlier studies revealed that the 
addition of 4 equivalents of a monodentate phosphoramidite (MonoPhos™) 
to Rh(COD)2BF4 forms an unreactive complex with 4 ligands coordinated to 
the  Rh centre.4    Also the use of an 1:2 ratio of L5 to PPh3 diminished the 
enantioselectivity (entries 3 and 8). The use of the corresponding methyl 
ester of 4 gave a higher e.e. than 4 itself when only L5 was applied as a 
ligand. Addition of an equivalent of PPh3 resulted in a nearly racemic 
mixture (entries 1, 9 and 10). A similar effect, in which the free acid 
performs better than the methyl ester, was 
observed by Yamada et al.16 They ascribed this 
effect to the participation of an electrostatic 
interaction between their ligand and the 
substrate (see picture). In our case it is probably 
due to the fact that the free acid coordinates 
better to the rhodium, than the methyl ester. 
This second coordination is well-known (see also 
§1.5.5) and proves to be important for enantiodiscrimination.23 Another 
remarkable effect was observed; although the same enantiomer of L5 was 
used, the configuration of the product changed when the methyl ester was 
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Table 5.3: Variation of the phosphoramidite / phosphine ratio in the 






 25 bar H2, 60°C, i-PrOH 20% H2O
 
Entry Mol % L5  Mol % PPh3 E.e.c,d 
1 2 0 10 
2 3 0 14 
3 2 1 81 
4 2 0.5 81 
5 2 0.2 70 
6 2 2 77 
7 1 1 77 
8 1 2 73 
9e 2 0 30f 
10e 2 1 4 
(a) Reaction conditions: 1 mmol of substrate in 4 ml of solvent with 0.01 mmol of 
Rh(COD)2BF4, phosphoramidite and PPh3 (b) Reactions were run for 16 h (c) E.e.’s were 
determined by chiral GC after conversion of product to the corresponding methyl ester (for 
details see experimental section), full conversion was obtained otherwise indicated in brackets 
(d) In all cases the R enantiomer of ligand led to the S enantiomer of products (e) Methyl ester 
was used (f) R enantiomer of ligand gave R enantiomer of product.   
5.2.3.2   Structural variation in the phosphine ligand 
 
A screening of structurally different phosphines was performed to 
achieve further optimization of the reaction outcome. A variety of achiral 
alkyl phosphines and substituted aryl phosphines was tested in the 
rhodium-catalyzed asymmetric hydrogenation of α-methylcinnamic acid (4) 
using L7 (Table 5.4). The reactions were performed with 1 and 0.5 














Table 5.4: Screening of achiral phosphines in the rhodium-catalyzed 





 25 bar H2, 30°C, i-PrOH 20% H2O
4 12  
Entry R 
1 eq. PR3 
E.e.c,d           T.O.F.e  
0.5 eq. PR3 
 E.e.                  T.O.F.e 
1 - 16 (34) 2 - - 
2 Ph (P1) 88 46 88 78 
3 o-tolyl (P2) 97 33 95 20 
4 m-tolyl (P3) 87 69 87 78 
5 p-tolyl (P4) 86 61 86 81 
6 xylyl (P5) 89 92 89 50 
7 mesityl (P6) 33 (55) 3 30 (56) 3 
8 m-ClPh (P7) 89 46 87 78 
9 p-ClPh (P8) 90 18 86 19 
10 cyclohexyl (P9) 87 28 86 26 
11  n-butyl (P10) 67 17 56 (84) 5 
12 t-butyl (P11) 13 (39) 2 4 (27) 1.4 
(a) Reaction conditions: 1 mmol of substrate in 4 ml of solvent with 0.01 mmol of 
Rh(COD)2BF4, 0.02 mmol of phosphoramidite and 0.01 or 0.005 mmol of PPh3 (b) Reactions 
were run for 16 h (c) E.e.’s were determined by chiral GC after conversion of product to the 
corresponding methyl ester (for details see experimental section), full conversion was obtained 
unless indicated in brackets (d) In all cases the R enantiomer of ligand led to the S 
enantiomer of products (e) T.O.F. in mol (substrate) mol-1 (catalyst) h-1. 
In most cases there was hardly any difference in e.e. between the use of 
0.5 or 1 equivalent of phosphine. Only in a few cases slightly higher 
selectivities were obtained with 1 equivalent of achiral ligand. Substitution 
at the ortho position of triphenylphosphine increased the e.e. significantly 
(entries 2 and 3, Table 5.4), whereas substitution at the meta- or para-
position had hardly any influence on the enantioselectivity (compare 
entries 2, 4, 5, 8 and 9). Linear or branched alkyl phosphines showed a 
decrease in rate and enantioselectivity compared to tricyclohexylphosphine 
P9 (entries 10, 11, 12). 
Electron donating or withdrawing substituents on the arylphosphines 
had no influence on the e.e. (compare entries 2 with 4,5 and 8,9). While 
reactions were in general complete after 2 h, incomplete conversions were 
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obtained with the sterically hindered phosphines P6 and P11 after 16 h 
(entries 7, 12). In these cases not only the rate of the hydrogenations 
decreased, but also the enantioselectivities dropped dramatically. In most 
cases, higher T.O.F.’s were observed when 1 equivalent of phosphine was 
used compared to 0.5 equivalent. As mentioned before, besides bulky 
phosphines, alkyl phosphines also induced lower T.O.F.’s compared to the 
aryl phosphines (entries 2, 10-12). Introduction of an electron withdrawing 
chloro substituent decreased the T.O.F. (entries 2, 8, 9) On the other hand, 
introduction of alkyl groups on the aromatic ring increased the T.O.F. 
(entries 2-7). The highest T.O.F.’s were observed with meta substituted aryl 
phosphines (entries 2, 4, 6 and 8). 
5.2.4   Broadening the scope of substrates 
The scope of substrates was broadened by studying a number of 
disubstituted acrylic acids (Scheme 5-2). In addition to the commercially 
available benchmark substrates 5 and 6, some substituted α-i-
propylcinnamic acids were studied. These substrates are not commercially 


















13: R = H
14: R = 3,4-diMeO
15: R = 4-CF3
H
 
Scheme 5.3: Synthesis of substrates 20-22. 
A straightforward Claisen condensation followed by dehydration and 
saponification gave the desired products in >50% yield over two steps. In 
























L6: X = O
L7: X = CH2
5: R1 = Ph, R2 = Ph
6: R1 = Me, R2 = Me
20: R1 = Ph, R2 = i-Pr
21: R1 = 3,4-(MeO)2Ph, R2 = i-Pr
22: R1 = 4-CF3Ph, R2 = i-Pr
23: R1 = Ph, R2 = Ph
24: R1 = Me, R2 = Me
25: R1 = Ph, R2 = i-Pr
26: R1 = 3,4-(MeO)2Ph, 
      R2 = i-Pr
27: R1 = 4-CF3Ph, 
      R2 = i-Pr  









1f 5 23 P1 87 N.D. 86 N.D. 
2f 5 23 P2 92 N.D. 95 N.D. 
3f 5 23 P3 72 N.D. 81 N.D. 
4f 5 23 P4 76 N.D. 80 N.D. 
5 6 24 P1 87 10 78 13 
6 6 24 P2 73 (39) 2.0 84 10 
7 6 24 P3 87 8.0 79 46 
8 6 24 P4 86 10 76 16 
9 20 25 P1 96 9.0 95 35 
10 20 25 P2 86 (30) 2.0 99 22 
11 20 25 P3 96 10 95 22 
12 20 25 P4 96 12 93 13 
13 21 26 P1 - - 92 17 
14 21 26 P2 - - 90 (40) 3.0 
15 21 26 P3 - - 91 15 
16 21 26 P4 - - 89 15 
17 22 27 P1 - - 94 18 
18 22 27 P2 - - 94 6 
19 22 27 P3 - - 95 18 
20 22 27 P4 - - 93 24 
(a) Reaction conditions: 1 mmol of substrate in 4 ml of solvent with 0.01 mmol of 
Rh(COD)2BF4, 0.02 mmol of phosphoramidite and 0.01 mmol of phosphine (b) Reactions were 
run for 16 h  (c) E.e.’s were determined by chiral GC or HPLC, full conversion was obtained 
unless indicated otherwise (d) In all cases the S enantiomer of ligand led to the S enantiomer 
of products24 (e) T.O.F. in mol (substrate) mol-1 (catalyst) h-1 (f) Reactions were performed at 
60°C. 
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confirmed for two substrates by X-ray analysis (see §5.6). The substrates 
were tested under optimized conditions, i.e. 25 bar H2, 30°C and i-PrOH : 
H2O (4:1) as solvent and L6 or L7 in combination with phosphine P1-P4 as 
ligands (L:P = 2:1) (Table 5.5). 
In all cases, full conversions of the substrates were obtained with high 
to excellent e.e.’s. With the exception of substrate 6, best results were 
obtained with a combination of L7 and a phosphine (Table 5.5). In cases 
were R1 is an aromatic group the enantioselectivity is higher than when R1 
is an alkyl group as in tiglic acid 6 (compare Table 5.4, entries 2-5 with 
Table 5.5 entries 5-8). Electron donating as well as electron withdrawing 
substituents at the aromatic moiety hardly affected the enantioselectivity 
(entries 9-20, Table 5.5). The size of R2 also has hardly any influence on 
the enantioselectivities. Enantiomeric excesses of ≥ 95% for 12, 16 and 18 
could be obtained by fine tuning of the phosphine-phosphoramidite 
combination (Table 5.4 entry 3, Table 5.5 entries 2 and 10). 
In general, using L7 the T.O.F.’s were higher than when L6 was used. 
In addition to the enantioselectivities, the T.O.F.’s for tiglic acid (6) were 
also lower than for α-methylcinnamic acid (4) (Table 5.4 entries 2-5, Table 
5.5 entries 5-8). Introduction of a bulky i-propyl group at R2 decreased the 
T.O.F. (Table 5.4 entries 2-5, Table 5.5 entries 9-20), as well as the 
introduction of electron withdrawing or electron donating groups on the 
aromatic moiety (Table 5.5, entries 9-12 vs. 13-20). 
5.3   31P-NMR experiments 
 
Although the initial formed complexes are not the active catalytic 
species, they can give insight into a possible structure of this species. 31P-
NMR spectroscopy was used to elucidate the structure of the formed 
complexes in our mixed ligand system. Three different complexes are 
formed on mixing the rhodium precursor with phosphoramidite L7 and 
triphenylphosphine P1 (Figure 5.2).25 Next to the homo-complexes RL2 and 
RP2, hetero-complex RLP will be formed. Both homo-complexes will give a 
doublet, showing only a phosphorus-rhodium coupling. 26  The hetero-
complex will show two signals, one arising from the triphenylphosphine 










doublet, showing a rhodium-phosphorus as well as a phosphorus-
phosphorus coupling.  
Rh(P)2(COD)BF4














Figure 5.2: Equilibria in Rh / ligand complex formation. 
Figure 5.3 shows the 31P signals which can be attributed to 
phosphoramidite L7 in complexes formed with a 1:1 (a) and a 1:2 (b) ratio 
of L7 and P1. Spectrum (a) in Figure 5.3  shows the presence of mainly the 
hetero-complex (double doublet at 135.8 ppm) and only a small trace of 
homo-complex RL2 (doublet at 132.7 ppm). In a 1:2:1 mixture of 
Rh(COD)2BF4 , L7 and P1 (Figure 5.3b), the amount of hetero-complex 
decreases and the amount of homo-complex increases. Furthermore, a 
substantial amount of free phosphoramidite (L7) (singlet at 142.7 ppm) is 
present. This is not surprising since an excess of L7 has been used (entries 
5 and 6, Table 5.6). 
Figure 5.4 shows the signals which are attributed to P1 in the former 
mentioned complexes. In a 1:1 mixture of L7 : P1 both the homo-complex 
RP2 (doublet at 25.9 ppm) and the hetero-complex RLP (double doublet at 
30.6 ppm) can be observed (Figure 5.4a). On the other hand, a 2:1 mixture 
of L7:P1 shows only the presents of the hetero-complex and a trace of 
triphenylphosphine oxide (entries 5 and 6, Table 5.6). The absence of 
detectable amounts of homo-complex RP2 in a 2:1 mixture explains the 
higher e.e. compared to a 1:1 mixture (entries 3 and 7, Table 5.3). 
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Figure 5.3: 31P-NMR of L7 in Rh(COD)2BF4 / L7 / P1 mixtures; (a) 1:1:1 




Figure 5.4: 31P-NMR of P1 in Rh(COD)2BF4 / L7 / P1 mixtures; (a) 1:1:1 
ratio (b) 1:2:1 ratio. 
In addition to the selective reaction by hetero-complex RLP a competing 
non-selective reaction by homo-complex RP2 takes place. Since there is 
only a slight drop in selectivity, this indicates that the rate of reaction of 
the hetero-complex RLP is much higher than the rate of reaction of the 
homo-complex RP2 (entries 3 and 7, Table 5.3).27 Furthermore, this also 











Table 5.6 shows the percentage of different complexes in a series of 
experiments. In a mixture with a 2:1 ratio of L7 : P1 approximately 40% of 
the Rh-ligand complex is present as a hetero-complex, while in a 1:1 
mixture the hetero-complex is present in about 70% (entries 5 and 6). 
Mixing homo-complexes RL2 and RP2 shows a very fast exchange of 
ligands. In this case, an equilibrium is obtained which is stable over hours 
and which gives the same ratios of complexes as obtained when 
Rh(COD)2BF4, L7 and P1 are mixed in a 1:2:1 ratio (compare entries 6 and 
7). In both entries some other species were formed, which are probably 
complexes with only 1 ligand coordinated to the rhodium. The process of 
exchange proceeds most likely via a dissociative kind of mechanism, since 
there is no free ligand present in both mixtures containing only homo-
complexes. Dissociative mechanisms have been reported before in ligand 
exchange processes of rhodium complexes.28 
Table 5.6: Ratio’s of complexes.a 
 
Entry Mixtureb Tc L7  RL2  P1  RP2  RLP  LOd  POe 
1 L7 5 min 100 - - - - - - 
2 Rh + 2L7 5 min - 100 - - - - - 
3 P1 5 min - - 100 - - - - 
4 Rh + 2P1 5 min - - - 100 - - - 
5 Rh + 2L7 + P1 1 h 27 19 5 - 39 4 6 
6f Rh + L7 + P1 1 h - 5 - 14 69 - - 
5 min - 11 - 16 73 - - 
1 h - 5 - 12 65 - - 7f 
(Rh + 2L7) + 
(Rh + 2P1) 2 h - 6 - 10 68 - - 
5 min 38 13 14 - 35 - - 8 (Rh + 2L7) + P1 
1 h 34 13 10 1 34 3 5 
5 min 7 - 36 14 37 - 6 9 (Rh + 2P1) + L7 
1 h 7 - 29 16 37 - 12 
(a) Amounts are given in percentages (b) Rh = Rh(COD)2BF4 (c) Time were the spectra have 
been recorded (d) Hydrolyzed L7 (e) Triphenylphosphine oxide (f) Some unidentified complexes 
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Also in the cases when a homo-complex was mixed with an equivalent 
of the other P-ligand a fast exchange of ligands was observed (entries 8 and 
9). Again, a fast equilibrium was established which did not change in time. 
In both cases about 35% of hetero-complex was formed, as was observed 
before in a 2:1 mixture of L7 and P1 (entries 5,8 and 9). In those mixtures 
where 3 equivalents of ligands were used compared to the rhodium 
precursor, small amounts of hydrolyzed phosphoramidite and/or oxidized 
triphenylphosphine were observed. This indicates that ligands which are 
not complexed to the metal are more prone to hydrolysis or oxidation than 
ligands which are complexed. Similar results have been found in the 
rhodium-catalyzed boronic acid additions.21 
These mixtures of complexes were used in a range of hydrogenation 
experiments. The results are depicted in Table 5.7. 






 25 bar H2, 60°C, i-PrOH 20% H2O
 
Entry Mixturesc E.e.d,e 
1 Rh + 2L7 + P1 (in situ) 85 
2 Rh + 2L7 + P1 (pre-formed) 85 
3 Rh + L7 + P1 (pre-formed) 83 
4 Rh + 2L7 (pre-formed) 11 
5 Rh + 2P1 (pre-formed) - 
6 (Rh + 2L7 + P1) (pre-formed) + P1 85 
7f Rh + 2L7 + P1 (in situ) 83 
(a) Reaction conditions: 1 mmol of substrate in 4 ml of solvent with 0.01 mmol of 
Rh(COD)2BF4, 0.02 mmol of phosphoramidite and 0.01 mmol of phosphine or 1 mol % of 
preformed catalyst (b) Reactions were run for 16 h (c) In situ mixtures were formed by mixing 
ligands, Rh(COD)2BF4 and substrate in reaction vial and adding solvent. The obtained yellow 
solution was used in hydrogenation experiment. Pre-formed mixtures were formed by 
dissolving 1 eq. of Rh(COD)2BF4 and 2 or 3 eq. of appropriate ligand(s) in CH2Cl2. The mixture 
was stirred for 15 min and the CH2Cl2 was evaporated. The obtained yellow solid was used as 
obtained (d) E.e.’s were determined by chiral GC or HPLC, full conversion was obtained 
unless indicated otherwise (e) In all cases the S enantiomer of ligand led to the S enantiomer 











Entries 1 and 2 show, that there is no difference regarding the 
enantioselectivity in using an in situ formed complex or a preformed 
complex. As was observed before, application of a 1:1 mixture of L7:P1  
shows a slight decrease in e.e. (entry 3). The homo-complex RL2 gave a 
poor e.e. (entry 4). Identical enantioselectivities as for entries 1 and 2 were 
obtained when homo-complex RL2 was used with an extra equivalent of 
P1, which supports the results obtained from the 31P-NMR experiments. 
Using the Na-salt of the substrate showed just a slight decrease in e.e. 
(entry 7). 
The results obtained from the 31P-NMR experiments and the 
hydrogenation with different complexes clearly shows that exchange of 
ligands takes place. This is contradictory to earlier results obtained from 
UV and NMR experiments.30 Furthermore, the choice of MonoPhos™ (L1) 
to perform these initial experiments might have been unfortunate, since 
the behavior of MonoPhos™ (L1) is not completely representative for the 
class of BINOL-based phosphoramidites.31 
5.4   Applications 
 
As already mentioned in the introduction, chiral substituted carboxylic 
acids are important building blocks for a range of bioactive compounds. 
Not only in this field, but also in nanotechnology the building blocks have 
proven to be important. In 1999, Feringa and co-workers reported the first 
unidirectional molecular motor, which was based on a sterically 
overcrowded alkene.32 The motors were synthesized as racemates and a 
tedious separation of the enantiomers by chiral preparative HPLC was 
required afterwards to obtain the enantiomerically pure motors.  
An asymmetric synthesis, based on a diastereoselective alkylation using 
the Evans protocol was developed, to avoid the time consuming and costly 
resolution step (Scheme 5.4).33 Alkylation of oxazolidinone 24, which could 
be obtained by amidation of 22 with 23, gave 25 in 72% yield with perfect 
stereocontrol. Cyclic ketone 27 was obtained after deprotection of 25, 
followed by a Friedel-Crafts acylation, without racemization. A titanium 
tetrachloride and zinc powder mediated McMurry coupling gave 
enantiomerically pure sterically overcrowded alkene 29 in solely the E-
configuration.  
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Disadvantage of this method is that a stoichiometrical amount of a chiral 
auxiliary has to be used. Furthermore, attempts to couple the analogous 
five membered cyclic ketone under McMurry conditions, yielded the 
racemic overcrowded alkene.34 
In an attempt to improve this method, a route based on a rhodium-
catalyzed asymmetric hydrogenation was developed. This work was done in 
collaboration with Dr. Javier Vicario and Dr. Steve Davey. Substrate 30 



















1) 1,2-bis-TBS-hydrazine, Sc(OTf)3, 
    100°C, 3h
2) PhI(CO2CF3)2, DMF, -50°C, 34
3) PPh3, xylene, reflux, 16h





Scheme 5.5: Stereoselective synthesis of overcrowded alkene 
Hydrogenation of 30 with a mixed ligand system of L7 and P2 yielded 
chiral carboxylic acid 31 in 98% enantioselectivity. The reaction was 
performed on a multigram scale. A single crystallization from n-hexane 
afforded optically pure 31 in 84% yield. Cyclization via a Friedel-Crafts 
acylation according to a reported method gave cyclic ketone 32 in 70% 
yield.34 No racemization occurred in this step as was determined by chiral 
HPLC analysis. Initial attempts to couple ketone 32 under standard 
’Barton-Kellogg’ conditions failed. In all cases, the overcrowded alkene was 
obtained as a racemic mixture. Applying a combination of elegant work by 
Furrow et al. 35  and the hypervalent iodine mediated ‘Barton-Kellogg’ 
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coupling chemistry developed by Feringa et al.36 yielded the overcrowded 
alkene 33 in 40% yield without lost of enantioselectivity, which was 
confirmed by HPLC analysis. An advantage of the ‘Barton-Kellogg’ method 
compared to the McMurry coupling is the possibility to synthesize 
unsymmetrical alkenes. In general, the McMurry coupling is used to 
couple two of the same ketones, to avoid mixtures of products which will 
be formed when two different ketones are coupled. Because the ‘Barton-
Kellogg’ couples two compounds with two different functionalities, i.e. a 
thioketone with a diazo moiety, it gives the possibility to synthesize 
unsymmetrical alkenes in good yields without a tedious separation of 
mixture of products. 
5.5   Conclusion 
 
In conclusion, a new catalytic system, based on a mixed ligand 
approach, has been developed for the rhodium-catalyzed asymmetric 
hydrogenation of cinnamic acid derivatives with e.e.’s up to 99%. The 
obtained enantioselectivities are comparable to or better than the best 
enantioselectivities reported for a variety of Rh- and Ru-based catalysts.  
Easy variation of the chiral and achiral monodentate ligands makes it 
possible to screen a variety of catalytic systems in a short time. It has been 
shown further that a catalyst complex based on a hetero-combination of a 
chiral and an achiral monodentate ligand gives a dramatically higher 
enantioselectivity than any of the corresponding homo-complexes. 
Furthermore, 31P-NMR experiments clearly showed the formation of hetero-
complexes. In addition, the results obtained from a combination of 
hydrogenation experiments and 31P-NMR spectroscopy clearly reveals that 
a fast exchange of ligands takes place until an equilibrium in the ratio of 
complexes has been reached. The developed method has been applied 
















For general remarks see chapter 2. Substrates 4, 5 and 6 were 
commercially available. Substrates 13, 14 and 15 were synthesized (see 
Scheme 5-2). Phosphoramidites L1 – L4 were commercially available or 
made by literature procedures. 37  (S)-3,3’-dimethylbinol and 
phosphoramidite L5 were generously donated by DSM. Phosphines P1-P11 
were purchased from Aldrich or Strem Chemicals.  
 
General procedure for the synthesis of ligands L6-L8: 
 
To a solution of 0.17 ml (1.93 mmol) of PCl3 and 0.54 ml (3.86 mmol) of 
Et3N in 5 ml of toluene at 0°C was added dropwise a solution of 606 mg 
(1.93 mmol) of (S)-3,3’-dimethylbinol in 5 ml of toluene. The reaction 
mixture was warmed to rt and stirred for 6 h. To the suspension was 
added 5 ml of ether. The resulting suspension was filtered under N2 over a 
path of Celite. To the filtrate was added 0.59 ml (4.24 mmol) of Et3N. The 
mixture was cooled to 0°C and 1.93 mmol of the corresponding amine was 
added dropwise. The mixture was warmed to rt and stirred for 16 h. 5 ml 
of ether was added to the suspension. The mixture was filtered over celite 
and the filtrate was concentrated in vacuo. The crude product was purified 
by a short column chromatography on silica gel (eluens pentane : EtOAc 




morpholine (L6): 1H --NMR (200 MHz, CDCl3) δ = 
7.86–7.79 (m, 4H), 7.42-7.17 (m, 6H), 3.57-3.43 (m, 
4H), 3.13-2.95 (m, 4H), 2.63 (s, 3H), 2.58 (s, 3H); 31P-
NMR (81.0 MHz, CDCl3) δ =141.6; 13C-NMR (50.32 
MHz, CDCl3) δ = 148.8 (s), 148.8 (s), 148.4 (s), 131.5 (s), 131.4 (s), 131.2 
(s), 130.7 (s), 130.2 (s), 129.7 (s), 129.6 (s), 127.4 (d), 126.8 (d), 126.7 (d), 
125.1 (d), 124.7 (d), 124.6 (d), 123.9 (d), 123.8 (d), 122.8 (d), 67.9 (t), 67.8 
(t), 44.4 (t), 44.0 (t), 17.7 (q), 17.5 (q) HRMS calculated for C26H24NO3P 
429.149 found 429.149; [α]D20 = -488° (c= 1.08, CHCl3). 
 
(S)-1-(2,6-Dimethyl-3,5-dioxa-4-phospha-cyclohepta[2,1-a;3,4-
a']dinaphthalen-4-yl)-piperidine (L7): 1H-NMR (200 
MHz, CDCl3) δ = 7.86–7.77 (m, 4H), 7.42-7.13 (m, 6H),  
3.02-2.94 (m, 4H), 2.63 (s, 3H), 2.55 (s, 3H), 1.30-
1.59 (m, 6H); 31P-NMR (81.0 MHz, CDCl3) δ =142.7; 
13C-NMR (52.32 MHz, CDCl3) δ = 149.3 (s), 149.2 (s), 
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130.5 (s), 130.4 (s), 130.0 (s), 129.6 (s), 127.4 (d), 126.9 (d), 126.8 (d), 
124.9 (d), 124.6 (d), 124.4 (d), 124.0 (d), 123.9 (d), 122.7 (d), 45.2 (t), 44.7 
(t), 27.0 (t), 26.9 (t), 24.8 (t), 17.7 (q), 17.5 (q); HRMS calculated for 




pyrrolidine (L8): 1H-NMR (400 MHz, CDCl3) δ = 7.80–
7.72 (m, 4H), 7.36-7.10 (m, 6H), 3.14-3.16 (m, 2H), 
2.83-2.80 (m, 2H), 2.58 (s, 3H), 2.50 (s, 3H), 1.69-
1.63 (m, 4H); 31P-NMR (161.9 MHz, CDCl3) δ =147.6; 
13C-NMR (101.0 MHz, CDCl3) δ = 149.7 (s), 149.0 (s), 131.6 (s), 131.5 (s), 
131.0 (s), 130.6 (s), 130.4 (s), 130.0 (s), 129.5 (s), 129.1 (s), 128.2 (d), 
127.4 (d), 127.4 (d), 126.9 (d), 126.8 (d), 124.9 (d), 124.5 (d), 124.4 (d), 
123.9 (d), 123.0 (d), 45.65 (t), 45.4 (t), 25.8 (t), 25.8 (t), 17.7 (q), 17.6 (q); 
HRMS calculated for C26H24NO2P 413.154 found 413.152; [α]D20 = -445° 
(c= 1.03, CHCl3). 
 
General procedure for the synthesis of substrates 13-15:38 
 
At -20°C, 37.06 ml (92.6 mmol) of n-BuLi (2.5M in hexane) was added to a 
solution of 13.95 ml (99.3 mmol) of diisopropylamine in 60 ml of THF. This 
mixture was stirred for 30 min at -20°C. Then a solution of 10.97 ml (72.8 
mmol) of ethylisovalerate in 40 ml of THF was added. The mixture was 
stirred for 1 h. Next, a solution of 66.2 mmol of the appropriate 
benzaldehyde in 40 ml of THF was added at -20°C. The resulting mixture 
was stirred for 2 h. The reaction was quenched with NH4Cl(aq) at -20°C. The 
layers were separated and the aqueous layer was extracted with EtOAc (2 x 
200 ml). The combined organic layers were dried on MgSO4, filtered and 
concentrated to yield the products in ≥ 90%. The crude products were used 
without purification in the next step. 
 
A solution of 78.1 mmol of the crude product and 478 mg (3.90 mmol) of 
DMAP in 125 ml of THF was cooled to 0°C. 7.4 ml (78.1 mmol) of acetic 
acid anhydride was added dropwise and the reaction mixture was stirred 
for 1 hour. A solution of 26.3 g (234.2 mmol) of potassium t-butylate in 
170 ml of THF was added drop by drop over a period of 30 min at 0°C and 
the mixture was stirred for 2 h at this temperature. After the addition of 80 
ml of water and removal of THF by distillation, 250 ml of ethanol and 35 
ml of 2M KOH(aq) was added to the aqueous residue. The mixture was 
stirred for 20 h under reflux. The reaction mixture was cooled and 
concentrated. At 0°C, 280 ml of t-butyl methyl ether and 120 ml of 2M 
HCl(aq) were added to the residue. The organic phase was separated and the 













combined organic layers were washed consecutively with water and brine, 
dried over MgSO4, filtered and concentrated. The product was 
recrystallized from diisopropyl ether and hexane. 
 
3-Methyl-2-[1-phenyl-meth-(E)-ylidene]-butyric acid 
(13): 1H-NMR (200 MHz, CDCl3) δ = 7.77 (s, 1H), 7.47-7.26 
(m, 5H), 3.28-3.14 (m, 1H), 1.31 (d, J = 7.1 Hz, 6H); 13C-
NMR (50.32 MHz, CDCl3) δ = 173.7, 140.4, 138.2, 135.7, 
128.9, 128.4, 128.3, 27.4, 21.0; HRMS calculated for C12H14O2 190.099 
found 190.100. Additional information was obtained from the X-ray 
structure: 
 
C12H14O2, Mr = 190.24, triclinic, P-1, a = 6.013(2), b = 9.450(3), c = 9.751(3) 
Å, α = 75.168(6)°, β = 76.505(5)°, γ = 78.664(5)°, V = 515.3(3) Å3, Z = 2, Dx = 
1.226 gcm-3, F(000) = 204, µ = 0.82 cm-1, λ(MoKα ) = 0.71073 Å, T = 100(1) 
K, 3296 reflections measured, GooF = 1.203, wR(F2) = 0.1843 for 2222 
unique reflections and 183 parameters and R(F) = 0.0529 for 1738 
reflections obeying Fo ≥  4.0 σ (Fo) criterion of observability. The 
asymmetric unit consists of one molecule of the title compound. 
 
2-[1-(3-Hydroxy-4-methoxy-phenyl)-meth-(E)-
ylidene]-3-methyl-butyric acid; compound with 
ethane (14): 1H-NMR (200 MHz, CDCl3) δ = 7.67 (s, 
1H), 6.98-6.88 (m, 3H), 3.90 (s, 3H), 3.89 (s, 3H), 3.33-
3.26 (m, 1H), 1.30 (d, J = 7.1 Hz, 6H) 13C-NMR (50.32 MHz, CDCl3) δ = 
173.7, 149.2, 148.6, 140.2, 136.6, 128.2, 122.1, 112.3, 110.9, 55.8, 55.8 
27.4, 21.0 HRMS calculated for C14H18O4 250.120 found 250.123. 
 
3-Methyl-2-[1-(4-trifluoromethyl-phenyl)-meth-(E)-
ylidene]-butyric acid (15): 1H-NMR (200 MHz, CDCl3) 
δ = 12.09 (bs, 1H), 7.73 (s, 1H), 7.65 (d, 2H, J = 8.2), 
7.42 (d, J = 8.2 Hz, 2H) 3.15-3.02 (m, 1H), 1.29 (d, 6.8 
Hz, 6H) 13C-NMR (50.32 MHz, CDCl3) δ = 173.0, 140.1, 139.3, 138.6, 
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found 258.087. Additional information was obtained from the X-ray 
structure: 
 
C13H13F3O2, Mr = 258.24, monoclinic, C2/c, a = 18.249(1), b = 13.7838(8), 
c = 20.838(1) Å, β = 110.359(1)°, V = 4914.2(5) Å3, Z = 16, Dx = 1.396 gcm-3, 
F(000) = 2144, µ = 1.23 cm-1, λ(MoKα ) = 0.71073 Å, T = 100(1) K, 22892 
reflections measured, GooF = 1.046, wR(F2) = 0.1223 for 6437 unique 
reflections and 429 parameters and R(F) = 0.0450 for 5157 reflections 
obeying Fo ≥  4.0 σ (Fo) criterion of observability. The asymmetric unit 












General procedure for hydrogenation reactions: 
 
In a glass tube, 4.06 mg (10 µmol) of Rh(COD)2BF4, 20 µmol of ligand, 1 
mmol of the substrate and 4 ml of solvent, was added. This small glass 
tube was placed in a semi-automated autoclave with eight reactors 
(Endeavor™) 39  that was purged 4 times with nitrogen and once with 
hydrogen and heated if necessary. Then, the autoclave was pressurized 
with 5 or 25 bar of hydrogen. The reaction mixture was stirred for 16 h. A 
sample of the resulting mixture was filtered over a silica or Na2SO4 plug 
and subjected to conversion (1H-NMR) and e.e. determination (capillary GC 
or HPLC). (See Table 5.8) Full conversion was observed in most cases. 
Absolute configurations were determined by comparison with reference 
compounds (24) or literature data (12 and 23)40, by X-ray analysis (27) or 
assigned by analogy (25 and 26). 
 
2-Methyl-3-phenyl-propionic acid (12) 1H-NMR (200 
MHz, CDCl3)41 δ = 11.02 (bs, 1H), 7.32-7.25 (m, 2H), 7.23-
7.13 (m, 3H), 3.11-3.06 (m, 1H), 2.78-2.75 (m, 1H), 2.70-
2.67 (m, 1H), 1.18 (d, J = 7.0 Hz, 3H); 13C-NMR (50.32 
MHz, CDCl3)7 δ = 182.8, 139.0, 129.0, 128.4, 126.4, 41.2, 39.2, 16.4; 













2,3-Diphenyl-propionic acid (16): 1H-NMR (200 MHz, 
CDCl3)42 δ = 7.34–7.09 (m, 10H), 3.87 (t, J = 7.7 Hz, 1H), 
3.42 (dd, J = 8.2 Hz, 7.7 Hz, 1H) 3.04 (dd, J = 8.2 Hz, 7.7 
Hz, 1H); 13C-NMR (50.32 MHz, CDCl3)8 δ = 179.3, 138.6, 
137.9, 128.9, 128.7, 128.3, 128.1, 127.6, 126.4, 53.4, 39.2; 
HRMS8 calculated for C10H12O2 226.099 found 226.101. 
 
2-Methyl-butyric acid (17): 1H-NMR (200 MHz, CDCl3)43 δ = 
12.12 (bs, 1H), 2.35-2.30 (m, 1H), 1.67-1.60 (m, 1H), 1.46-1.39 
(m, 1H), 1.10 (d, J = 7.3 Hz, 3H), 0.87 (t, J = 7.5 Hz, 3H); 13C-
NMR (50.32 MHz, CDCl3)44 δ = 183.7, 40.9, 26.5, 16.3, 11.5; MS m/z (%)5 
102 (M+, 0.8), 87 (25), 74 (100), 57 (49). 
 
2-Benzyl-3-methyl-butyric acid (18): 1H-NMR (200 MHz, 
CDCl3)45 δ = 11.05 (bs, 1H), 7.32-7.14 (m, 5H), 2.89-2.79 
(m, 2H), 2.55-2.44 (m, 1H), 2.06-1.89 (m, 1H), 1.35-0.93 
(m, 6H); 13C-NMR (50.32 MHz, CDCl3) δ = 181.1 (s), 139.6 
(s) , 128.8 (d), 128.4 (d), 126.3 (d), 54.8 (d), 35.3 (d), 30.4, 20.3, 20.0; 
HRMS calculated for C12H16O2 192.115 found 192.114. 
 
2-(3,4-Dimethoxy-benzyl)-3-methyl-butyric acid (19): 
1H-NMR (200 MHz, CDCl3) δ = 6.78-6.69 (m, 3H), 3.83 
(s, 3H), 3.82 (s, 3H), 2.83-2.78 (m, 2H), 2.51-2.45 (m, 
1H), 2.00-1.90 (m, 1H), 1.18-0.96 (m, 6H); 13C-NMR 
(50.32 MHz, CDCl3) δ = 180.9, 148.7, 147.4, 132.1, 120.6, 112.0, 111.1, 
55.8, 55.7, 54.5, 35.0, 30.4, 20.3, 19.9; HRMS calculated for C14H20O4 
252.136 found 252.137. 
 
3-Methyl-2-(4-trifluoromethyl-benzyl)-butyric acid 
(20): 1H-NMR (200 MHz, CDCl3) δ = 7.51 (d, J = 8.2 Hz, 
2H), 7.28 (d, J = 8.2 Hz, 2H), 2.93-2.84 (m, 2H), 2.55-
2.48 (m, 1H), 2.07-1.90 (m, 1H), 1.18-0.95 (m, 6H); 
13C-NMR (50.32 MHz, CDCl3) δ = 173.4, 136.8, 122.1, 
118.3, 118.2, 47.0, 28.0, 23.6, 13.2, 12.9; HRMS calculated for 
C13H15O2F3 260.102 found 260.103. 
 
Synthesis of α-methylbenzylamine derivative of 20: 
 
To determine the absolute configuration of 20, the (S)-(-)-α-
methylbenzylamine derivative of 20 was synthesized.46 From the resulting 
product crystals were grown and submitted to X-ray analysis. From the 
structural data it could be concluded that product 20 has the R-
configuration. 
To a cold (0°C) solution of 260 mg (1 mmol) of 20 in 5 ml of CH2Cl2 was 














Asymmetric Hydrogenation of Unsaturated Carboxylic Acids Using a Mixed 
Ligand Approach  
 
 






was stirred for 30 min. To the mixture was added a solution of 0.13 ml (1 
mmol) (S)-(-)-α-methylbenzylamine in 5 ml CH2Cl2. The reaction mixture 
was slowly warmed to rt and stirred overnight. The precipitate was 
removed by filtration. The filtrate was successively washed with a 2% 
HCl(aq) solution, a 4% NaHCO3(aq) solution, water, and brine and dried over 
Na2SO4. The solvent was removed in vacuo, and the crude product was 
recrystallized from pentane / EtOAc to obtain 30 mg (= 0.083 mmol; 8.3%) 




(200 MHz, CDCl3) δ = 7.40 (d, J = 8.06 Hz, 2H), 
7.17 (m, 5H), 6.82 (m, 2H), 5.27 (bd, J = 7.7 Hz, 
1H), 5.01 (m, 1H), 2.89 (m, 2H), 1.93 (m, 2H), 1.40 (d, J = 7.0 Hz, 3H), 1.08 
(d, J = 6.6 Hz, 3H), 1.01 (d, J = 6.6 Hz, 3H); 13C-NMR (50.32 MHz, CDCl3) δ 
= 177.5, 172.5, 144.5, 142.5, 129.3, 128.4, 127.2, 126.0, 125.2, 58.1, 
48.0, 36.4, 31.1, 21.1, 20.8, 20.6; HRMS calculated for C21H24F3NO 
363.181 found 363.180; [α]D = -21° (c= 0.18, CHCl3). 
 
 Absolute configuration assignment was obtained from the X-ray structure: 
C21H24F3NO, Mr = 363.42, monoclinic, P21, a = 11.180(1), b = 4.9299(6), c = 
17.602(2) Å, β = 96.528(2)°, V = 963.87(18) Å3, Z = 2, Dx = 1.252 gcm-3, 
F(000) = 384, µ = 0.96 cm-1, λ(MoKα ) = 0.71073 Å, T = 100(1) K, 7298 
reflections measured, GooF = 1.031, wR(F2) = 0.1175 for 3682 unique 
reflections and 359 parameters, 7 restraints and R(F) = 0.0447 for 3325 
reflections obeying Fo ≥ 4.0 σ(Fo) criterion of observability. 
The asymmetric unit consists of one molecule of the title compound. 
 
 (E)-2-Methyl-3-naphthalen-2-yl-acrylic acid (30): 
1H-NMR (400 MHz, CDCl3): δ 8.01 (bs, 1H), 7.85 – 
















(s, 3H); 13C-NMR (75 MHz, CDCl3): δ 174.2 (s), 141.2 (d), 133.1 (s), 133.0 
(s), 129.8 (d), 128.4 (d), 128.0 (d), 127.7 (s), 127.6 (d), 127.0 (d), 126.9 (d), 
126.5 (d), 13.9 (q): HRMS calculated for C14H12O2 212.083 found 212.083. 
 
 (S)-(+)-2-Methyl-3-naphthalen-2-yl-propionic acid 
(31). An autoclave was loaded with a mixture of 2.0 g 
(9.43 mmol) of 30, 78 mg (0.183 mmol) of L7, 37.1 mg 
(0.091 mmol) of Rh(COD)2BF4, 27.8 mg (0.091 mmol) of 
P(o-tolyl)3 in 100 ml i-PrOH / H2O (4:1). The autoclave was flushed three 
times with N2 and twice with H2 and subsequently pressurized with 19 bar 
of H2. The mixture was stirred for 16 h at 30°C and i-PrOH was evaporated 
under reduced pressure. The resulting mixture was extracted with CH2Cl2 
(100 mL), and the organic solution washed with water (2x50 mL), dried 
over MgSO4, filtered and concentrated under reduced pressure. The crude 
residue was purified by column chromatography (SiO2, pentane:ether = 
9:1), affording 31 as a white solid (e.e = 97 %). After crystallization from 
hexane 1.69 g (84 %) of 31 was obtained as a white solid with e.e. > 99%. 
[α]D20 = + 26.2 º (c = 0.99, CH2Cl2). Spectroscopic data were according to 
the values described in the literature.34 
 
 (S)-(+)-2-Methyl-2,3-dihydro-cyclopenta[a]naphthalen-1-
one (32). A solution of 1.50 g (7.0 mmol) of 31, 10 ml of SOCl2 
and 1 drop of DMF in 21 ml CH2Cl2 was refluxed for 1h. All 
volatiles were removed under reduced pressure, giving the 
crude acid chloride, which was dissolved in ClCH2CH2Cl and 
cooled to 0 ºC. To the solution was quickly added 2.66 g (20 mmol) of AlCl3 
and the reaction mixture was stirred at 0 ºC for 30 min. The reaction was 
quenched with 50 mL of saturated NaHCO3(aq) and the mixture extracted 
with CH2Cl2. The organic layer was dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude residue was purified by 
column chromatography (SiO2, pentane:ether = 5:1), affording 31 as a 
white solid (e.e. = 97 %). Crystallization from Et2O afforded 0.97 g (70 %) of 
31 with e.e. > 99 % (see Table 5.8). [α]D20 = + 96.0 º (c = 1.21, CH2Cl2). 
Spectroscopic data were according to the literature values.34 
 
A mixture of 100 mg (0.5 mmol) of 32, 200 mg (0.75 
mmol) 1,2-bis(tert-butyldimethylsilyl)hydrazine and 1 mg 
(4 mol%) scandium trifluoromethanesulfonate  was heated 
to 100 °C for 4h. Volatile by-products were removed in 
vacuo and the product used without further purification. 
To a cooled (-50°C) solution of 162 mg (0.5 mmol) of 
silylhydrazone in 5 ml of DMF was added 215 mg (0.5 mmol) 
bis(trifluoroacetoxy)iodobenzene and after 5s, a solution of  135 mg (0.5 
mmol) thiocarbonylxanthone  in 1.5 ml of DMF. The mixture was allowed 





Asymmetric Hydrogenation of Unsaturated Carboxylic Acids Using a Mixed 
Ligand Approach  
 
 






partitioned between EtOAc and water. The organic layer was dried over 
MgSO4, filtered and the solvent removed in vacuo. The product was 
precipitated by addition of cold methanol and collected by filtration (78mg, 
40%). Yield reported for 2 steps. 
 
A solution of 70 mg (0.18 mmol) of thiirane and 262 mg (1 mmol) of 
triphenylphosphine in 5 ml of m-xylene was heated to reflux for 16h. After 
cooling to r.t. 425 mg (3 mmol) of iodomethane was added dropwise and 
the mixture stirred at r.t. for 1h. The resulting mixture was filtered 
through a plug of silica eluting with 4: 1 heptane: toluene and the solvent 
removed in vacuo to afford the product as a pale yellow solid (65 mg, 90 
%). Spectroscopic data were according to the literature values.36 
 
Table 5.8: Ee determination for compounds 12, 23-27, 31-33. 
Entry Compound Method Rt (min) 
1a 12 A 23.3 (R) / 23.5 (S) 
2 23 B 7.5 (R) / 8.5 (S) 
3 24 C 9.9 (S) / 10.5 (R) 
4 25 D 39.6 (S) / 40.9 (R) 
5 26 E 9.7 (S) / 12.0 (R) 
6 27 B 15.6 (R) / 18.0 (S) 
7 31 F 23.5 (R) / 26.3 (S) 
8 32 G 19.3 (S) / 22.1 (R) 
9 33 H 3.64 / 3.96 
(a) Product was analyzed as its methyl ester; To the crude product in MeOH was added 
dropwise a 2M solution of trimethylsilyl diazomethane in ether untill the yellow colour 
persisted 
Method A: GC – Chiraldex GTA – 80°C (10 min) -> 3°C/min -> 180°C   
Method B: HPLC – Chiralpak AD – 99 : 1 (Heptane : i-PrOH) 
Method C: GC – Chiraldex BP-M – 80°C isotherm 
Method D: GC – Chiraldex BP-M – 135°C isotherm 
Method E: HPLC – Chiralcel OD – 95 : 5 (Heptane : i-PrOH) 
Method F: HPLC – Chiralcel OB – 99 : 1 (Heptane : i-PrOH) 
Method G: HPLC – Chiralcel OB-H – 99 : 1 (Heptane : i-PrOH) 


















Spectra were recorded on a Varian Mercuri Plus at a frequency of 162 
MHz. Sample preparation: 4.06 mg (0.01 mmol) of Rh(COD)2BF4 and two or 
three times 0.01 mmol (2 or 3 equivalents) of ligand were dissolved in 0.8 
ml CDCl3. A 31P-NMR was recorded of the resulting yellow solution. 
 
Homo-complexes: RL2: δ 132.7 (d, JRh-L = 229.5 Hz)   
          RP2 : δ 25.9 (d, JRh-P = 145.5 Hz) 
 
Hetero-complex:  RLP: δ 135.8 (dd, JRh-L = 239.2 Hz, JL-P = 35.0 Hz) 
                 δ 30.6 (dd, JRh-P = 146.3 Hz, JL-P = 35.0 Hz) 
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In this chapter, the rhodium-catalyzed asymmetric hydrogenation of a series 
of β2-amino acids, with a mixed ligand system consisting of a chiral 
phosphoramidite and an achiral phosphine, is described. Full conversions 


















6.1   Introduction 
6.1.1   β –Peptides and β –amino acids 
β-Peptides have been extensively studied in the last ten years.1 
Interesting features of these molecules are that they can fold in a 
predictable way to form secondary structures in solution. They are 
resistant to cleavage by peptidases and metabolic transformations and 
they can mimic α-peptides in protein-protein and peptide–protein 
interactions. The building blocks for β-peptides are β-amino acids which 









β2-amino acid β3-amino acid β2,3-amino acid  
Figure 6.1: Structures of β-amino acids. 
6.1.2   Synthesis of β2-amino acids 
A wide variety of methods is known to synthesize enantiomerically pure 
β-amino acids.2 Most extensively studied is the synthesis of β3-amino acids 
although some research has also been focused on β2-amino acids. Five 
methods can be distinguished for the synthesis of enantiomerically pure 
β2-amino acids:3 
* Stereoselective alkylation of β-homoglycine derivatives 
* Addition of chiral enolates to acyliminium salts 
* Curtius rearrangement of enantiomerically pure succinates 
* Resolution of racemic β2-amino acids  
* Asymmetric transition metal catalyzed reactions 
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6.1.2.1   Alkylation of β-homoglycine derivatives 
 
The alkylation of β-homoglycine derivatives is the most investigated 
method for the synthesis of β2-amino acids, since β-homoglycine is readily 
available at low cost. In general, N-protected β-homoglycine is derivatized 
with a chiral auxiliary and subsequently alkylated. Initial attention has 
been focused on cyclic derivatives but in the last ten years a number of 
methods have been reported were acyclic derivatives have been used.3 
Scheme 6.1 shows two representative examples of both approaches. The 
chiral β2-amino acids are obtained after deprotection in good yields and 
with high selectivity. The stoichiometric amounts of chiral auxiliaries make 
this method less elegant from an atom economy point of view.   
6.1.2.2   Addition of chiral enolates to acyliminium salts 
 
The second method, the addition of chiral enolates to acyliminium salts, 
is similar to the first method and is also based on enolate chemistry. In a 
Mannich-type approach, the amine functionality is introduced by 
alkylation, whereas in the first method this functionality was already 
present in the enolate. A representative example, developed by Wyatt and 
co-workers,4 is depicted in Scheme 6.2. As mentioned before, the use of 
stoichiometric amounts of chiral auxiliaries makes also this method less 
elegant. 
6.1.2.3   Curtius rearrangement of enantiomerically pure succinates 
 
The third route described here is the Curtius rearrangement (see also § 
4.2.1.5) of enantiomerically pure and regioselectively protected succinates. 
This method can lead to either β2- or β3-amino acids. One of the first 
examples based on this route has been reported by Monsanto (Scheme 
6.3).5 The preparation of the enantiomerically pure succinates is 
predominantly done by diastereoselective alkylation of chiral 
succinyloxazolidinones with alkyl and benzyl halides or by alkylation of 




















































2) 0.1M TFA, H2O, 4d















Scheme 6.1: Alkylation of β-homoglycine derivatives.7 
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Scheme 6.3: Curtius rearrangement of enantiomerically pure succinates.5 
6.1.2.4   Resolution of racemic β2-amino acids 
 
An easy method to obtain enantiomerically pure β2-amino acids is by 
classical resolution.  Only a few chiral resolving agents have been reported 
so far, which have been used in the resolution of β2-homoalanine, β2-
homophenylglycine, β2-homoproline and β2-iso-proline.8 The resolving 




























Figure 6.2: Resolving agents for the classical resolution of β2-amino 
acids.8 
In addition to classical resolution, a number of enzymatic resolutions 
have been developed.9 A nice example has recently been reported by 
DSM.10 An enzymatic resolution of β2-phenyl alanine could be performed 









(rac)-21 methyl ester (R)-21 (S)-21 methyl ester  
Scheme 6.4: Resolution of β2-phenyl alanine by Alcalase 2.5L DX.10 
6.1.2.5   Transition metal catalyzed reactions 
 
So far, only a limited number of reports have been published on the 
synthesis of β2-amino acids by transition metal catalysis. Among them are 
Pd-catalyzed allylic substitutions,11 Rh-catalyzed CH activation,12 Cu-
catalyzed conjugate additions13 and Rh-catalyzed hydrogenations.14  
In a series of articles, Robinson and co-workers report on the 
asymmetric hydrogenation of β2-amino acids precursors.14 In an approach 
were phthalimido nitriles are hydrogenated, which form β2-amino acids 
after hydrolysis of the nitrile functionality, modest enantioselectivities 
(78%) were obtained with Rh-Duphos or Rh-BPE complexes. Another 
drawback of this method is the synthesis of the substrates. The substrates 
Rhodium-catalyzed Asymmetric Hydrogenation of β2-Dehydroamino acids  
 
 






are prepared by a Ni-catalyzed addition of the very toxic hydrogen cyanide 
to alkynes.  
A recent article describes the preparation of β2-amino acids in three 
steps (Scheme 6.5). Modest e.e.’s (67%) were obtained after rather long 


























Rh/L*, 4 bar H2
MeOH, 72 h, rt
Me-BPE
L* =
25a: R = Ph  (67% e.e.)




Scheme 6.5: Synthesis of β2-amino acids as reported by Robinson et al.14c 
6.1.3   Goal of this research 
Basavaiah and Satyanarayana reported the synthesis of β2-
dehydroamino acid methyl esters in a one-pot synthesis from the 
corresponding Baylis-Hillman adducts.16 Although these β2-dehydroamino 
acid methyl esters were undesired products for the authors, we envisioned 
that these products would be excellent substrates for the rhodium-
catalyzed asymmetric hydrogenation. The goal of this research is the 
asymmetric hydrogenation of these substrates in high enantioselectivities 
and high yields. This would be a short, elegant and atom economic method 












6.2   Synthesis of the substrates 
 
The synthesis of the substrates can be performed, on a multi-gram 
scale, in three steps starting from the commercially available 
benzaldehydes and methyl acrylate (34) (Scheme 6.6). The initial Baylis-
Hillman reaction is well reported15 and proceeded smoothly with good 
yields (77-87%) for substrates 35 and 39-42.  The yields for the methyl-
substituted substrates 36-38 were low, due to incomplete conversion, even 
after 10 d of stirring. This is a general feature for Baylis-Hilman reactions. 
The introduction of electron donating groups in the starting material 
decreases the reaction rate, whereas the introduction of electron 




























R = H      : 26, 35, 43, 51 
R = o-Me : 27, 36, 44, 52 
R = m-Me: 28, 37, 45, 53
R = p-Me : 29, 38, 46, 54
R = o-Br  : 30, 39, 47, 55 
R = m-Br : 31, 40, 48, 56
R = p-Br  : 32, 41, 49, 57
R = p-Cl  : 33, 42, 50, 58
 
Scheme 6.6: Synthesis of substrates 51-58. 
The second step, which was reported by Basavaiah et al.,16 is a Ritter 
reaction. This reaction proceeds in good yields with exclusive formation of 
the E-isomer. Dehydroamino acids 51-58 could be obtained in high yield 
after a straightforward hydrolysis of 43-50. 
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To broaden the scope, attempts were made to synthesize alkyl 
substituted substrates (Scheme 6.7). The Baylis-Hilman products of 
methyl acrylate (34) with formaldehyde (59) and butyraldehyde (62) could 
be obtained in modest yields. Unfortunately, attempts to convert 60 into 
61, using the method as described by Basavaiah et al.,16 failed. After 6 h 
incomplete conversion was observed. Attempts to separate the starting 
material from the product by column chromatography were not successful. 
Increasing the reaction time to 16 h, did not improve the results. A 












































Scheme 6.7: Attempted synthesis of substrates 61 and 64. 
The Baylis-Hilman product 63 derived from butyraldehyde (62) and 
methyl acrylate (34) could be converted by the method of Basavaiah et al.16 
Unfortunately, a 1:1 mixture of two regioisomers 64 and 65 was obtained 
which could not be separated. This can be explained by the formed 
intermediate. After protonation of the hydroxyl group followed by 
dehydration, an allyl cation is obtained which is depicted in Figure 6.3. 
Attack of acetonitrile will mainly take place on resonance structure B when 










phenyl ring as well as the carbonyl moiety. However, when R is an alkyl 
group no extra stabilization will take place and acetonitrile will attack in 
this case on resonance structure A as well as on resonance structure B 








Resonance structure A Resonance structure B
 
Figure 6.3: Allyl cation formed in the synthesis of the substrates 43-50, 
64 and 65. 
6.3   Optimization of the reaction conditions for the 
enantioselective hydrogenation of 43 
6.3.1   Initial experiments 
6.3.1.1   Literature conditions 
 
Initial attempts at the asymmetric hydrogenation of substrate 43, 
applying previous developed conditions17 for the hydrogenation of α- and β-
dehydroamino acids, failed (Table 6.1). 
 Surprisingly, all reactions performed in CH2Cl2 gave no conversion at 
25 bar of hydrogen and a temperature of 25°C. The reactions performed in 
i-PrOH gave in some cases low conversions, but the enantioselectivities 
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Solvent 25 bar H2, 25°C
L1 L2 L3 L4
43 66
 
Entry Solvent Ligand Conversion E.e.d,e 
1 CH2Cl2 L1 0 - 
2 CH2Cl2 L2 0 - 
3 CH2Cl2 L3 0 - 
4 CH2Cl2 L4 0 - 
5 i-PrOH L1 20 46 
6 i-PrOH L2 <10 ND 
7 i-PrOH L3 0 - 
8 i-PrOH L4 15 10 
(a) Reaction conditions: 0.2 mmol of substrate in 4 ml of solvent with 0.002 mmol of 
Rh(COD)2BF4, 0.004 mmol of phosphoramidite; (b) Reactions were run for 16 h at rt and 25 
bar H2 (c) Conditions are reported in ref. 17a and b; (d) E.e.’s were determined by chiral HPLC 
(for details see experimental section); (e) Absolute configuration of product is not known. 
6.3.1.2   The influence of PPh3 
 
In chapter 5, the rhodium-catalyzed asymmetric hydrogenation of α,β-
unsaturated carboxylic acids was described.18 In these cases, addition of 
an equivalent of an achiral phosphine to the chiral phosphoramidite 
increased the enantioselectivity and rate of the reaction. Furthermore, the 
presence of a free carboxylic acid instead of the corresponding methyl ester 
appeared to be important in the hydrogenation of α,β-unsaturated 
carboxylic acids. Since the structure of 51 is related to the substrates used 
in the previous chapter, attempts were made to perform the reaction under 




























i-PrOH / H2O (4:1)
 25 bar H2, 60°C
51 67
L6  
Entry Ligand Conversion E.e.c,d 
1 L3 100 0 
2 L3 + PPh3 100 66 
3 L5 100 0 
4 L5 + PPh3 100 75 
5 L6 100 0 
6 L6 + PPh3 100 83 
(a) Reaction conditions: 0.2 mmol of substrate in 4 ml of an i-PrOH / H2O (4:1) mixture with 
0.002 mmol of Rh(COD)2BF4, 0.004 mmol of phosphoramidites and possibly 0.002 mmol of 
PPh3; (b) Reactions were run for 16 h at 60°C and 25 bar H2; (c) E.e.’s were determined by 
chiral HPLC after conversion of product to the corresponding methyl ester (for details see 
experimental section); (d) Absolute configuration of product is not known. 
 
Raising the temperature to 60°C and adding 20% water as a co-solvent 
and using the free carboxylic acid led to full conversion, although still a 
racemic mixture was obtained (compare Table 6.1 entry 7, Table 6.2 entry 
1). Addition of an equivalent of triphenylphosphine increased the e.e. 
dramatically. The greatest increase was observed in combination with L6. 
The homo-combination of L6 showed no selectivity at all, whereas the 
hetero-combination of L6 with PPh3 induced an e.e. of 83%. (Entries 5 and 
6) As observed before, phosphoramidites substituted with two methyl 
groups at the 3 and 3’ positions of the BINOL moiety, gave higher 
enantioselectivities than the unsubstituted BINOL based phosphoramidites 
(entries 2 and 6). Also the introduction of a cyclic piperidine moiety had a 
beneficial effect on the enantioselectivity (entries 4 and 6). 
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6.3.1.3   Temperature and solvent optimization 
 
Further optimization of temperature and solvent employing L5 and PPh3 
as ligands showed that a decrease in temperature, led to a slight increase 
in e.e. (entries 1-7, Table 6.3) An optimal temperature for this system is 
40°C, since at lower temperatures no full conversions were obtained.  










Solvent, 25 bar H2, T
51 67  
Entry Solvent Temperature Conversion E.e.c,d 
1 i-PrOH / H2O (4:1) 60 100 75 
2 i-PrOH / H2O (4:1) 55 100 77 
3 i-PrOH / H2O (4:1) 50 100 78 
4 i-PrOH / H2O (4:1) 45 100 78 
5 i-PrOH / H2O (4:1) 40 100 78 
6 i-PrOH / H2O (4:1) 35 93 76 
7 i-PrOH / H2O (4:1) 30 66 80 
8 CH2Cl2 30 0 - 
9 EtOAc 60 0 - 
10 MeOH 60 100 77 
11 EtOH 60 87 75 
12 i-PrOH 60 92 69 
13 H2O 60 45 9 
(a) Reaction conditions: 0.2 mmol of substrate in 4 ml of solvent with 0.002 mmol of 
Rh(COD)2BF4, 0.004 mmol of phosphoramidites and 0.002 of mmol PPh3; (b) Reactions were 
run for 16 h and 25 bar H2; (c) E.e.’s were determined by chiral HPLC after conversion of 
product to the corresponding methyl ester (for details see experimental section); (d) Absolute 
configuration of product is not known. 
 
Optimization of the solvent revealed that protic polar solvents were the 
most suitable for this reaction (entries 8-13). No conversions were obtained 
in CH2Cl2 and EtOAc. This is caused by the poor solubility of the 
substrates in these solvents. Furthermore, breaking up of the possible 
internal hydrogen bond in 51, by protic solvents may also result in an 










full conversion and an enantioselectivity of 77%. Other alcohols gave 
incomplete conversions with slightly lower e.e.’s. A solvent mixture of i-
PrOH and water showed again (see chapter 5) higher selectivity and 
conversion than the pure solvents. With these results in hand, 
optimization of the ligands, with respect to the enantioselectivity, was 
carried out by high-throughput experimentation. 
6.3.2   Ligand optimization by high-throughput experimentation 
6.3.2.1   High-Throughput Experimentation 
 
One of the most frustrating aspects in homogeneous catalysis is the 
troublesome rational design of catalysts. Although in some cases well 
educated guesses can be made regarding structural elements of a good 
catalyst, optimization of these catalysts is often a matter of trial and error. 
The synthesis of many (bidentate) ligands is often a time-consuming and 
tedious work. On the other hand, the synthesis of monodentate 
phosphoramidites and phosphites is easy. Although the synthesis is short, 
screening a library of these ligands by hand would take a lot of time. DSM 
developed an automated method for the solution phase synthesis of 
monodentate phosphoramidite ligand libraries.19 Advantage of this method 
is that a large number of structurally diverse phosphoramidites can be 
screened in relatively small quantities in a short period of time. The setup 
of this automated system is depicted in Figure 6.4. 
Toluene solutions of a range of phosphorochloridites, amines and 
triethylamine are dispersed over a 96 wells microplate, consisting of an 
oleophobic filter. After the dispersion, the microplate is shaken for 2 h on 
an orbital shaker. The plate is transferred on top of another microplate 
and vacuum is applied, to remove the formed Et3N·HCl salt by filtration. 
The toluene solutions with the ligands are dispersed over 96 reaction vials. 
These are placed in a parallel reactor after addition of solutions of the 
metal precursor and the substrate. The system is fully automated and all 
the transferring of solutions is being done by a robot. After completion of 
the reactions, samples are taken automatically which are subjected to GC 
and/or HPLC analysis. In earlier reports19 it has been shown that in 
general ligands are formed in over 90% purity. 
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Figure 6.4: High throughput screening of libraries of phosphoramidites.20 
An initial screening of a library of 48 different phosphoramidites, based 
on 4 different phosphorochloridites and 12 different amines and alcohols, 
was done with substrates 43 and 51 at 25 bar of H2 and 40°C. Screening 
of substrate 51 was done with an additional equivalent of PPh3 using the 
mixed ligand approach as was discussed in chapter 5. The set up of the 
library is depicted in Scheme 6.8.  
The results of the screening on substrate 51 are depicted in Figure 6.5. 
Ligands based on a 3,3’-dimethyl BINOL (PCl-3) induced in most cases full 
conversion and modest to good e.e.’s. On the other hand, ligands based on 
BINOL (PCl-1), 8H BINOL (PCl-2) and 4,4’-dibromo BINOL (PCl-4) led to 
relatively low activity with in general poor e.e.’s.  The enantioselectivities 
induced by ligands based on primary amines A5-A8 and alcohols A10-A12 
were rather poor. The best results were obtained with combinations of PCl-
































































MeOH, 25 bar H2, 40°C
43:R = Me
51:R = H
66: R = Me





PCl-1 PCl-3 PCl-4PCl-2  
Scheme 6.8: First screening of a library of phosphoramidites. 
Figure 6.6 shows the results of screening the same library of ligands 
(Figure 6.4) on substrate 43. As was observed before, ligands based on 
3,3’-dimethyl BINOL (PCl-3) led to the best conversions. In contrast to 
what was observed in the hydrogenation of 51, ligands based on primary 
amines (A5-A8) induced higher e.e.’s compared to the secondary amines in 
the hydrogenation of substrate 43. Similar effects were observed in the 
rhodium-catalyzed hydrogenation of β3-amino acids with monodentate 
phosphoramidites.17b In these reactions a ligand based on PCl-1 and A7 
led to excellent results in the hydrogenation of substrates with a Z-
geometry at the alkene. Furthermore, monodentate phosphites (A10-A12) 
led to rather poor results, with low conversions and enantioselectivities. A 
combination of PCl-3 and A5 gave the best results, with full conversion 
and 70% e.e. 
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 A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 A12 
PCl-1             
PCl-2             
PCl-3             
PCl-4             
 
Conversion 
 A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 A12 
PCl-1             
PCl-2             
PCl-3             
PCl-4             
Figure 6.5: Results of first the library on substrate 51. 
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Since the results from the screening of substrate 51 were more 
promising than those of substrate 43, the reactions conditions for the 
asymmetric hydrogenation of 51 were further optimized. A second library 
with 16 different phosphoramidites based on 3,3’-dimethyl BINOL and 16 
different secondary amines was designed. Each phosphoramidite was 
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A16 A18 A19 A20 A21
A23 A24A22
P(4-CF3Ph)3 P(2-Furyl)3 P(4-MeOPh)3 P(o-tolyl)3
(P1) (P2) (P3) (P4) (P5) (P6)  
Scheme 6.9: Second screening of a library of phosphoramidites on 51. 
The results of the second screening are depicted in Figure 6.7. In 
general, most of the ligands performed well. Excellent to full conversions 
were obtained with some exceptions of phosphoramidites based on dialkyl 
substituted amines and phosphites. For most ligands, enantioselectivities 
of >80% were obtained with PPh3 (P1) as an achiral co-ligand. Substitution 
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of the phosphines did not show any improvements. Although modest to 
good e.e.’s were obtained with P5, the conversions were in most cases low 
with this phosphoramidite ligand. A reverse effect was observed with P6; 
good to excellent conversions were obtained, but the enantioselectivities 
remained low. 
Enantioselectivity   Conversion 
 P1 P2 P3 P4 P5 P6    P1 P2 P3 P4 P5 P6 
A1         A1       
A2         A2       
A4         A4       
A13         A13       
A14         A14       
A15         A15       
A16         A16       
A17         A17       
A18         A18       
A19         A19       
A20         A20       
A21         A21       
A22         A22       
A23         A23       
A24         A24       
A25         A25       
 
SCALE (%) 
0-10 10-20 20-30 30-40 40-50 50-60 60-70 70-80 80-90 90-100 
                    
Figure 6.7: Results of screening the second library on substrate 51 
(Scheme 6.9). 
In summary, the results of the screenings showed that L6 (a 
combination of PCl-3 and A4) in combination with PPh3 (P1) or P(o-tolyl)3 
(P5) led to the best results in terms of conversion and enantioselectivity 













6.3.3   Further optimization of reaction condition for the 
hydrogenation of 51 
6.3.3.1   Temperature Effect 
 
Another study of the variation in the temperature was performed, since 
earlier optimization was done for a different solvent. As was observed 
before, decreasing the temperature increased the enantioselectivity. At 
30°C a maximum of 83% e.e. was obtained with full conversion. The e.e. 
remained constant when the temperature was decreased even more, but in 
this case no full conversion was obtained. 










MeOH, 25 bar H2, T
51 67  
Entry Temperature  E.e.c,d,e 
1 60 77 
2 55 80 
3 50 80 
4 45 82 
5 40 82 
6 35 82 
7 30 83 
8 25 83 (96) 
(a) Reaction conditions: 0.2 mmol of substrate in 4 ml of MeOH with 0.002 mmol of 
Rh(COD)2BF4, 0.004 mmol of phosphoramidite and 0.002 mmol of PPh3; (b) Reactions were 
run for 16 h and 25 bar H2; (c) E.e.’s were determined by chiral HPLC after conversion of 
product to the corresponding methyl ester (for details see experimental section); (d) 
Conversion is depicted in brackets in case no full conversion is reached; (e) Absolute 
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6.3.3.2   Phosphine optimization 
 
In chapter 5 it was demonstrated that small alterations in the 
phosphine structure can have large effects on the selectivity and 
conversion in the hydrogenation reactions. Table 6.5 represents the results 
obtained from a screening of structural different phosphines on the 
hydrogenation of substrate 51 under optimized conditions.21 Although the 
variation in enantioselectivity is not as large as for the hydrogenation of 
α,β-unsaturated carboxylic acids, still some small effects can be observed.  










MeOH, 25 bar H2, 30°C
51 67  
Entry R  E.e.c,d,e 
1 Ph (P1) 89 
2 o-tolyl (P5) 91 
3 m-tolyl (P7) 89 
4 p-tolyl (P8) 85 
5 xylyl (P9) 85 
6 mesityl (P10) 33 (53) 
7 m-ClPh (P11) 89 
8 p-ClPh (P12) 88 
9 p-FPh (P13) 87 
10 1,2,3,4,5-FPh (P14) 0 (12) 
11 1-naphthyl (P15) 91 
12 p-MeOPh (P4) 66 (88) 
13 cyclohexyl (P6) 62 (86) 
14 t-butyl (P16) 0 (29) 
(a) Reaction conditions: 0.2 mmol of substrate in 4 ml of MeOH with 0.002 mmol of 
Rh(COD)2BF4, 0.004 mmol of phosphoramidite and 0.002 mmol of PR3; (b) Reactions were run 
for 16 h, 25 bar H2 and 30°C; (c) E.e.’s were determined by chiral HPLC after conversion of 
product to the corresponding methyl ester (for details see experimental section); (d) 
Conversion is depicted in brackets in case no full conversion is reached; (e) Absolute 












Substitution of the phenyl at the ortho position in the triarylphosphine 
increased the e.e. slightly (compare entries 1, 2 and 11). Substitution on 
other positions did not have any effect. Introduction of electron 
withdrawing groups did not have any influence on the enantioselectivity 
(entries 7-9). On the other hand, introduction of an electron donating 
methoxy group decreased the e.e. and the rate of the reaction (entry 12). 
Sterically crowded phosphines induced low reactivity and low selectivity 
(entries 6 and 14). Furthermore, alkyl phosphines led to poorer results 
than aryl phosphines (entries 1, 13 and 14). 
6.3.3.3   Pressure optimization 
 
In order to optimize the reaction conditions variation in the pressure 
was examined. The results are depicted in Table 6.6. 











51 67  
Entry Pressure E.e.c,d,e 
1 25 91 
2 20 92 
3 15 92 
4 10 92 (89) 
5 5 92 (64) 
6 1 83 (8) 
(a) Reaction conditions: 0.2 mmol of substrate in 4 ml of MeOH with 0.002 mmol of 
Rh(COD)2BF4, 0.004 mmol of L6 and 0.002 mmol of P(o-tolyl)3; (b) Reactions were run for 16 
h at 30°C; (c) E.e.’s were determined by chiral HPLC after conversion of product to the 
corresponding methyl ester (for details see experimental section); (d) Conversion is depicted in 
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Decreasing the pressure, i.e. lowering the hydrogen concentration, had 
no influence on the enantioselectivity, as was observed in the 
hydrogenation of α,β-unsaturated carboxylic acids. On the other hand, the 
reaction rate was decreased by lower pressure, as can be seen from the 
incomplete conversions obtained at pressures lower than 15 bar. 
6.3.4   Expanding the range of substrates 
The hydrogenations of substrates 52-54 and 58 with a variety of 
phosphines are depicted in Table 6.7.  


































69 83 86 84 84 91 
3 p-Me (54) 70 78 89 81 85 91 
4 p-Cl (58) 71 85 80 (65) 79 (90) 78 56 (86) 
(a) Reaction conditions: 0.2 mmol of substrate in 4 ml of MeOH with 0.002 mmol of 
Rh(COD)2BF4, 0.004 mmol of phosphoramidites and 0.002 mmol of PR3; (b) Reactions were 
run for 16 h at 25 bar H2 and 30°C; (c) E.e.’s were determined by chiral HPLC after 
conversion of the products to their corresponding methyl ester (for details see experimental 
section); (d) Conversion is depicted in brackets in cases no full conversion is reached; (e) 










The reactions have been performed in MeOH at 25 bar and 30°C. L6 
was used as ligand in combination with phosphines P1, P5, P7, P8 and 
P15. The highest enantioselectivities for substrates 52-54 have been 
obtained with ortho-substituted phosphines P5 and P15 (up to 91% e.e.). 
While for substrates 53 and 54 the best results were obtained with 
phosphine P15, substrate 52 was not converted, probably due to steric 
hindrance. The enantioselectivities obtained with chloro-substituted 
substrate 58 was in general lower than for those obtained with the methyl 
substituted derivatives. In addition to the lower e.e., a drop in reaction rate 
was observed, which can be seen from the incomplete conversions 
obtained with phosphines P5, P7 and P15. Whereas for 52-54 the ortho-
substituted phosphines gave the best results, for 58 the less hindered 
phosphines P1 gave the highest e.e. (85%).  
Attempts to hydrogenate the bromo-substituted substrates 55-57 did 
not succeed. In all cases incomplete conversion was obtained. In addition 
to the desired hydrogenation product, the formation of the dehalogenated 
products was observed, in combination with some other unidentified side-
products. 
6.4   Conclusion 
 
In this chapter the successful synthesis of β2-amino acids by 
asymmetric rhodium-catalyzed hydrogenation, employing a mixture of 
ligands, has been described. The substrates could be synthesized in a 
short 4-step procedure with reasonable yields (up to 50% over 3 steps), 
starting from commercially available aldehydes and methyl acrylate (34). 
Optimization of the catalytic system was done by library screening. 
Currently the scope of substrates is limited, due to synthetic limitations in 
the Baylis-Hilman reaction. The presence of electron-donating groups are 
limiting the synthesis of the Baylis-Hilman adducts. Alkyl substituted 
substrates could not be synthesized so far due to regioselectivity problems 
in the Ritter reactions. On the other hand, electron-withdrawing groups in 
the substrate show worse results in the hydrogenation reactions. The 
results obtained in the hydrogenations are the best so far reported for this 
kind of substrates, with a maximum e.e. of 91% obtained with 51, 53 and 
54.14 
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For general information see chapter 2. Phosphoramidites L1 – L6 were 
commercially available or made by literature procedures.17c (S)-3,3’-
dimethylbinol and phosphoramidite L5 were generously donated by DSM. 
Phosphines P1-P13 were purchased from Aldrich or Strem Chemicals. The 
synthesis and screening of the libraries has been done at DSM research in 
Geleen. The author likes to thank Laurent Lefort and Barbara Procuranti 
for their contribution to this part. 
 
2-(Hydroxy-phenyl-methyl)-acrylic acid methyl ester 
(35):22 To 4.06 ml (40 mmol) of benzaldehyde (26) and 10 
ml of a 33% (w/v) aqueous solution of Me3N in 40 ml of 
MeOH was added 120 mmol of methyl acrylate. The 
solution was stirred for 48 h and 400 ml of CHCl3 and 100 ml H2O were 
added. The layers were separated and the aqueous layer was extracted 
twice with 100 ml CHCl3. The organic layers were dried on Na2SO4, filtered 
and concentrated. The product was purified by column chromatography. 
(SiO2; heptane:EtOAc 5:1) to yield 5.9 g (30.7 mmol; 77%) of a colorless oil. 
1H --NMR (400 MHz, CDCl3) δ = 7.30-7.21 (m, 5H), 6.26 (d, J = 6.0 Hz, 1H), 
5.83 (s, 1H), 5.48 (d, J = 6.0 Hz, 1H), 3.62 (s, 1H), 3.60 (s, 3H); 13C --NMR 
(101.0 MHz, CDCl3) δ = 166.3 (s), 141.9 (s), 141.2 (s), 128.1 (d), 127.4 (d), 
126.4 (d), 125.4 (t), 72.4 (d), 51.6 (q); HRMS calcd. for C11H11O3 191.071 
found 191.070.  
 
General method for Baylis-Hillman reactions to 36-42. 
 
A mixture of 100 mmol of aldehyde, 150 mmol of methyl acrylate and 10 
mmol of DABCO in 50 ml of MeOH was stirred at RT until the reaction was 
completed (monitored by TLC). The mixture was diluted with 150 ml of 
Et2O. The organic layer was washed with water (2x 150 ml), brine (150 ml), 
dried on Na2SO4, filtered and concentrated. Products 36-42 were purified 
by column chromatography. (SiO2; heptane:EtOAc 5:1) Products 36-42 
were used as obtained. 
 
2-(Hydroxy-o-tolyl-methyl)-acrylic acid methyl ester 
(36): 4.65 g (22.6 mmol; 23%) of a colorless oil. 1H --NMR 
(400 MHz, CDCl3) δ = 7.73-7.35 (m, 1H), 7.18-7.10 (m, 3H), 
6.27 (s, 1H), 5.76 (s, 1H), 5.57 (s, 1H), 3.71 (s, 3H), 2,85 
(bs, 1H), 2.28 (s, 3H); 13C --NMR (101.0 MHz, CDCl3) δ = 167.1 (s), 141.2 
(s), 138.7 (s), 135.6 (s), 130.4 (d), 127.4 (d), 126.2 (d), 126.2 (t), 126.1 (d), 















2-(Hydroxy-m-tolyl-methyl)-acrylic acid methyl ester 
(37): 3.17 g (15.4 mmol; 31%) of a colorless oil.23 1H --
NMR (400 MHz, CDCl3) δ = 7.21-7.09 (m, 3H), 7.04 (d, J 
= 7.3 Hz, 1H), 6.29 (d, J = 1.1 Hz, 1H), 5.81 (d, J = 1.1 
Hz, 1H), 5.46 (s, 1H), 3.65 (s, 3H), 3.21 (bs, 1H), 2.30 (s, 3H); 13C --NMR 
(101.0 MHz, CDCl3) δ = 166.6 (s), 141.9 (s), 141.1 (s), 137.9 (s), 128.4 (d), 
128.2 (d), 127.2 (d), 125.8 (t), 123.6 (d) , 72.9 (d) , 51.8 (q), 21.3 (q); HRMS 
calcd for C12H14O3 206.094 found 206.095. 
 
2-(Hydroxy-p-tolyl-methyl)-acrylic acid methyl ester 
(38):22 3.64 g (17.7 mmol; 35%) of a colorless oil.23  1H --
NMR (400 MHz, CDCl3) δ = 7.21 (d, J = 7.9 Hz, 2H), 7.10 
(d, J = 7.7 Hz, 2H), 6.28 (d, J = 0.9 Hz, 2H), 5.82 (d, J = 
0.9 Hz, 2H), 5.47 (s, 1H), 3.66 (s, 3H), 3.03 (bs, 1H), 2.29 (s, 3H); 13C --
NMR (101.0 MHz, CDCl3) δ = 166.7 (s), 142.0 (s), 138.3 (s), 137.4 (s), 129.0 
(d), 126.5 (d), 125.7 (t), 72.9 (d), 51.8 (q), 21.0 (q); HRMS calcd for 
C12H14O3 206.094 found 206.094. 
 
2-[(2-Bromo-phenyl)-hydroxy-methyl]-acrylic acid 
methyl ester (39):22 23.6 g (87 mmol; 87%) of a colorless 
oil. 1H --NMR (400 MHz, CDCl3) δ = 7.44-7.40 (m, 2H), 
7.21 (dd, J = 7.7 Hz, 7.0 Hz, 1H), 7.04 (dt, J = 7.7 Hz, 1.5 
Hz, 1H), 6.23 (s, 1H), 5.84 (d, J = 4.4 Hz, 1H), 5.51 (s, 1H), 3.80 (d, J = 4.4 
Hz, 1H), 3.62 (s, 3H); 13C --NMR (101.0 MHz, CDCl3) δ = 166.5 (s), 140.6 
(s), 139.4 (s), 132.4 (d), 129.0 (d), 128.1 (d), 127.3 (d), 126.7 (t), 122.9 (s), 
70.8 (d), 51.8 (q); HRMS calcd for C11H11BrO3 270.979 found 270.981. 
 
2-[(3-Bromo-phenyl)-hydroxy-methyl]-acrylic acid 
methyl ester (40):22 9.62 g (35.5 mmol; 86%) of a 
colorless oil.24 1H --NMR (400 MHz, CDCl3) δ = 7.44 (d, 
J = 1.5, 1H), 7.32 (dd, J = 7.7 Hz, 1.1 Hz, 1H), 7.20 (d, 
J = 8.1 Hz, 1H), 7.12 (dt, J = 7.7 Hz, 1.8 Hz, 1H), 6.27 (s, 1H), 5.80 (s, 1H), 
5.40 (d, J = 4.4 Hz, 1H), 3.63 (s, 3H), 3.50 (bs, 1H); 13C --NMR (101.0 MHz, 
CDCl3) δ = 166.3 (s), 143.6 (s), 141.2 (s), 130.7 (d), 129.8 (d), 129.5 (d), 
126.4 (t), 125.1 (d), 122.3 (s), 72.2 (d), 51.9 (q); HRMS calcd. for 
C11H11BrO3 271.987 found 271.987. 
 
2-[(3-Bromo-phenyl)-hydroxy-methyl]-acrylic acid 
methyl ester (41): 23.1 g (85 mmol; 85%) of a colorless 
oil. 1H-NMR (400 MHz, CDCl3) δ = 7.38 (d, J = 8.4 Hz, 
2H), 7.16 (d, J = 8.4 Hz, 2H), 6.26 (s, 1H), 5.78 (s, 1H), 
5.41 (s, 1H), 3.63 (s, 1H), 3.39 (bs, 1H); 13C-NMR (101.0 MHz, CDCl3) δ = 
166.4 (s), 141.5 (s), 140.3 (s), 131.3 (d), 128.3 (d), 126.1 (t), 121.6 (s), 72.3 
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methyl ester (42):22 19.5 g (86 mmol; 86%) of a 
colorless oil. 1H-NMR (400 MHz, CDCl3) δ = 7.24 (s, 
4H), 6.27 (s, 1H), 5.78 (s, 1H), 5.44 (s, 1H), 3.65 (s, 1H), 
3.21 (bs, 1H); 13C-NMR (101.0 MHz, CDCl3) δ = 166.5 (s), 141.5 (s), 139.7 
(s), 133.4 (s), 128.4 (d), 127.9 (d), 126.2 (t), 72.4 (d), 51.9 (q); HRMS calcd. 
for C11H11ClO3 226.040 found 226.041. 
 
General procedure for the synthesis of 43-50: 
 
A solution of 80 mmol of Baylis-Hillman adduct in 350 ml of CH3CN was 
heated to 60°C. To this mixture was added 215 ml of CH3SO3H. The 
resulting solution was warmed to 110°C and stirred for 6 h. After cooling, 
the mixture was poured into 150 ml of H2O. The solution was neutralized 
with K2CO3(s) (pH paper). The resulting solution was extracted with Et2O 
(2x 400 ml). The combined organic layers were washed with brine, dried 
over Na2SO4, filtered and concentrated. To the remaining yellow solid was 
added 100 ml of Et2O. The pure product precipitated as a white solid and 
was collected (58-65%). 
 
(E)-2-(Acetylamino-methyl)-3-phenyl-acrylic acid 
methyl ester (43):16 1H-NMR (400 MHz, CDCl3) δ = 7.78 (s, 
1H), 7.50 (d, J = 7.3 Hz, 2H), 7.42-7.34 (m, 3H), 6.18 (bs, 
1H), 4.32 (d, J = 5.9 Hz, 2H), 3.83 (s, 3H), 1.96 (s, 3H); 13C-
NMR (101.0 MHz, CDCl3) δ = 169.6 (s), 168.2 (s), 142.4 (d), 
134.0 (s), 129.5 (d), 129.2 (d), 128.6 (d), 127.7 (s), 52.1 (q), 
36.7 (t), 23.2 (q); HRMS calcd. for C13H15NO3 233.105 found 233.106; 
Anal. Calc. for C13H15NO3: C, 66.92 %; H, 6.49 %; N, 6.01 %, found: C, 
66.65 %; H, 6.44 %; N, 5.98 %. 
 
(E)-2-(Acetylamino-methyl)-3-o-tolyl-acrylic acid 
methyl ester (44): 1H-NMR (400 MHz, CDCl3) δ = 7.82 (s, 
1H), 7.29-7.14 (m, 4H), 6.05 (bs, 1H), 4.14 (d, J = 5.5 Hz, 
2H), 3.81 (s, 3H), 2.23 (s, 3H), 1.89 (s, 3H); 13C-NMR 
(101.0 MHz, CDCl3) δ = 169.3 (s), 168.1 (s), 141.9 (d), 
136.7 (s), 133.5 (s), 130.1 (d), 129.1 (d), 128.8 (d), 128.6 
(s), 126.0 (d), 52.2 (q), 36.8 (t), 23.3 (q), 19.9 (q); HRMS calcd. for 
C14H17NO3 247.121 found 247.122. 
 
(E)-2-(Acetylamino-methyl)-3-m-tolyl-acrylic acid 
methyl ester (45): 1H-NMR (400 MHz, CDCl3) δ = 7.71 
(s, 1H), 7.21 (m, 3H), 7.12 (d, J = 5.1 Hz, 1H), 6.01 (bs, 
1H), 4.28 (d, J = 5.5 Hz, 2H), 3.78 (s, 3H), 2.32 (s, 3H), 
1.92 (s, 3H); 13C-NMR (101.0 MHz, CDCl3) δ = 169.5 (s), 

























127.5 (s), 126.6 (d), 52.2 (q), 36.8 (t), 23.3 (q), 21.3 (q); HRMS calcd. for 
C14H17NO3 247.121 found 247.122; 
 
(E)-2-(Acetylamino-methyl)-3-p-tolyl-acrylic acid 
methyl ester (46):16 1H-NMR (400 MHz, CDCl3) δ = 7.74 
(s, 1H), 7.37 (d, J = 8.1 Hz, 2H), 7.19 (d, J = 8.1 Hz, 2H), 
6.27 (bs, 1H), 4.31 (d, J = 5.5 Hz, 2H), 3.80 (s, 3H), 2.33 
(s, 3H), 1.95 (s, 3H); 13C-NMR (101.0 MHz, CDCl3) δ = 
169.7 (s), 168.3 (s), 142.6 (d), 139.6 (s), 131.1 (s), 129.6 (d), 129.3 (d), 
126.6 (s), 52.1 (q), 36.7 (t), 23.1 (q), 21.3 (q); HRMS calcd. for C14H17NO3 
247.121 found 247.121. 
 
(E)-2-(Acetylamino-methyl)-3-(2-bromo-phenyl)-acrylic 
acid methyl ester (47): 1H-NMR (400 MHz, CDCl3) δ = 
7.78 (s, 1H), 7.59 (t, J = 7.7 Hz, 2H), 7.35 (t, J = 7.7 Hz, 
1H), 7.19 (t, J = 7.7 Hz, 1H), 6.22 (bs, 1H), 4.16 (d, J = 5.5 
Hz, 2H), 3.83 (s, 3H), 1.91 (s, 3H); 13C-NMR (101.0 MHz, 
CDCl3) δ = 169.3 (s), 167.6 (s), 141.2 (d), 134.6 (s), 132.5 
(d), 130.6 (d), 130.3 (d), 129.5 (s), 127.5 (d), 123.8 (s), 52.3 (q), 36.7 (t), 
23.2 (q); HRMS calcd. for C13H14BrNO3 313.014 found 313.013; Anal. 
Calc. for C13H14BrNO3: C, 50.16 %; H, 4.54 %; N, 4.50 %, found: C, 50.25 
%; H, 4.52 %; N, 4.45 %. 
 
(E)-2-(Acetylamino-methyl)-3-(3-bromo-phenyl)-
acrylic acid methyl ester (48): 1H-NMR (400 MHz, 
CDCl3) δ = 7.58 (s, 2H); 7.39 (dd, J = 7.3 Hz, 7.0 Hz, 
2H), 7.18 (t, J = 8.1 Hz, 1H), 6.22 (bs, 1H), 4.19 (d, J = 
5.9 Hz, 2H), 3.74 (s, 3H), 1.87 (s, 3H); 13C-NMR (101.0 
MHz, CDCl3) δ = 169.6 (s), 167.8 (s), 140.4 (d), 136.1 
(s), 132.3 (d), 132.0 (d), 130.1 (d), 129.2 (s), 127.9 (d), 122.6 (s), 52.2 (q), 
36.6 (t), 23.1 (q); HRMS calcd. for C13H14BrNO3 313.014 found 313.014; 
Anal. Calc. for C13H14BrNO3: C, 50.16 %; H, 4.54 %; N, 4.50 %, found: C, 
50.30 %; H, 4.53 %; N, 4.48 %. 
 
(E)-2-(Acetylamino-methyl)-3-(4-bromo-phenyl)-
acrylic acid methyl ester (49): 1H-NMR (400 MHz, 
CDCl3) δ = 7.64 (s, 1H), 7.48 (d, J = 8.4, 2H), 7.36 (d, J 
= 8.4 Hz, 2H), 6.30 (bs, 1H), 4.23 (d, J = 5.5 Hz, 2H), 
3.79 (s, 3H), 1.92 (s, 3H); 13C-NMR (101.0 MHz, CDCl3) 
δ = 169.6 (s), 167.8 (s), 140.8 (d), 132.8 (s), 131.7 (d), 
131.0 (d), 128.4 (s), 123.5 (s), 52.1 (q), 36.5 (t), 23.1 (q); HRMS calcd. for 
C13H14BrNO3 313.014 found 313.013; Anal. Calc. for C13H14BrNO3: C, 
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acrylic acid methyl ester (50): 1H-NMR (400 MHz, 
CDCl3) δ = 7.72 (s, 1H), 7.51 (d, J = 8.4 Hz, 2H), 7.39 
(d, J = 8.4 Hz, 2H), 6.12 (bs, 1H), 4.31 (d, J = 5.9 Hz, 
2H), 3.85 (s, 3H), 1.99 (s, 3H); 13C-NMR (101.0 MHz, 
CDCl3) δ = 169.6 (s), 168.0 (s), 140.9 (d), 135.3 (s), 
132.5 (s), 130.9 (d), 128.9 (d), 128.3 (s), 52.2 (q), 36.6 (t), 23.2 (q); HRMS 
calcd. for C13H14ClNO3 267.066 found 267.066; Anal. Calc. for 
C13H14ClNO3: C, 58.41 %; H, 5.28 %; N, 5.24 %, found: C, 58.45 %; H, 5.22 
%; N, 5.21 %. 
 
General procedure for synthesis of 51-58: 
 
25.8 mmol of ester and 250 mmol of LiOH in 160 ml of a 1:1 mixture of 
H2O and MeOH were stirred overnight at RT. The mixture was diluted with 
100 ml of H2O. The aqueous layer was washed with CH2Cl2 and then 
acidified with 2M HCl(aq) until pH = 1. The white precipitate was collected 
and dried in vacuum oven. The products were obtained as white solids in 
>85% yield. 
 
(E)-2-(Acetylamino-methyl)-3-phenyl-acrylic acid (51): 
1H-NMR (400 MHz, CDCl3) δ = 12.68 (bs, 1H), 7.98 (bs, 
1H), 7.72 (s, 1H), 7.48-7.38 (m, 5H), 4.01 (d, J = 4.2 Hz, 
2H), 1.82 (s, 3H); 13C-NMR (101.0 MHz, CDCl3) δ = 169.1 
(s), 168.3 (s), 141.0 (d), 134.5 (s), 129.5 (d), 129.2 (s), 
129.1 (d), 128.6 (d), 36.3 (t), 22.3 (q); HRMS calcd. for 
C12H13NO3 219.090 found 219.089; Anal. Calc. for C12H13NO3: C, 65.74 %; 
H, 5.98 %; N, 6.39 %, found: C, 65.35 %; H, 5.95 %; N, 6.40 %. 
 
(E)-2-(Acetylamino-methyl)-3-o-tolyl-acrylic acid (52): 
1H-NMR (400 MHz, CDCl3) δ = 7.90 (bs, 1H), 7.76 (s, 1H), 
7.29-7.20 (m, 4H), 3.85 (d, J = 4.4 Hz, 2H), 2.23 (s, 3H), 
1.78 (s, 3H); 13C-NMR (101.0 MHz, CDCl3) δ = 168.8 (s), 
168.1 (s), 140.1 (d), 136.6 (s), 134.0 (s), 130.1 (s), 129.9 
(d), 128.7 (d), 128.5 (d), 125.7 (d), 36.4 (t), 22.4 (q), 19.6 
(q); HRMS calcd. for C13H15NO3 233.105 found 233.106;  
 
(E)-2-(Acetylamino-methyl)-3-m-tolyl-acrylic acid 
(53): 1H-NMR (400 MHz, CDCl3) δ = 7.97 (bs, 1H), 7.68 
(s, 1H), 7.33-7.26 (m, 3H), 7.20 (d, J = 6.2 Hz, 1H), 4.01 
(d, J = 4.0 Hz, 2H), 2.30 (s, 3H), 1.83 (s, 3H); 13C-NMR 
(101.0 MHz, CDCl3) δ = 169.0 (s), 168.5 (s), 141.2 (d), 



























(d), 126.6 (d), 36.3 (t), 22.4 (q), 21.0 (q); HRMS calcd. for C13H15NO3 
233.105 found 233.106; Anal. Calc. for C13H15NO3: C, 66.92 %; H, 6.49 %; 
N, 6.01 %, found: C, 67.00 %; H, 6.56 %; N, 5.84 %. 
(E)-2-(Acetylamino-methyl)-3-p-tolyl-acrylic acid (54): 
1H-NMR (400 MHz, CDCl3) δ = 7.96 (bs, 1H), 7.68 (s, 1H), 
7.38 (d, J = 8.1 Hz, 2H), 7.23 (d, J = 8.1 Hz, 2H), 4.01 (d, 
J = 4.4 Hz, 2H), 2.32 (s, 3H), 1.82 (s, 3H); 13C-NMR 
(101.0 MHz, CDCl3) δ = 169.1 (s), 168.5 (s), 141.2 (d), 
138.9 (s), 131.6 (s), 129.6 (d), 129.3 (d), 128.3 (s), 126.0 
(d), 36.4 (t), 22.4 (q), 20.9 (q); HRMS calcd. for C13H15NO3 233.105 found 
233.106; Anal. Calc. for C13H15NO3: C, 66.92 %; H, 6.49 %; N, 6.01 %, 
found: C, 66.75 %; H, 6.49 %; N, 5.84 %. 
 
(E)-2-(Acetylamino-methyl)-3-(2-bromo-phenyl)-acrylic 
acid (55): 1H-NMR (400 MHz, CDCl3) δ = 7.95 (bs, 1H), 
7.70 (d, J = 8.1 Hz, 1H), 7.65 (s, 1H), 7.53 (d, J = 5.9 Hz, 
1H), 7.43 (dd, J = 7.7 Hz, 7.3 Hz, 1H), 7.32 (dd, J = 7.7 Hz, 
7.3 Hz, 1H), 3.87 (d, J = 4.0 Hz, 2H), 1.78 (s, 3H); 13C-NMR 
(101.0 MHz, CDCl3) δ = 169.0 (s), 167.8 (s), 139.4 (d), 
134.7 (s), 132.6 (d), 131.3 (s), 130.7 (d), 130.6 (d), 127.8 (d), 123.6 (s), 36.2 
(t), 22.4 (q); HRMS calcd. for C12H12BrNO3 297.000 found 296.999; Anal. 
Calc. for C12H12BrNO3: C, 48.34 %; H, 4.06 %; N, 4.70 %, found: C, 48.40 
%; H, 4.03 %; N, 4.67 %. 
 
(E)-2-(Acetylamino-methyl)-3-(3-bromo-phenyl)-
acrylic acid (6): 1H-NMR (400 MHz, CDCl3) δ = 7.99 
(bs, 1H), 7.72 (s, 2H); 7,65 (s, 1H), 7.57 (d, J = 8.1 Hz, 
1H), 7.49 (d, J = 7.7 Hz, 1H), 7.38 (t, J = 7.7 Hz, 1H), 
3.97 (d, J = 4.4 Hz, 2H), 1.81 (s, 3H); 13C-NMR (101.0 
MHz, CDCl3) δ = 169.1 (s), 168.1 (s), 139.2 (d), 137.0 
(s), 131.9 (d), 131.6 (d), 130.9 (s), 130.6 (d), 128.4 (d), 121.9 (s), 36.2 (t), 
22.4 (q); HRMS calcd. for C12H12BrNO3 297.000 found 296.998; Anal. 
Calc. for C12H12BrNO3: C, 48.34 %; H, 4.06 %; N, 4.70 %, found: C, 48.35 
%; H, 4.00 %; N, 4.65 %. 
 
(E)-2-(Acetylamino-methyl)-3-(4-bromo-phenyl)-
acrylic acid (57): 1H-NMR (400 MHz, CDCl3) δ = 8.00 
(bs, 1H), 7.64 (s, 1H), 7.61 (d, J = 8.4 Hz, 2H), 7.44 (d, J 
= 8.4 Hz, 2H), 3.97 (d, J = 4.0 Hz, 2H), 1.81 (s, 3H); 13C-
NMR (101.0 MHz, CDCl3) δ = 169.2 (s), 168.2 (s), 139.7 
(d), 133.8 (s), 131.6 (d) (4x), 130.1 (s), 122.5 (s), 36.2 (t), 
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acrylic acid (58): 1H-NMR (400 MHz, DMSO-d6) δ = 
8.00 (bs, 1H), 7.67 (s, 1H), 7.52 (d, J = 8.8 Hz, 2H), 7.48 
(d, J = 8.8 Hz, 2H), 3.98 (d, J = 4.4 Hz, 2H), 1.81 (s, 3H); 
13C-NMR (101.0 MHz, CDCl3) δ = 169.1 (s), 168.2 (s), 
139.6 (d), 133.7 (s), 133.4 (s), 131.3 (d), 131.0 (s), 128.6 (d), 36.2 (t), 22.4 
(q); HRMS calcd. for C12H12ClNO3 253.051 found 253.050; Anal. Calc. for 
C12H12ClNO3: C, 56.82 %; H, 4.77 %; N, 5.52 %, found: C, 56.50 %; H, 4.74 
%; N, 5.50 %. 
 
2-Hydroxymethyl-acrylic acid methyl ester (60):22 A solution 
of 21.4 g (250 mmol) of 35% aqueous formaldehyde, 67.5 ml 
(750 mmol) of methyl acrylate, 28 g (250 mmol) of DABCO in 
500 ml of a 1:1 mixture of dioxane and H2O was stirred for 9 d at RT. The 
mixture was diluted with 150 ml of H2O. The aqueous layer was extracted 
with MtBE (1x 1 l and 1x 200 ml), washed with brine (2x 400 ml), dried 
over Na2SO4, filtered and concentrated. The product was purified by 
distillation under reduced pressure. 7.91 g (68.2 mmol; 27%) of a colorless 
oil was obtained. (46-47°C at 2 mbar).  1H-NMR (400 MHz, CDCl3) δ = 6.23 
(d, J = 1.5 Hz, 1H), 5.84 (d, J = 1.5 Hz, 1H), 3.71 (s, 3H), 3.27 (s, 2H); 13C-
NMR (101.0 MHz, CDCl3) δ = 167.0 (s), 138.7 (s), 126.2 (t), 54.5 (t), 51.6 
(q).  
 
3-Hydroxy-2-methylene-hexanoic acid methyl ester 
(63):22 A mixture of 28 g (389 mmol) of butyraldehyde, 54 
ml (600 mmol) of methylacrylate, 14.4 g (129 mmol) of 
DABCO in 100 ml MeOH was stirred for 11 d at RT. The mixture was 
diluted with 100 ml H2O. The aqueous layer was extracted Et2O (2x 100 
ml). The organic layers were washed with brine, dried over Na2SO4, filtered 
and concentrated. The product was purified by distillation under reduced 
pressure. 28.9 g (183 mmol; 47%) of a colorless oil was obtained. (66-72°C 
at 1 mbar) 1H-NMR (400 MHz, CDCl3) δ = 6.17 (d, J = 2.4 Hz, 1H), 5.76 (d, 
J = 2.4 Hz, 1H), 4.36 (t, J = 6.4 Hz, 1H), 3.72 (s, 3H), 2.81 (bs, 1H), 1.60-
1.49 (m, 2H), 1.47-1.26 (m, 2H), 0.93-0.86 (m, 3H); 13C-NMR (101.0 MHz, 































General procedure for the synthesis of solution phase phosphoramidite 
ligand libraries: 
 
Stock solutions were prepared by dissolving the proper amounts of every 
reagent necessary for the library synthesis in anhydrous toluene (all by 
weight). For the phosphorochloridites a concentration of 0.150 M was 
used, for the amines 0.158 M, and for the triethylamine 0.538 M. Using 
the liquid handling robot in a glovebox 0.333 ml (1.00 eq.) of each of the 
phosphorochloridites was transferred into one of the 3 corresponding 32 
wells of the Whatman PKP filter plate. The triethylamine solution, 0.100 ml 
(1.00 eq.) was added to each of the 96 wells. Next 0.333 ml (1.05 eq.) of 
each of the amines was added to one of the 3 corresponding 32 wells of 
one of the 3 plates. The microplate was placed on an orbital shaker and 
vortexed for 2 h at room temperature. The microplate was then placed onto 
the vacuum manifold and filtration was performed upon application of 
vacuum. The filtrates, i.e. the solutions of different phosphoramidites in 
dry toluene (0.766 ml; 0.065 M) were collected and stored into a 96-well 
polypropylene microplate.  
 
General procedure for the screening of solution phase phosphoramidite 
ligand libraries in rhodium-catalyzed hydrogenation of 4 and 5: 
 
Using the liquid handling robot 0.100 ml (2.0 eq.) of the ligand solutions 
was transferred from the microplate into 96 vials, equipped with stirring 
bars. Then 0.1 ml (1.0 eq.) of a 0.0329 M PPh3 stock solution in DCM,25 
0.25 ml (0.1 eq.) of a 0.0131 M Rh(COD)2BF4 stock solution in DCM and 
2.25 ml of a 0.073 M (50 eq.) substrate stock solution in MeOH was added. 
The mixtures were capped under inert atmosphere and transferred to a 
parallel hydrogenation reactor. The vials were purged with nitrogen and 
then with hydrogen (25 bar) and heated to 40°C. The reaction mixtures 
were left stirring for 16 h. Samples of the mixtures were analyzed by chiral 
HPLC to determine the conversion and the e.e. 
 
General procedure for hydrogenation reactions in Endeavor™26: 
 
In a glass tube, 0.81 mg (2 µmol) of Rh(COD)2BF4, 4 µmol of ligand, 0.2 
µmol of phosphine, 0.2 mmol of the substrate and 4 ml of solvent, was 
added. The small glass tube was placed in a semi-automated autoclave 
with eight reactors (Endeavor™)26 that was purged 4 times with nitrogen 
and once with hydrogen and heated if necessary. Then, the autoclave was 
pressurized with hydrogen. The reaction was stirred for 16 h. A sample of 
the resulting mixture was converted into the corresponding methyl ester by 
2M solution of trimethylsilyl diazomethane in ether until the yellow color 
persisted. This sample was filtered over a silica plug and subjected to 
conversion (1H NMR) and e.e. determination (HPLC). 
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2-(Acetylamino-methyl)-3-phenyl-propionic acid (67): 
1H-NMR (400 MHz, CDCl3) δ = 9.12 (bs, 1H), 7.25-7.07 (m, 
5H), 6.56 (s, 1H), 3.58-3.42 (m, 1H), 3.32-3.22 (m, 1H), 
2.98-2.84 (m, 2H), 2.77-2.67 (m, 1H), 1.85 (s, 3H); 13C-
NMR (101.0 MHz, CDCl3) δ = 177.4 (s), 171.7 (s), 138.0 (s), 
128.8 (d), 128.5 (d), 126.6 (d), 46.5 (d), 40.4 (t), 35.7 (t), 
22.7 (q); HRMS calcd. for C12H15NO3 221.105 found 221.106. 
 
2-(Acetylamino-methyl)-3-o-tolyl-propionic acid (68): 
1H-NMR (400 MHz, CDCl3) δ = (400 MHz, CDCl3) δ = 9.21 
(bs, 1H), 7.15-7.08 (m, 4H), 6.38 (bs, 1H), 3.51-3.38 (m, 
2H), 3.06-3.01 (m, 1H), 2.93-2.88 (m, 1H), 2.77-2.72 (m, 
1H), 2.31 (s, 3H), 1.92 (s, 3H); 13C-NMR (101.0 MHz, 
CDCl3) δ = 178.1 (s), 171.5 (s), 136.3 (s), 136.2 (s), 130.5 (d), 129.4 (d), 
126.8 (d), 126.1 (d), 45.4 (d), 40.7 (t), 33.1 (t), 22.9 (q), 19.4 (q); HRMS 
calcd. for C13H15NO3 235.121 found 235.122.  
 
2-(Acetylamino-methyl)-3-m-tolyl-propionic acid (69): 
1H-NMR (400 MHz, CDCl3) δ = 9.19 (bs, 1H), 7.16 (t, J = 
7.4 Hz, 1H), 7.03-6.97 (m, 3H), 6.33 (bs, 1H), 3.54-3.49 
(m, 1H), 3.36-3.32 (m, 1H), 3.01-2.90 (m, 2H), 2.78-2.73 
(m, 1H), 2.30 (s, 3H), 1.92 (s, 3H); 13C-NMR (101.0 MHz, 
CDCl3) δ = 177.9 (s), 171.4 (s), 138.1 (s), 137.9 (s), 129.6 (d), 128.4 (d), 
127.4 (d), 125.8 (d), 46.6 (d), 40.5 (t), 35.7 (t), 22.9 (q), 21.3 (q); HRMS 
calcd. for C13H15NO3 235.121 found 235.122. 
 
2-(Acetylamino-methyl)-3-p-tolyl-propionic acid (70): 
1H-NMR (400 MHz, CDCl3) δ = 9.12 (bs, 1H), 7.07 (s, 4H), 
6.32 (bs, 1H), 3.53-3.48 (m, 1H), 3.36-3.30 (m, 1H), 3.00-
2.89 (m, 2H), 2.79-2.72 (m, 1H), 2.30 (s, 3H), 1.92 (s, 
3H); 13C-NMR (101.0 MHz, CDCl3) δ = 178.0 (s), 171.4 
(s), 136.2 (s), 134.8 (s), 129.2 (d), 128.7 (d), 46.7 (d), 40.4 




propionic acid (71): 1H-NMR (400 MHz, CDCl3) δ = 
9.22 (bs, 1H), 7.23 (d, J = 8.4 Hz, 2H), 7.12 (d, J = 8.4 
Hz, 2H), 6.43 (bs, 1H), 3.52-3.47 (m, 1H), 3.37-3.30 (m, 
1H), 2.99-2.88 (m, 2H), 2.78-2.74 (m, 1H), 1.93 (s, 3H); 
13C-NMR (101.0 MHz, CDCl3) δ = 177.4 (s), 171.6 (s), 136.5 (s), 132.5 (s), 
130.2 (d), 128.7 (d), 46.6 (d), 40.5 (t), 35.0 (t), 22.9 (q); HRMS calcd. for 
































Table 6.8: E.e. determination of 67-71.a,b 
Retention Timesc 
Entry Product 
Enantiomer 1 Enantiomer 2 Starting material 
1 67 19.5 21.7 33.0 
2 68 26.8 31.5 39.9 
3 69 31.5 35.1 64.1 
4 70 35.4 40.3 75.5 
5 71 52.7 59.3 96.6 
a) Products were analyzed as their corresponding Me-esters b) All products were 
analyzed by the same method: RP-HPLC, AD-RH Chiralpak; acetonitrile / NaH2PO4 
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Table 6.9: Results of first library on 51 (column 1-4) and 43 (column 5-8). 
Amine PCl e.e. (%) Conv. (%) Amine PCl e.e. (%) Conv. (%) 
A1 PCl-1 67 71 A1 PCl-1 1 80 
A2 PCl-1 56 27 A2 PCl-1 44 6 
A3 PCl-1 58 16 A3 PCl-1 1 10 
A4 PCl-1 65 89 A4 PCl-1 2 64 
A5 PCl-1 12 58 A5 PCl-1 14 34 
A6 PCl-1 24 100 A6 PCl-1 38 96 
A7 PCl-1 34 100 A7 PCl-1 15 65 
A8 PCl-1 20 99 A8 PCl-1 18 82 
A9 PCl-1 17 81 A9 PCl-1 9 21 
A10 PCl-1 2 23 A10 PCl-1 6 42 
A11 PCl-1 2 59 A11 PCl-1 1 53 
A12 PCl-1 45 100 A12 PCl-1 6 77 
A1 PCl-2 49 40 A1 PCl-2 1 28 
A2 PCl-2 59 51 A2 PCl-2 16 13 
A3 PCl-2 26 19 A3 PCl-2 14 9 
A4 PCl-2 50 66 A4 PCl-2 2 33 
A5 PCl-2 4 27 A5 PCl-2 28 71 
A6 PCl-2 5 79 A6 PCl-2 55 97 
A7 PCl-2 13 99 A7 PCl-2 34 95 
A8 PCl-2 3 64 A8 PCl-2 43 87 
A9 PCl-2 2 70 A9 PCl-2 21 40 
A10 PCl-2 2 23 A10 PCl-2 16 14 
A11 PCl-2 1 37 A11 PCl-2 15 26 
A12 PCl-2 18 60 A12 PCl-2 21 38 
A1 PCl-3 89 100 A1 PCl-3 89 100 
A2 PCl-3 89 100 A2 PCl-3 89 100 
A3 PCl-3 38 19 A3 PCl-3 38 19 
A4 PCl-3 89 100 A4 PCl-3 89 100 
A5 PCl-3 57 64 A5 PCl-3 57 64 
A6 PCl-3 47 100 A6 PCl-3 47 100 
A7 PCl-3 53 100 A7 PCl-3 53 100 
A8 PCl-3 46 100 A8 PCl-3 46 100 
A9 PCl-3 65 100 A9 PCl-3 65 100 
A10 PCl-3 29 77 A10 PCl-3 29 77 
A11 PCl-3 50 96 A11 PCl-3 50 96 
A12 PCl-3 67 100 A12 PCl-3 67 100 
A1 PCl-4 24 58 A1 PCl-4 24 58 
A2 PCl-4 14 21 A2 PCl-4 14 21 
A3 PCl-4 7 15 A3 PCl-4 7 15 
A4 PCl-4 31 33 A4 PCl-4 31 33 
A5 PCl-4 8 25 A5 PCl-4 8 25 
A6 PCl-4 7 80 A6 PCl-4 7 80 
A7 PCl-4 11 73 A7 PCl-4 11 73 
A8 PCl-4 7 68 A8 PCl-4 7 68 
A9 PCl-4 44 96 A9 PCl-4 44 96 
A10 PCl-4 5 53 A10 PCl-4 5 53 
A11 PCl-4 3 42 A11 PCl-4 3 42 












Table 6.10: Results of second library on 51. 
 
Amine P e.e. (%) Conv. (%) Amine P e.e. (%) Conv. (%) 
A1 P1 -89 100 A14 P1 -74 72 
A1 P2 -76 99 A14 P2 -63 69 
A1 P3 -83 99 A14 P3 -57 47 
A1 P4 -81 99 A14 P4 -6 60 
A1 P5 -76 69 A14 P5 -39 26 
A1 P6 -69 99 A14 P6 15 56 
A18 P1 -84 99 A22 P1 -88 100 
A18 P2 -73 99 A22 P2 -84 97 
A18 P3 -79 76 A22 P3 -86 99 
A18 P4 -64 34 A22 P4 -57 27 
A18 P5 -75 29 A22 P5 -82 40 
A18 P6 -49 34 A22 P6 -68 99 
A2 P1 -89 100 A15 P1 -84 99 
A2 P2 -77 100 A15 P2 -78 97 
A2 P3 -77 100 A15 P3 -71 42 
A2 P4 -72 99 A15 P4 -54 15 
A2 P5 -77 88 A15 P5 -72 16 
A2 P6 -66 98 A15 P6 -63 88 
A19 P1 -74 72 A23 P1 -88 76 
A19 P2 -61 73 A23 P2 -81 60 
A19 P3 -65 30 A23 P3 -77 25 
A19 P4 -29 77 A23 P4 -61 21 
A19 P5 -50 2 A23 P5 -74 31 
A19 P6 8 77 A23 P6 -63 58 
A4 P1 -90 100 A16 P1 -89 100 
A4 P2 -76 100 A16 P2 -84 96 
A4 P3 -84 100 A16 P3 -85 100 
A4 P4 -89 100 A16 P4 -84 100 
A4 P5 -77 75 A16 P5 -79 94 
A4 P6 -68 99 A16 P6 -70 100 
A20 P1 -86 100 A24 P1 -87 99 
A20 P2 -72 100 A24 P2 -83 97 
A20 P3 -80 99 A24 P3 -74 84 
A20 P4 -77 100 A24 P4 -63 85 
A20 P5 -76 57 A24 P5 -67 25 
A20 P6 -63 98 A24 P6 -49 100 
A13 P1 -90 60 A17 P1 -63 16 
A13 P2 -83 68 A17 P2 -54 22 
A13 P3 -78 27 A17 P3 -53 10 
A13 P4 -75 5 A17 P4 -12 36 
A13 P5 -82 6 A17 P5 -60 3 
A13 P6 -75 5 A17 P6 6 19 
A21 P1 -83 99 A25 P1 -57 48 
A21 P2 -76 97 A25 P2 -40 44 
A21 P3 -77 90 A25 P3 -39 29 
A21 P4 -68 97 A25 P4 -9 75 
A21 P5 -72 71 A25 P5 -8 28 
A21 P6 -47 95 A25 P6 11 48 
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In this chapter the synthesis and application of phenol-based 






















7.1   Phenol-based monodentate phosphoramidites 
7.1.1   Introduction 
Chapter two describes the successful synthesis and application of 
catechol-based phosphoramidites. These represent the first examples of 
monodentate ligands based on an achiral diol backbone. To extend this 
research, libraries of phenol-based phosphoramidites were screened in the 
rhodium-catalyzed asymmetric hydrogenation of benchmark substrates. 
Phenol-based phosphoramidites are known in literature,1 but to the best of 
our knowledge chiral equivalents of these ligands have not been 
synthesized so far. It was reported that these ligands could be isolated in 
good yields after purification by column chromatography.1d 
7.1.2   Library setup  
The one-step synthesis of libraries of BINOL-based phosphoramidites or 
phosphites, starts with stock solutions of the corresponding 
phosphorochloridites and chiral amines (see chapter 6). A two step 
strategy was chosen for the synthesis of libraries of phenol-based 
phosphoramidites, starting with stock solutions of PCl3, phenols and chiral 




















Scheme 7.1: Synthesis of phenol-based phosphoramidites suitable for a 
library approach. 
In the first step, PCl3 is reacted with one equivalent of an amine. The 
dichlorophosphino amine subsequently reacts with the corresponding 
phenol to form a phosphoramidite (for information about conversion and 










7.1.3   Results 
In the first run, a library of 20 phenol-based phosphoramidites was 
tested in the rhodium-catalyzed asymmetric hydrogenation of N-acetyl α-
dehydrophenylalanine methyl ester (1) and N-acetyl β2-dehydroalanine 
methyl ester (2) (Scheme 7.2). The results of the screening are depicted in 
Figure 7.1. Four different chiral secondary amines were combined with 
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10 mol% Rh(COD)2BF4, 20 mol% Ligand
10 bar H2, DCM, RT, 2 h
10 mol% Rh(COD)2BF4, 20 mol% Ligand

































                             Substrate 1 
   Conversion        E.e.  
 A1 A2 A3 A4    A1 A2 A3 A4 
P1           P1         
P2           P2         
P3           P3         
P4           P4         
P5           P5         
 
Scale (%) 
          
0-10 10-20 20-30 30-40 40-50 50-60 60-70 70-80 80-90 90-100 
 
                              Substrate 2 
   Conversion        E.e.  
 A1 A2 A3 A4    A1 A2 A3 A4 
P1           P1         
P2           P2         
P3           P3         
P4           P4         
P5           P5         
 
Figure 7.1: Results of the screening of library 1 on substrate 1 and 2. 
   Conversion        E.e. 
 A1 A2 A3 A4    A1 A2 A3 A4 
P1           P1         
P6           P6         
P5           P5         
 
Scale (%) 
          
0-10 10-20 20-30 30-40 40-50 50-60 60-70 70-80 80-90 90-100 










The conversions of substrate 1 show that only catalysts based on 
ligands with amines A2 and A4 gave full conversion, except in the 
combination with catechol P5 (Figure 7.1). The enantioselectivities were in 
all cases low. The only exception was the combination of amine A3 and 
catechol (P5), with which 86% e.e. was obtained. This was a reference 
reaction since this reaction was performed before with full conversion and 
92% e.e. (see chapter 2). 
Also in the hydrogenation of 2, catalysts containing phosphoramidites 
based on amines A2 and A4 gave the highest conversions, although these 
conversions were lower than those obtained with 1 (Figure 7.1). 
Unfortunately, all the obtained enantioselectivities were low. Again the best 
result was obtained with a phosphoramidite based on catechol (P5) and 
amine A3. The conversion and enantioselectivity are in the same range as 
those obtained earlier (see chapter 2). It was decided to continue the 
screening of phenol-based phosphoramidites on substrate 1. A small 
second library was designed based on four amines, two phenols and one 

















10 mol% Rh(COD)2BF4, 20 mol% Ligand






















Remarkably, in this library all ligands based on phenol (P1) gave full 
conversion, whereas in the first library low conversions were obtained for 
ligands based on P1 in combination with A1 and A3. This indicates that 
the formation of the ligands in the first library did not proceed or that the 
formation of the catalyst did not take place. Also catalysts bearing ligands 
based on ethanol (P6) gave good to full conversions. In all cases the 
enantioselectivities were low. The results in this library for the ligands 
based on catechol (P5) should be ignored, since erroneously in the 
preparation of the ligands, two equivalents of catechol were added instead 
of one.  
10 mol% Rh(COD)2BF4, 20 mol% Ligand
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Scheme 7.4: Setup of library 3 for the hydrogenation of 1. 
Although the results were disappointing so far, it was decided to design a 
new library with 96 members (Scheme 7.4). This library was tested again 










and16 different phenols or other alcohols. The results of this library are 
depicted in Figure 7.3. Again catechol (P5) based ligands were used as 
control. 
   Conversion      E.e. 
 A2 A3 A4 A5 A6 A7    A2 A3 A4 A5 A6 A7 
P1               P1             
P2               P2             
P3               P3             
P5               P5             
P6               P6             
P7               P7             
P8               P8             
P9               P9             
P10               P10             
P11               P11             
P12               P12             
P13               P13             
P14               P14             
P15               P15             
P16               P16             
P17               P17             
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Figure 7.3: Results of the screening of library 3 on substrate 1. 
 
As can been seen from Figure 7.3, most ligands gave good to full 
conversions. The only exceptions are ligands based on phenol P9 and 
alcohol P10. A possible explanation for the low conversions obtained with 
ligands based on P9 and P10 might be the steric hindrance of these 
compounds. Other ligands based on ortho substituted phenols, e.g. P2, P8 
and P12, also showed lower conversions in most cases. The increase of 
steric hindrance might be causing difficulties in the formation of the 










In all cases the enantioselectivities were low. The best e.e. obtained was 
with the reference ligand based on P5 and A3. One other hit can be 
observed in  
. The phosphoramidite based on P10 and A7 induced an e.e. of 78%, 
but with only 2% conversion. This low conversion makes the e.e. value 
arguable. No attempts were made to synthesize this ligand independently, 
since 31P-NMR spectroscopy revealed that the formation of the ligand in the 
library did not take place. A typical phosphoramidite absorption in a 31P-
NMR spectrum is in the range of 135 to 150 ppm (see §7.1.4). Remarkable 
then again is the obtained enantioselectivity in the hydrogenation of 1 
since no chiral phosphorus ligand was present. This indicates that the free 
amine compound probably must have act as a ligand. Diamines have been 
used before successfully as ligands in Rh-catalyzed hydrogenations.3 
7.1.4   31P-NMR-analysis of library members 
A number of 6 NMR-samples were taken from the library, in order to 
determine if the formation of the phosphoramidites was successful. The 
samples were analyzed by 31P-NMR and the results are depicted in Table 
7.1. 
Table 7.1: 31P-NMR values of some library members.a,b,c,d 
PCl3 PNCl2 PO2N PO3 ? 
Entry Sample 
ppm % ppm % ppm % ppm % ppm % 
1 P1 / A4         137.9 100         
2 P1 / A5         137.9 100         
3 P1 / A7             128.5 100     
4 P8 / A3         141.1 100         
5 P12 / A3     162.2 42 141.9 58         
6 P15 / A4 224.7 35 150.5 48 142.3 13     67.3 36 
(a) All samples were taken in a glovebox under N2 and diluted with toluene and subsequently 
subjected to 31P-NMR analysis (b) Ppm values are relative to external H3PO4 standard (c) 













The samples in entries 1,2 and 4 show only one absorption in the 31P-
NMR which can be attributed to the corresponding phosphoramidites, 
which have at typical absorption between 135 and 150 ppm. Formation of 
the ligands has been successful in these cases. Remarkably is that even in 
the case where the more sterically hindered phenol P8 was used, complete 
conversion into the phosphoramidite has been observed (entry 4). The 
ligand based on P1 and A7, bearing an amide functionality, gave only one 
absorption in the 31P-NMR at 128.5 ppm, which was attributed to 
triphenylphosphite.5 In this case, the formation of the initial 
dichlorophosphino amine had apparently not taken place. The formation of 
the phosphoramidite based on the sterically demanding P12 was not 
complete (entry 5). Two peaks were observed, i.e. at 162.2 ppm and 141.9 
ppm, attributed to the corresponding dichlorophosphino amine and 
phosphoramidite. These results suggest that the formation of the initial 
dichlorophosphino amine was successful. The second step, the reaction of 
P12 and the corresponding dichlorophosphino amine, did not go to 
completion. A mixture of products was obtained in the formation of a 
phosphoramidite based on benzylalcohol (P15) and A4 (entry 6). Not all the 
absorptions could be assigned in this mixture. We observed that the 
reaction of A4 as well as P15 with PCl3 is slow, since traces of unreacted 
PCl3 (224.7 ppm) were found. 
7.2   Conclusion 
 
The synthesis and screening of libraries of phosphoramidites based on 
phenol have been described in this chapter. The libraries have been 
screened in the rhodium-catalyzed hydrogenation of benchmark substrates 
1 and 2. Although in many cases the conversion of the substrates in the 
hydrogenated products was successful, low enantioselectivities have been 
obtained. This suggests that the presence of a more rigid diol backbone is 
necessary for good enantioselectivities. 
 31P-NMR of representative members of the library revealed that the 
synthesis of these phosphoramidites was successful in most cases. Only 
when A7, bearing an amide functionality, was used as an amine, no 










alcohol P15 the corresponding phosphoramidite is formed, although in 
rather low quantities. This proves that the reversed synthetic approach 
used in this chapter is successful. Although in the rhodium-catalyzed 
hydrogenation the ligands have not been successful so far, it would be 
worthwhile to screen these ligands in other types of reactions. 




For general remarks see chapter 2. Amines A2-A7 were made according to 
literature procedures.6 A1 and P1 - P17 were commercially available. The 
synthesis and screening of the libraries of ligands was done at DSM 
research in Geleen. The author likes to thank Laurent Lefort and Barbara 
Procuranti for their assistance. 
 
General procedure for the synthesis of solution phase phosphoramidite 
ligand libraries: 
 
Stock solutions were prepared by dissolving the proper amounts of every 
reagent necessary for the library synthesis in anhydrous toluene (all by 
weight). For PCl3 a concentration of 0.269 M was used, for the amines 
0.158 M, for the alcohols 0.158 M7 and for the triethylamine 0.269 M 
solutions were employed. Using the liquid handling robot 0.100 ml (1.00 
eq.) of PCl3 solution was dispersed over each of the 96 wells of the 
Whatman PKP filter plate. Then 0.100 ml (1.00 eq.) triethylamine solution 
and 0.170 ml (1.00 eq.) of the corresponding amines, was added to each of 
the 96 wells. The microplate was placed on an orbital shaker and vortexed 
for 2 h at room temperature. Next, 0.200 ml (2.00 eq.) triethylamine 
solution and 0.34 ml (2.00 eq.) of the corresponding alcohols, was added to 
each of the 96 wells. The microplate was placed on an orbital shaker and 
vortexed for 2 h at room temperature. The microplate was then placed onto 
the vacuum manifold and filtration was performed upon application of 
vacuum. The filtrates, i.e. the solutions of different phosphoramidites in 
dry toluene (0.766 ml; 0.030 M) were collected and stored into a 96-well 
















General procedure for the screening of solution phase phosphoramidite 
ligand libraries in rhodium-catalyzed hydrogenation of 4 and 5: 
 
Using the liquid handling robot 0.200 ml (2.0 eq.) of the ligand solutions 
was transferred from the microplate into 96 vials, equipped with stirring 
bars. Then 0.25 ml (0.1 eq.) of a 0.013 M Rh(COD)2BF4 stock solution in 
DCM and 2.00 ml of a 0.015 M (10 eq.) substrate stock solution in DCM8 
was added. The mixtures were capped under inert atmosphere and 
transferred to a parallel hydrogenation reactor. The vials were purged with 
nitrogen and then with hydrogen (10 bar). After purging, the vials were 
pressurized with 10 bar of H2. The reaction mixtures were left stirring for 2 
h. Samples of the mixtures were analyzed by chiral GC to determine the 
conversion and the e.e. (see chapter 2 for details on chromatographic 
separation). 
Table 7.2: Results of library 1 on substrate 1 and 2. 
Conversion substrate 1     E.e. product 3 
 A1 A2 A3 A4    A1 A2 A3 A4 
P1 9 100 21 100   P1 -4 -1 19 -6 
P2 0 100 24 100   P2 0 0 -9 -1 
P3 15 100 4 100   P3 -2 -1 14 -7 
P4 9 100 10 100   P4 -4 -1 34 -15 
P5 6 5 100 31   P5 -7 -2 86 -11 
 
Conversion substrate 2    E.e. product 4 
 A1 A2 A3 A4    A1 A2 A3 A4 
P1 0 31 3 15   P1 0 -1.3 48 0 
P2 0 52 8 57   P2 0 -12 -6 -15 
P3 0 39 10 49   P3 0 22.1 31 25 
P4 0 25 5 44   P4 0 3.43 31 1 
P5 2 0 51 1   P5 -2 0 66 8 
 
Table 7.3: Results of library 2 on substrate 1. 
Conversion substrate 1    E.e. product 3 
 A1 A2 A3 A4    A1 A2 A3 A4 
P1 97 100 97 100   P1 -3 -1 0 -18 
P6 52 100 61 100   P6 -20 0 13 -7 











Table 7.4: Results of library 3 on substrate 1. 
Conversion substrate 1   E.e. product 3 
  A2 A3 A4 A5 A6 A7     A2 A3 A4 A5 A6 A7 
P1 16 100 100 61 54 100   P1 18 -9 -12 -8 -10 -3 
P2 23 96 77 25 61 100   P2 -5 -2 -2 -2 -4 -4 
P3 16 100 100 98 100 100   P3 24 -16 -10 -15 -9 -5 
P5 99 13 11 70 72 18   P5 83 -4 -7 -9 -3 -4 
P6 35 99 98 44 100 68   P6 -3 -7 -14 -12 -12 -3 
P7 13 100 100 86 98 100   P7 21 -10 -13 -11 -8 -4 
P8 35 71 38 41 100 100   P8 -12 -5 -3 -3 -2 -5 
P9 10 3 3 4 3 16   P9 8 -10 0 -11 -9 -7 
P10 0 11 11 17 18 2   P10 20 -2 -2 -2 8 78 
P11 11 92 99 79 94 96   P11 15 -9 -12 -9 -5 -4 
P12 13 24 20 11 23 100   P12 -21 3 -3 1 0 -1 
P13 81 100 100 63 100 96   P13 9 -6 -12 -9 -6 -5 
P14 92 99 100 100 100 100   P14 9 -6 -14 -14 -6 -4 
P15 99 100 100 98 100 100   P15 9 -6 -5 -6 -5 -6 
P16 11 100 100 100 100 100   P16 20 -6 -9 -7 -5 -5 
P17 8 91 91 76 93 96   P17 11 -11 -9 -13 -12 -6 
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New approaches in asymmetric rhodium-catalyzed hydrogenations with 
monodentate phosphoramidites 
 
Molecules are spatial structures of atoms. 
Carbon (C) is one of the most abundant atoms in 
nature. Carbon can have maximum 4 
substituents, which form together with the central 
carbon atom a tetrahedral structure. Two different 
kinds of structures are possible when those 4 
substituents are different. These two structures 
are mirror images and can not be superimposed. 
These molecules are chiral or asymmetric. The two mirror images are also named 
enantiomers. Enantiomers have the same physical properties, i.e. boiling point, 
melting point, molecular weight etc. The only aspect in which they differ is the 
optical activity and the interaction with other chiral molecules, like for example 
enzymes in the human body. The importance of chiral molecules can be illustrated 
by the following example; Ketamine can be used as 
an anesthesia if the correct enantiomer is 
administered. The other enantiomer on the other 
hand has hallucinating properties. This example 
shows that it can be important to use only one 
enantiomer of biological active compounds. 
  One way to obtain enantiomers is via chemical reactions. 
Normally a chemical reaction is not selective and both enantiomers 
will be formed in equal amounts. A possibility to influence a 
reaction, so that only one of the two enantiomers will be formed, is 
by adding a small amount of a chiral catalyst. The catalysts that are described in 
this thesis consist of a metal (rhodium) which is surrounded by two chiral ligands, 
i.e. chiral monodentate phosphoramidites. These monodentate phosphoramidites 
are organic molecules and possess a phosphorus atom which is bound to two 
oxygens and one nitrogen atom. They are called monodentate, because these 
ligands coordinate with only one position to the metal. Monodentate ligands 
change the properties of the metal and cause that the metal stays in solution. The 
use of a chiral catalyst in a chemical reaction does not automatically mean that 
only one enantiomer is formed. The selectivity of the catalyst is expressed in e.e. 

































an equal amount of both enantiomers, whereas 100% corresponds with the 
presence of solely one of the two enantiomers. 
This thesis describes the development of new homogeneous* catalysts, which 
are used to make chiral compounds by asymmetric hydrogenation reactions. 
 
Contents of this thesis 
An introduction into chirality is given in chapter 1, followed by a short 
historical overview of the developments in the field of homogeneous asymmetric 
hydrogenation as well as the current state of the art using monodentate ligands. 
Until a few years ago, mainly bidentate† ligands were used in asymmetric catalysis. 
The structure of monodentate ligands can be modified easily due to the 
straightforward synthesis of monodentate ligands. On the other hand, modification 
of the structure of bidentate ligands is often more difficult. This, in combination 
with the fact that monodentate ligands give equally good results in several 
asymmetric catalysis reactions, made that there has been a rapid increase in the 
development of monodentate ligands in the last six years. The chapter finishes 
with an overview of the application of monodentate ligands in asymmetric catalysis 
in the last two years. The overview has been limited to the use of monodentate 
phosphoramidites due to the extended number of publications in this field. 
Most successful chiral monodentate ligands used in asymmetric hydrogenation 
reactions are based on a chiral backbone. The first examples of the synthesis and 
use of monodentate phosphoramidites possessing an achiral catechol-backbone 
are presented in chapter 2. These catechol-based ligands gave excellent results in 













Scheme 1: Asymmetric hydrogenation with phosphoramidites L1. 
                                                     
* Homogeneous means that the catalyst is soluble in the reaction medium 
† Bidentate means that the ligand is coordinated to the metal with two positions 
  
 






In general organic solvents are used for hydrogenation reactions. On the other 
hand, water is rarely used, because a lot of catalysts are not soluble or stable in 
water. The synthesis and application of the first water-soluble monodentate 



























Scheme 2: Asymmetric hydrogenation with PegPhos (L2) in water. 
Monodentate phosphoramidites are excellent ligands for rhodium-catalyzed 
hydrogenations. On the other hand monodentate diamidophosphites are hardly 
reported as ligands for asymmetric catalysis. Chapter 4 describes the synthesis of 
2,2’-diamino-1,1’-binaphthyl and the attempts to make monodentate 








2,2'-Diamino-1,1'-binaphthyl Diamidophosphite  
Scheme 3: Attempted synthesis of diamidophosphites. 
The asymmetric hydrogenation of unsaturated carboxylic acids, using a mixed 
monodentate ligand approach, is described in chapter 5. In this approach a 
combination of two different monodentate ligands are used instead of two identical 
ligands. A mixture of three catalysts is obtained when employing a combination of 
two different monodentate ligands, i.e. 2 homo-complexes (2 identical ligands 
coordinated to the metal) and 1 hetero-complex (2 different ligands coordinated to 
the metal) (Scheme 4). This will lead to better results if the hetero-complex shows a 











The combination of ligands, described in this chapter, consist of a chiral 
phosphoramidite and an achiral phosphine. Remarkably, the addition of an achiral 
ligand to a chiral phosphoramidite increases the reaction rate as well the 
enantioselectivity of the product. The formation of the hetero-complexes has been 
proven by 31P-NMR spectroscopy. The products obtained are interesting 
intermediates among other things for molecular motors or medicines.  












Scheme 4: The mixed monodentate ligand approach. 
The mixed monodentate ligand approach, using a combination of a chiral 
phosphoramidite and an achiral phosphine, has also been employed in the 
asymmetric hydrogenation of β2-dehydroamino acids (Scheme 5). Ligand 
optimization has been done by an automatic system. Enantioselectivities up to 

















Scheme 5: Asymmetric hydrogenation of β2-dehydroamino acids. 
The synthesis and screening of phenol-based phosphoramidites, using an 
automatic system, are described in chapter 7. In most cases good reactivities were 
obtained, although the enantioselectivities were poor in all cases. The formation of 
the ligands has been studied by 31P-NMR spectroscopy, which showed that in most 
cases the phenol-based phosphoramidites were formed. 
  








Nieuwe ontwikkelingen in asymmetrische rhodium-gekatalyseerde 
hydrogeneringen met monodentaat liganden 
 
Moleculen zijn ruimtelijke structuren 
opgebouwd uit atomen. Koolstof (C) is een van de 
meest voorkomende atomen in de natuur. Koolstof 
kan worden omringd door maximaal vier 
substituenten, die samen met het koolstofatoom 
een tetraedrische structuur vormen. Wanneer deze 
vier substituenten verschillend zijn, zijn er twee 
verschillende structuren mogelijk (zie inzet). Deze 
twee mogelijke structuren zijn spiegelbeelden van elkaar en kunnen niet over 
elkaar gelegd worden. Deze moleculen worden asymmetrisch of chiraal genoemd. 
De twee spiegelbeelden worden ook wel enantiomeren genoemd. Enantiomeren 
hebben dezelfde fysische eigenschappen zoals kookpunt, smeltpunt, molecuul 
gewicht enz. Het enige waarin ze verschillen is de optische activiteit en de 
interactie met andere chirale verbindingen, zoals 
bijvoorbeeld enzymen in het menselijke lichaam. 
Het belang van enantiomeren kan geïllustreerd 
worden met het volgende voorbeeld; Ketamine kan 
gebruikt worden als een narcosemiddel, mits het 
juiste enantiomeer wordt toegediend. Het andere 
enantiomeer werkt echter als een hallucinerend middel (zie inzet). Voor biologisch 
actieve verbindingen, zoals geneesmiddelen, is het dus van belang dat slechts een 
enantiomeer gebruikt wordt.  
Enantiomeren kunnen onder andere verkregen worden door 
chemische reacties. Normaal gesproken is een chemische reactie 
niet selectief en zal er evenveel van beide enantiomeren worden 
gevormd. Een mogelijkheid om een reactie te beïnvloeden, zodat 
maar een van beide enantiomeren wordt gevormd, is door het toevoegen van een 
kleine hoeveelheid chirale katalysator. De katalysatoren die in dit proefschrift 
beschreven zijn bestaan uit een metaal (rhodium) dat omringd wordt door twee 
chirale liganden, dwz chirale monodentaat fosforamidieten. Deze monodentaat 
fosforamidieten zijn organische moleculen die een fosfor atoom bevatten die 
omringd wordt door twee zuurstof atomen en één stikstof atoom. Ze zijn 
monodentaat, omdat ze maar met een positie aan het metaal gecoördineerd zijn. 
Monodentaat liganden veranderen de eigenschappen van het metaal en zorgen 

































een chirale katalysator in een chemische reactie er altijd maar één enantiomeer 
wordt gevormd. De selectiviteit van een katalysator wordt uitgedrukt in e.e. naar 
het Engelse enantiomeric excess (= enantiomere overmaat). 0% komt overeen met 
een gelijke verhouding van beide enantiomeren en 100% met de aanwezigheid van 
uitsluitend één van beide enantiomeren.  
Dit proefschrift gaat over het ontwikkelen van nieuwe homogene* katalysatoren 
die gebruikt worden om chirale, enantiomeer zuivere, verbindingen te maken 
d.m.v. hydrogeneringsreacties. 
Inhoud van dit proefschrift 
In hoofdstuk 1 wordt een inleiding gegeven over chiraliteit, gevolgd door een 
kort historisch overzicht van de ontwikkelingen in het veld van de asymmetrische 
hydrogeneringen en de huidige stand van zaken in de asymmetrische 
hydrogenering met monodentaat liganden. Tot een aantal jaren geleden werden 
voornamelijk bidentaat liganden gebruikt in de asymmetrische katalyse. Doordat 
monodentaat liganden over het algemeen eenvoudig kunnen worden 
gesynthetiseerd, is het relatief eenvoudig in de structuur van deze liganden kleine 
veranderingen aan te brengen. Bidentaat† liganden daarentegen zijn over het 
algemeen moeilijker te  synthetiseren, wat variatie van deze liganden ingewikkelder 
maakt. Dit, gecombineerd met het feit dat monodentaat liganden even goede 
resultaten geven als bidentaat liganden in diverse asymmetrische katalyse 
processen, heeft er voor gezorgd dat er de laatste zes jaar een stroomversnelling 
heeft plaats gevonden in de ontwikkeling van monodentaat liganden. Het 
hoofdstuk eindigt met een overzicht van de laatste twee jaren op het gebied van 
asymmetrische katalyse met monodentaat liganden. Vanwege de grote aantal 
publicaties wordt dit overzicht beperkt tot het gebruik van monodentaat 
fosforamidieten in de asymmetrische katalyse. 
De meeste succesvolle chirale monodentaat liganden die gebruikt worden in de 
asymmetrische hydrogenering zijn gebaseerd op een chirale backbone. In 
hoofdstuk 2 worden de eerste voorbeelden gegeven van monodentaat 
fosforamidieten die gebaseerd zijn op een achirale backbone. Deze catechol-
gebaseerde liganden geven uitstekende resultaten in de asymmetrische 
hydrogenering van een tal van substraten. Een voorbeeld is gegeven in Schema 1. 
                                                     
* Homogeen wil zeggen dat de katalysator oplosbaar is in het reactiemedium  
† Bidentaat betekent dat deze liganden met twee posities aan het metaal gecoördineerd zijn. 
  















Schema 1: Asymmetrische hydrogenering met fosforamidiet L1. 
Voor hydrogeneringen worden meestal organische oplosmiddelen gebruikt. 
Water wordt zelden gebruikt, omdat veel katalysatoren niet oplosbaar of stabiel 
zijn in water. In hoofdstuk 3 wordt de synthese en het gebruik van het eerste 

























Schema 2: Asymmetrische hydrogenering met PegPhos (L2) in water. 
Monodentaat fosforamidieten zijn uitstekende liganden voor o.a. rhodium-
gekatalyseerde hydrogeneringen. Monodentaat diamidofosfieten daarentegen 
worden zelden beschreven als liganden voor asymmetrische katalyse. In hoofdstuk 
4 wordt de synthese van 2,2’-diamino-1,1’-binaftyl beschreven en de poging om 








2,2'-Diamino-1,1'-binaftyl Diamidofosfiet  
Schema 3: Poging tot synthese van diamidofosfieten. 
In hoofdstuk 5 wordt de asymmetrische hydrogenering van onverzadigde 










combinatie methode, waarbij twee verschillende monodentaat liganden i.p.v. twee 
identieke liganden gebruikt wordt. Hierbij ontstaat een mengsel van drie 
katalysatoren, d.w.z. 2 homocomplexen (2 identieke liganden gecomplexeerd aan 
het metaal) en 1 heterocomplex (2 verschillende liganden gecomplexeerd aan het 
metaal) (Schema 4). Wanneer het heterocomplex sneller en selectiever is dan de 
homocomplexen leidt dit tot betere resultaten.  
De in dit hoofdstuk beschreven combinatie van liganden bestaat uit een chiraal 
fosforamidiet en een achiraal fosfine. Het is opmerkelijk dat het toevoegen van een 
achiraal ligand zowel de reactiesnelheid als de enantioselectiviteit van de reactie 
toeneemt. De formatie van de heterocomplexen is aangetoond met 31P-NMR 
spectroscopie. De verkregen producten zijn interessante tussenproducten voor o.a. 
moleculaire motoren en geneesmiddelen.  












Schema 4: De monodentaat ligand combinatie methode. 
De monodentaat ligand combinatie methode, gebruik makend van een 
combinatie van een chiraal fosforamidiet en een achiraal fosfine, is tevens 
toegepast in de hydrogenering van β2-dehydroamino zuren. Ligand optimalisatie is 
uitgevoerd door het parallel screenen van verschillende liganden m.b.v. een 
geautomatiseerd systeem. Enantioselectiviteiten tot 92% zijn bereikt (Schema 5). 















Schema 5: Asymmetrische hydrogenering van β2-dehydroamino zuren. 
In hoofdstuk 7 wordt de synthese en screening van phenol-gebaseerde 
fosforamidieten beschreven. De synthese en screening zijn gedaan m.b.v. een 
geautomatiseerd systeem. In de meeste gevallen werden goede reactiviteiten 
gevonden. De enantioselectiviteiten waren echter in alle gevallen laag. De formatie 
van liganden werd bestudeerd met behulp van 31P-NMR spectroscopie, waarbij 
geobserveerd werd dat de meeste phenol-gebaseerde liganden gevormd werden. 
  
 








Neue Methoden zur asymmetrischen Rhodium-katalysierten Hydrierung 
unter Verwendung von monodentaten Phosphoramiditen 
 
Moleküle sind räumliche Strukturen von 
Atomen. Kohlenstoff (C) ist eines der am 
häufigsten in der Natur vorkommenden Atome. 
Kohlenstoff ist vierbinding, d.h. er hat bis zu vier 
Substituenten, die gemeinsam mit dem zentralen 
Kohlenstoffatom einen Tetraeder bilden. Falls 
diese vier Substituenten unterschiedlich sind, sind 
zwei verschiedene Strukturen möglich. Diese 
beiden Strukturen sind Spiegelbilder und können nicht ineinander überführt 
werden. Man bezeichnet solche Moleküle als chiral oder asymmetrisch. Die beiden 
Spiegelbilder werden auch Enantiomere genannt. Enantiomere haben die selben 
physikalischen Eigenschaften, d.h. Siedepunkt, Schmelzpunkt, Molekulargewicht 
usw.. Die einzigen Unterschiede sind die optische Aktivität und die 
Wechselwirkung mit anderen chiralen Molekülen, 
wie den Enzymen im menschlichen Körper. Die 
Bedeutung von chiralen Molekülen kann durch 
folgendes Beispiel verdeutlicht werden: Ein 
Enantiomer des Ketamins kann als Anestetikum 
verwendet werden. Das andere Enatiomer hingegen 
hat halluzinogene Eigenschaften. Dieses Beispiel zeigt, wie wichtig es ist, daß nur 
ein Enantiomer von biologisch aktiven Substanzen verwendet wird. 
  Eine Möglichkeit nur ein Enantiomer zu erhalten, bieten 
chemische Reaktionen. Normalerweise sind chemische Reaktionen 
nicht selektiv und beide Enantiomere werden in gleicher Menge 
gebildet. Man kann die Reaktion aber durch Zugabe eines chiralen 
Katalysators so beeinflussen, daß nur eines der beiden Enantiomere entsteht. Die 
Katalysatoren, die in dieser Arbeit beschrieben werden, bestehen aus einem 
Metallzentrum (Rhodium), welches durch zwei chirale Liganden (z.B. chirale 
monodentate Phosphoramidite) umgeben ist. Diese monodentaten 
Phosphoramidite sind organische Verbindungen und beinhalten ein 
Phosphoratom, das an zwei Sauerstoffatome und ein Stickstoffatom gebunden ist. 
Sie werden als Monodentate bezeichnet, da diese Liganden nur mit einer Position 
an das zentrale Metallatom koordinieren. Monodentate Liganden verändern die 
































Verwendung eines chiralen Katalysators in einer chemischen Reaktion bedeutet 
aber nicht automatisch, daß nur ein Enantiomer gebildet wird. Die Selektivität des 
Katalysators kann als e.e. (Enantiomerenüberschuß) des gebildeten chiralen 
Produktes ausgedrückt werden. Ein e.e. von 0% bedeutet, daß beide Enantiomere 
in gleicher Menge vorliegen, wohingegen ein e.e. von 100% besagt, daß nur ein 
Enantiomer vorliegt. 
Diese Arbeit beschreibt die Entwicklung von neuen homogenen* Katalysatoren 
zur Herstellung chiraler Verbindungen durch asymmetrische Hydrierung. 
Inhalt der Arbeit 
Im ersten Kapitel wird eine Einführung in die Thematik der Chiralität gegeben, 
gefolgt von einem kurzen geschichtlichen Überblick über die Entwicklung der 
homogenen asymmetrischen Hydrierung und einem Überblick über die 
Verwendung von monodentaten Liganden. Bis vor wenigen Jahren wurden 
hauptsächlich bidentaten Liganden† in der asymmetrischen Katalyse eingesetzt. 
Variationen in der Struktur der monodentaten Liganden sind durch ihre gradlinige 
Synthese einfach zu realisieren. Variationen in der Struktur von bidentaten 
Liganden hingegen sind oft schwer zugänglich. Dies, in Kombination mit der 
Tatsache, daß monodentate Liganden gleich gute Ergebnisse in vielen 
asymmetrisch katalysierten Reaktionen erzielen, hat zur Entwicklung vieler 
Monodentatliganden in den letzten sechs Jahren geführt. Das Kapitel endet mit 
einem Überblick über die Verwendung von monodentaten Liganden in der 
asymmetrischen Katalyse in den letzten beiden Jahren. Aufgrund der großen 
Anzahl von Publikationen auf diesem Gebiet wurde die Übersicht auf die 












Schema 1: Asymmetrische Hydrierung mit Phosphoramidit L1. 
Die am erfolgreichsten bei der asymmetrischen Hydrierung eingesetzten 
monodentaten Liganden basieren auf einem chiralen Rückgrat. Die ersten 
                                                     
* Homogen bedeutet, daß der Katalysator im Reaktionsmedium löslich ist. 
† Bidentat bedeutet, daß der Ligand mit zwei Positionen an das Metall koordiniert. 
  
 






Beispiele zur Synthese und Verwendung von monodentaten Phosphoramiditen mit 
einem achiralen Catecholrückgrat werden in Kapitel 2 behandelt. Diese 
catecholbasierten Liganden erzielten exzellente Ergebnisse bei der asymmetrischen 
Hydrierung einer großen Anzahl von Substraten. Ein Beispiel wird in Schema 1 
gegeben. 
Im Allgemeinen werden organische Lösungsmittel für Hydrierungsreaktionen 
verwendet. Wasser wird selten verwendet, da viele Katalysatoren in Wasser nicht 
löslich oder nicht stabil sind. Die Synthese und Anwendung des ersten 
wasserlöslichen monodentaten Phosphoramidits, PegPhos (L2), wird in Kapitel 3 

























Schema 2: Asymmetrische Hydrierung mit PegPhos (L2) in Wasser. 
Monodentate Phosphoramidite sind exzellente Liganden für die Rhodium-
katalysierte Hydrierung. Allerdings werden die monodentaten Phosphoramidite 
bislang kaum in der asymmetrischen Katalyse verwendet. Kapitel 4 beschreibt die 
Synthese von 2,2’-Diamino-1,1’-binaphthyl und die Versuche daraus ein 








2,2'-Diamino-1,1'-binaphthyl Diamidophosphit  
Schema 3: Versuchte Synthese eines Diamidophosphits. 
Die asymmetrische Hydrierung von ungesättigten Carbonsäuren unter 
Verwendung von monodentaten Ligandmischungen wird in Kapitel 5 beschrieben. 
Hierbei wird eine Kombination von zwei verschiedenen monodentaten Liganden 










erhält man eine Mischung von drei Katalysatoren, d.h. zwei Homo-Komplexe (zwei 
identische Liganden koordinieren an das Metall) und ein Hetero-Komplex (zwei 
verschiedene Liganden koordinieren an das Metall) (Schema 4). Dies führt zu 
besseren Ergebnissen, wenn der Hetero-Komplex eine höhere Aktivität und eine 
höhere Selektivität zeigt als der vergleichbare Homo-Komplex. 
Die in diesem Kapitel beschriebene Ligandenkombination besteht aus einem 
chiralen Phosphoramidit und einem achiralen Phosphin. Bemerkenswert ist, daß 
die Zugabe eines achiralen Liganden die Reaktivität wie auch die 
Enantioselektivität erhöht. Die Bildung des Hetero-Komplexes konnte durch 31P-
NMR bewiesen werden. Die in diesen Reaktionen erhaltenen Produkte sind 
interessante Intermediate z.B. für die Synthese von Naturstoffen oder 
Medikamenten.  












Schema 4: Verwendung von Ligandmischungen. 
Die Verwendung von Ligandmischungen aus chiralen Phosphoramiditen und 
achiralen Phosphinen wurde auch bei der asymmetrischen Hydrierung von β2-
Dehydroaminosäuren (siehe Schema 5) getestet. Die Ligandoptimierung wurde 
automatisch durchgeführt. Enantioselektivitäten von bis 92% konnten dabei erzielt 

















Schema 5: Asymmetrische Hydrierung von β2-Dehydroaminosäuren. 
Die Synthese und das Screening von Phenol-basierten Phosphoramiditen, ebenfalls 
unter Verwendung eines automatischen Systems, wird in Kapitel 7 beschrieben. In 
den meisten Fällen können gute Reaktivitäten beobachtet werden. Die 
Enantioselektivitäten hingegen sind gering. Die Bildung der Liganden wird mittels 
31P-NMR-Spektroskopie beobachtet, die zeigt, daß in den meisten Fällen Phenol-









NUEVOS CATALIZADORES DE RODIO QUE POSEEN LIGANDOS 
FOSFORAMIDITOS MONODENTADOS PARA LA OBTENCIÓN DE 
COMPUESTOS QUIRALES VIA HIDROGENACIONES ASIMÉTRICAS 
 
Las moléculas son estructuras espaciales de los 
átomos. El carbono es uno de los átomos más 
abundantes de la naturaleza. El carbono puede 
tener como máximo cuatro sustituyentes, los 
cuales junto con el carbono central forman una 
estructura tetraédrica. Cuando estos cuatro 
sustituyentes son diferentes, es posible formar dos 
estructuras distintas que son imágenes 
especulares y que por lo tanto no se pueden superponer. De modo que cada una 
de estas estructuras se consideran asimétricas o quirales. Las dos estructuras que 
son imágenes especulares se denominan enantiómeros. Los enantiómeros tienen 
las mismas propiedades físicas, como por ejemplo, el punto de ebullición, el punto 
de fusión, el peso molecular, etc. Sin embargo, se diferencian en la actividad óptica 
o en su interacción con otras moléculas quirales, como por ejemplo los enzimas en  
el cuerpo humano. La importancia de las moléculas quirales se ve reflejada en el 
siguiente ejemplo; la Ketamina se puede usar como anestésico si se administra el 
enantiómero correcto, sin embargo la 
administración del otro enantiómero tiene 
propiedades alucinógenas.  Este ejemplo nos 
muestra lo importante que puede ser el poder usar 
uno solo de los enantiómeros del compuesto 
biológicamente activo.  
Una manera de obtener enantiómeros es vía reacciones químicas. 
Normalmente las reacciones químicas no son selectivas, lo que 
supone que se obtendrán los dos enantiómeros en cantidades 
equimolares. Una manera de favorecer que en una reacción química 
se forme uno de los enantiómeros es añadiendo una pequeña cantidad de un 
catalizador quiral. Los catalizadores descritos en esta tesis consisten en un metal 
(Rodio) que está rodeado por ligandos quirales, en concreto fosforamiditos quirales 
monodentados. Los fosforamiditos monodentados son moléculas orgánicas que 
poseen un átomo de fósforo unido a dos átomos de oxígeno y a un átomo de 
nitrógeno.  La denominación de monodentados es debido a que estos ligandos sólo 
se coordinan al metal a través de una posición. Los ligandos monodentados se 
unen al metal cambiando así sus propiedades, como por ejemplo, haciendo que el 
metal sea estable en disolución. El uso de un catalizador quiral en una reacción 
química no implica que automáticamente se forme un solo enantiómero. La 
selectividad de un catalizador viene expresada en e.e. (exceso enantiomérico) del 

































los dos enantiómeros, mientras que un e.e. del 100% corresponde a la presencia 
exclusiva de uno de los dos enantiómeros. Esta tesis describe el desarrollo de 
nuevos catalizadores homogéneos* para su uso en la obtención de compuestos 
quirales a través de hidrogenaciones asimétricas.  
CONTENIDOS DE LA TESIS 
En el capítulo 1 se presenta una introducción sobre quiralidad, seguida de una 
pequeña descripción histórica de los conocimientos en el campo de las 
hidrogenaciones asimétricas homogéneas, así como de la importancia del uso de 
ligandos monodentados. Hasta hace unos años, en catálisis asimétrica se usaban 
principalmente ligandos bidentados.† Las ventajas que supone el usar ligandos 
monodentados frente al uso de ligandos bidentados se basa principalmente en que 
los ligandos monodentados se pueden modificar fácilmente ya que su síntesis es 
muy directa. En cambio, las modificaciones en la estructura de los ligandos 
bidentados son en general más difíciles. Además de esta ventaja, se ha observado 
que los ligandos monodentados dan buenos resultados en muchas reacciones de 
catálisis asimétrica, de ahí que el desarrollo de nuevos ligandos monodentados 
haya aumentado en los últimos seis años. El capítulo termina con una descripción 
de las aplicaciones de los ligandos monodentados en catálisis asimétrica en los 
últimos dos años. Debido a la enorme cantidad de publicaciones que existen en 












Esquema 1: Hidrogenación asimétrica con fosforamiditos L1. 
Los ligandos monodentados con los que se han obtenido mejores resultados en 
las hidrogenaciones asimétricas son aquellos que poseen un esqueleto quiral. Los 
primeros ejemplos de la síntesis y el uso de fosforamiditos monodentados, 
presentados en el capítulo 2,  poseen un esqueleto catecol aquiral. Estos ligandos 
derivados del catecol han dado muy buenos resultados en las hidrogenaciones 
asimétricas de un gran numero de sustratos, como en el ejemplo que se presenta 
en el Esquema 1. 
                                                 
* Homogéneo significa que el catalizador es soluble en el medio de reacción.  







En general, las reacciones de hidrogenación se llevan a cabo en disolventes 
orgánicos ya que la mayoría de los catalizadores que se utilizan no son estables o 
no son solubles en disoluciones acuosas. Sin embargo en el capítulo 3 se describe 
la síntesis y aplicaciones de los primeros fosforamiditos monodentados solubles en 



























Esquema 2: Hidrogenación asimétrica con PegPhos (L2) en agua. 
Los fosforamiditos monodentados son unos ligandos excelentes para las 
hidrogenaciones catalizadas por Rodio. Sin embargo, los diamidofosfitos 
monodentados apenas se han utilizado como ligandos en catálisis asimétrica. Por 
lo tanto, en el capítulo 4 se describe la síntesis del 2,2’-diamino-1,1’-binaftilo y su 








2,2'-diamino-1,1'-binaftilo Diamidofosfito  
Esquema 3: Ruta sintética para la síntesis de diamidofosfitos. 
En el capítulo 5 se describe la hidrogenación asimétrica de ácidos carboxílicos 
insaturados, usando la estrategia de los ligandos monodentados combinados. En 
esta estrategia se utilizan dos ligandos monodentados diferentes en lugar de dos 
idénticos. Cuando utilizamos la combinación de dos ligandos monodentados 
diferentes entonces obtenemos una mezcla de tres catalizadores, dos homo-
complejos (2 ligandos idénticos unidos al metal) y un hetero-complejo (2 ligandos 
diferentes unidos al metal) (Esquema 4). Este método nos proporcionará mejores 
resultados en las reacciones catalíticas siempre y cuando el hetero-complejo 











La combinación de ligandos, tratada en este capítulo, consiste en un 
fosforamidito quiral y una fosfina aquiral. Sorprendentemente, la adición de un 
ligando aquiral al fosforamidito quiral aumenta la conversión así como la 
enantioselectividad del producto. La formación de los hetero-complejos ha sido 
confirmada por espectroscopia 31P-NMR. Los productos obtenidos tienen 
interesantes aplicaciones, por ejemplo, en la generación de motores moleculares o 
en el campo de la medicina, entre otros. 












Esquema 4: Estrategia para la obtención de ligandos monodentados combinados. 
Además, estos ligandos monodentados combinados han sido utilizados en las 
hidrogenaciones asimétricas de β2-aminoácidos (Esquema 5). La optimización y 
selección de los ligandos más satisfactorios para estas hidrogenaciones se ha 
llevado a cabo en un equipo automatizado, en el que se han observado 


















Esquema 5: Hidrogenación asimétrica de β2-aminoácidos. 
En el capítulo 7 se describe la síntesis y análisis, incluyendo la selección, de 
ligandos fosforamiditos basados en grupos fenol, usando un equipo automatizado. 
La formación de estos ligandos ha sido confirmada por análisis espectroscópico de 
31P-NMR. En la mayoría de los casos la reactividad obtenida es buena incluso 
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